JP2005508336A - キナーゼ阻害物質としての３−（アリールアミノ）メチレン−１，３−ジヒドロ−２ｈ−インドール−２−オン類 - Google Patents
キナーゼ阻害物質としての３−（アリールアミノ）メチレン−１，３−ジヒドロ−２ｈ−インドール−２−オン類 Download PDFInfo
- Publication number
- JP2005508336A JP2005508336A JP2003530690A JP2003530690A JP2005508336A JP 2005508336 A JP2005508336 A JP 2005508336A JP 2003530690 A JP2003530690 A JP 2003530690A JP 2003530690 A JP2003530690 A JP 2003530690A JP 2005508336 A JP2005508336 A JP 2005508336A
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- indol
- methylene
- phenylamino
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IGXUUWYVUGBMFT-UHFFFAOYSA-N 3-methyleneoxindole Chemical class C1=CC=C2C(=C)C(=O)NC2=C1 IGXUUWYVUGBMFT-UHFFFAOYSA-N 0.000 title 1
- 125000001769 aryl amino group Chemical group 0.000 title 1
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims abstract description 22
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims abstract description 22
- 230000011664 signaling Effects 0.000 claims abstract description 15
- -1 3-fluoropyrrolidinyl Chemical group 0.000 claims description 594
- 150000001875 compounds Chemical class 0.000 claims description 203
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 57
- 238000000034 method Methods 0.000 claims description 45
- 125000000217 alkyl group Chemical group 0.000 claims description 37
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 32
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 32
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 25
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 23
- 229910052736 halogen Inorganic materials 0.000 claims description 22
- 150000002367 halogens Chemical class 0.000 claims description 21
- 125000002757 morpholinyl group Chemical group 0.000 claims description 21
- 208000035475 disorder Diseases 0.000 claims description 19
- 229910052739 hydrogen Inorganic materials 0.000 claims description 18
- 125000003118 aryl group Chemical group 0.000 claims description 17
- 229910052799 carbon Inorganic materials 0.000 claims description 17
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 125000004193 piperazinyl group Chemical group 0.000 claims description 17
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 16
- 201000010099 disease Diseases 0.000 claims description 13
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 12
- 125000003282 alkyl amino group Chemical group 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 230000002062 proliferating effect Effects 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 206010028980 Neoplasm Diseases 0.000 claims description 9
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 206010016654 Fibrosis Diseases 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 8
- 201000011510 cancer Diseases 0.000 claims description 8
- 125000001153 fluoro group Chemical group F* 0.000 claims description 8
- 208000030159 metabolic disease Diseases 0.000 claims description 8
- 150000003568 thioethers Chemical class 0.000 claims description 8
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 7
- 150000002431 hydrogen Chemical class 0.000 claims description 7
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 7
- 230000002792 vascular Effects 0.000 claims description 7
- ZCCPVTVGEQLONB-UHFFFAOYSA-N 1-(1,3-dioxolan-2-yl)-n-methylmethanamine Chemical compound CNCC1OCCO1 ZCCPVTVGEQLONB-UHFFFAOYSA-N 0.000 claims description 6
- QAFODUGVXFNLBE-UHFFFAOYSA-N 1-methoxybutan-2-amine Chemical compound CCC(N)COC QAFODUGVXFNLBE-UHFFFAOYSA-N 0.000 claims description 6
- ZUUQKDDUUOFCNP-UHFFFAOYSA-N 2-(1,3-dioxolan-2-yl)-n-methylethanamine Chemical compound CNCCC1OCCO1 ZUUQKDDUUOFCNP-UHFFFAOYSA-N 0.000 claims description 6
- 125000004364 3-pyrrolinyl group Chemical group [H]C1=C([H])C([H])([H])N(*)C1([H])[H] 0.000 claims description 6
- 206010012689 Diabetic retinopathy Diseases 0.000 claims description 6
- 201000004681 Psoriasis Diseases 0.000 claims description 6
- 150000001408 amides Chemical class 0.000 claims description 6
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 claims description 6
- 230000004761 fibrosis Effects 0.000 claims description 6
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims description 6
- RZVWBASHHLFBJF-UHFFFAOYSA-N methyl piperidine-4-carboxylate Chemical compound COC(=O)C1CCNCC1 RZVWBASHHLFBJF-UHFFFAOYSA-N 0.000 claims description 6
- AHVQYHFYQWKUKB-UHFFFAOYSA-N oxan-4-amine Chemical compound NC1CCOCC1 AHVQYHFYQWKUKB-UHFFFAOYSA-N 0.000 claims description 6
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims description 6
- 201000001320 Atherosclerosis Diseases 0.000 claims description 5
- 206010003246 arthritis Diseases 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 208000002780 macular degeneration Diseases 0.000 claims description 5
- KDHWOCLBMVSZPG-UHFFFAOYSA-N 3-imidazol-1-ylpropan-1-amine Chemical compound NCCCN1C=CN=C1 KDHWOCLBMVSZPG-UHFFFAOYSA-N 0.000 claims description 4
- 206010064930 age-related macular degeneration Diseases 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- IPBPLHNLRKRLPJ-UHFFFAOYSA-N oxan-4-ylmethanamine Chemical compound NCC1CCOCC1 IPBPLHNLRKRLPJ-UHFFFAOYSA-N 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 206010038933 Retinopathy of prematurity Diseases 0.000 claims description 3
- 206010052779 Transplant rejections Diseases 0.000 claims description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 206010012601 diabetes mellitus Diseases 0.000 claims description 3
- 208000037803 restenosis Diseases 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000005647 linker group Chemical group 0.000 claims 10
- 125000003386 piperidinyl group Chemical group 0.000 claims 7
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims 4
- 210000003584 mesangial cell Anatomy 0.000 claims 4
- 125000006309 butyl amino group Chemical group 0.000 claims 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 3
- 206010063209 Chronic allograft nephropathy Diseases 0.000 claims 2
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims 2
- 206010018364 Glomerulonephritis Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 208000034841 Thrombotic Microangiopathies Diseases 0.000 claims 2
- 208000031737 Tissue Adhesions Diseases 0.000 claims 2
- 230000007882 cirrhosis Effects 0.000 claims 2
- 208000019425 cirrhosis of liver Diseases 0.000 claims 2
- 208000033679 diabetic kidney disease Diseases 0.000 claims 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims 2
- 208000016097 disease of metabolism Diseases 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 230000003211 malignant effect Effects 0.000 claims 2
- 201000009925 nephrosclerosis Diseases 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 230000029663 wound healing Effects 0.000 claims 2
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 abstract description 6
- 230000010261 cell growth Effects 0.000 abstract description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 133
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 101
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 90
- 239000007787 solid Substances 0.000 description 87
- 239000011541 reaction mixture Substances 0.000 description 83
- 239000000243 solution Substances 0.000 description 54
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 48
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 45
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 42
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 41
- 238000006243 chemical reaction Methods 0.000 description 40
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 37
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical compound C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 37
- 230000002829 reductive effect Effects 0.000 description 37
- 239000003921 oil Substances 0.000 description 32
- 239000012074 organic phase Substances 0.000 description 29
- 239000002904 solvent Substances 0.000 description 27
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 26
- 238000010992 reflux Methods 0.000 description 25
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 22
- 102000005962 receptors Human genes 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 20
- 108020003175 receptors Proteins 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 18
- 239000000725 suspension Substances 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 13
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 13
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 13
- 229920006395 saturated elastomer Polymers 0.000 description 13
- 239000000758 substrate Substances 0.000 description 13
- JVUCUNQXFYLSJI-UHFFFAOYSA-N 2-hydroxy-1H-indole-3-carbaldehyde Chemical compound C1=CC=C2C(C=O)=C(O)NC2=C1 JVUCUNQXFYLSJI-UHFFFAOYSA-N 0.000 description 12
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- 229910052796 boron Inorganic materials 0.000 description 12
- 238000010898 silica gel chromatography Methods 0.000 description 12
- 239000007868 Raney catalyst Substances 0.000 description 11
- 229910000564 Raney nickel Inorganic materials 0.000 description 11
- 125000001424 substituent group Chemical group 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 10
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 102000037979 non-receptor tyrosine kinases Human genes 0.000 description 10
- 108091008046 non-receptor tyrosine kinases Proteins 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 239000003446 ligand Substances 0.000 description 9
- QHJCASNXAPQWFF-UHFFFAOYSA-N 6-fluoro-3-(hydroxymethylidene)-1h-indol-2-one Chemical compound FC1=CC=C2C(=CO)C(=O)NC2=C1 QHJCASNXAPQWFF-UHFFFAOYSA-N 0.000 description 8
- 239000012043 crude product Substances 0.000 description 8
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
- 239000003480 eluent Substances 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 8
- 230000026731 phosphorylation Effects 0.000 description 8
- 238000006366 phosphorylation reaction Methods 0.000 description 8
- 230000019491 signal transduction Effects 0.000 description 8
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 7
- UALFVGAUFYTZSV-UHFFFAOYSA-N 3-(hydroxymethylidene)-4-methyl-1h-indol-2-one Chemical compound CC1=CC=CC2=C1C(=CO)C(=O)N2 UALFVGAUFYTZSV-UHFFFAOYSA-N 0.000 description 7
- SHBOEOYGYJZCNX-UHFFFAOYSA-N 3-[[4-(3-iodopropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(OCCCI)=CC=C1NC=C1C2=CC=CC=C2NC1=O SHBOEOYGYJZCNX-UHFFFAOYSA-N 0.000 description 7
- PHRIUQSKFHJANS-UHFFFAOYSA-N 3-[[4-(4-iodobutoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(OCCCCI)=CC=C1NC=C1C2=CC=CC=C2NC1=O PHRIUQSKFHJANS-UHFFFAOYSA-N 0.000 description 7
- VTBHKDHFDNLZNG-UHFFFAOYSA-N 4-(2-piperidin-1-ylethoxy)aniline Chemical compound C1=CC(N)=CC=C1OCCN1CCCCC1 VTBHKDHFDNLZNG-UHFFFAOYSA-N 0.000 description 7
- ROPJHTWQKBBFTF-UHFFFAOYSA-N 4-(3-piperidin-1-ylpropoxy)aniline Chemical compound C1=CC(N)=CC=C1OCCCN1CCCCC1 ROPJHTWQKBBFTF-UHFFFAOYSA-N 0.000 description 7
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 7
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 7
- 125000002877 alkyl aryl group Chemical group 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- UALFVGAUFYTZSV-ALCCZGGFSA-N (3z)-3-(hydroxymethylidene)-4-methyl-1h-indol-2-one Chemical compound CC1=CC=CC2=C1C(=C/O)/C(=O)N2 UALFVGAUFYTZSV-ALCCZGGFSA-N 0.000 description 6
- HNQLLEWMVJHVME-UHFFFAOYSA-N 3-(hydroxymethylidene)-6-(3-methoxyphenyl)-1h-indol-2-one Chemical compound COC1=CC=CC(C=2C=C3NC(=O)C(=CO)C3=CC=2)=C1 HNQLLEWMVJHVME-UHFFFAOYSA-N 0.000 description 6
- OTYZNDKWNPQQJP-UHFFFAOYSA-N 4-(2-pyrrolidin-1-ylethoxy)aniline Chemical compound C1=CC(N)=CC=C1OCCN1CCCC1 OTYZNDKWNPQQJP-UHFFFAOYSA-N 0.000 description 6
- WQQRLTZBDUWWAU-UHFFFAOYSA-N 4-[3-(diethylamino)propoxy]aniline Chemical compound CCN(CC)CCCOC1=CC=C(N)C=C1 WQQRLTZBDUWWAU-UHFFFAOYSA-N 0.000 description 6
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 6
- JYGFTBXVXVMTGB-HOSYLAQJSA-N 1,3-dihydroindol-2-one Chemical class N1C([13CH2]C2=CC=CC=C12)=O JYGFTBXVXVMTGB-HOSYLAQJSA-N 0.000 description 5
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 5
- WNYFVEFUHMDIRQ-UHFFFAOYSA-N 4-(morpholin-4-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCOCC1 WNYFVEFUHMDIRQ-UHFFFAOYSA-N 0.000 description 5
- GHHQEFHFJVAIQD-UHFFFAOYSA-N 4-[(1-methylpiperidin-3-yl)methoxy]aniline Chemical compound C1N(C)CCCC1COC1=CC=C(N)C=C1 GHHQEFHFJVAIQD-UHFFFAOYSA-N 0.000 description 5
- GRSFQNVAPVZAOV-UHFFFAOYSA-N 4-[3-(diethylamino)propoxy]-3-fluoroaniline Chemical compound CCN(CC)CCCOC1=CC=C(N)C=C1F GRSFQNVAPVZAOV-UHFFFAOYSA-N 0.000 description 5
- AGCYANRKPLCKEW-UHFFFAOYSA-N 4-fluoro-3-(hydroxymethylidene)-1h-indol-2-one Chemical compound C1=CC(F)=C2C(=CO)C(=O)NC2=C1 AGCYANRKPLCKEW-UHFFFAOYSA-N 0.000 description 5
- CGTFYYYJFQYSSZ-UHFFFAOYSA-N 5-chloro-3-(hydroxymethylidene)-1h-indol-2-one Chemical compound C1=C(Cl)C=C2C(=CO)C(=O)NC2=C1 CGTFYYYJFQYSSZ-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 5
- 125000000304 alkynyl group Chemical group 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000005587 bubbling Effects 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 125000004093 cyano group Chemical group *C#N 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000011491 glass wool Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- YBADLXQNJCMBKR-UHFFFAOYSA-N (4-nitrophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C([N+]([O-])=O)C=C1 YBADLXQNJCMBKR-UHFFFAOYSA-N 0.000 description 4
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 4
- ZRKPUQFDPAIVPD-UHFFFAOYSA-N 3-(hydroxymethylidene)-1h-indol-2-one Chemical compound C1=CC=C2C(=CO)C(=O)NC2=C1 ZRKPUQFDPAIVPD-UHFFFAOYSA-N 0.000 description 4
- BUEFNCLNVXCFFS-UHFFFAOYSA-N 4-(2-piperidin-1-ylethyl)aniline Chemical compound C1=CC(N)=CC=C1CCN1CCCCC1 BUEFNCLNVXCFFS-UHFFFAOYSA-N 0.000 description 4
- WQMLUHZFRFCQDB-UHFFFAOYSA-N 4-(4-nitrophenyl)butyric acid Chemical compound OC(=O)CCCC1=CC=C([N+]([O-])=O)C=C1 WQMLUHZFRFCQDB-UHFFFAOYSA-N 0.000 description 4
- LFJGGGIWERIGNX-UHFFFAOYSA-N 4-[2-(diethylamino)ethoxy]aniline Chemical compound CCN(CC)CCOC1=CC=C(N)C=C1 LFJGGGIWERIGNX-UHFFFAOYSA-N 0.000 description 4
- OTLNPYWUJOZPPA-UHFFFAOYSA-N 4-nitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C=C1 OTLNPYWUJOZPPA-UHFFFAOYSA-N 0.000 description 4
- WGTYWBFIXLUQAI-UHFFFAOYSA-N 5-fluoro-2-hydroxy-1H-indole-3-carbaldehyde Chemical compound Oc1[nH]c2ccc(F)cc2c1C=O WGTYWBFIXLUQAI-UHFFFAOYSA-N 0.000 description 4
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 102000014400 SH2 domains Human genes 0.000 description 4
- 108050003452 SH2 domains Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000033115 angiogenesis Effects 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 102000020233 phosphotransferase Human genes 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 4
- 239000005483 tyrosine kinase inhibitor Substances 0.000 description 4
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 3
- LLPIMIMXCXEFER-UHFFFAOYSA-N 4-(2-morpholin-4-ylethyl)aniline Chemical compound C1=CC(N)=CC=C1CCN1CCOCC1 LLPIMIMXCXEFER-UHFFFAOYSA-N 0.000 description 3
- SALAKQGKZTZEDY-UHFFFAOYSA-N 4-(4-morpholin-4-ylbutyl)aniline Chemical compound C1=CC(N)=CC=C1CCCCN1CCOCC1 SALAKQGKZTZEDY-UHFFFAOYSA-N 0.000 description 3
- PCQPUMMBTHQDBY-UHFFFAOYSA-N 4-(4-piperidin-1-ylbutoxy)aniline Chemical compound C1=CC(N)=CC=C1OCCCCN1CCCCC1 PCQPUMMBTHQDBY-UHFFFAOYSA-N 0.000 description 3
- HNPYNSRMAAJEOG-UHFFFAOYSA-N 4-(4-piperidin-1-ylbutyl)aniline Chemical compound C1=CC(N)=CC=C1CCCCN1CCCCC1 HNPYNSRMAAJEOG-UHFFFAOYSA-N 0.000 description 3
- DRYFDUUAYSVNSN-UHFFFAOYSA-N 4-(piperidin-1-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCCCC1 DRYFDUUAYSVNSN-UHFFFAOYSA-N 0.000 description 3
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 3
- MIWXNKDIADESJW-UHFFFAOYSA-N 4-n-(2-morpholin-4-ylethyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NCCN1CCOCC1 MIWXNKDIADESJW-UHFFFAOYSA-N 0.000 description 3
- SSGNTACICQYKFJ-UHFFFAOYSA-N 4-n-(3-morpholin-4-ylpropyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NCCCN1CCOCC1 SSGNTACICQYKFJ-UHFFFAOYSA-N 0.000 description 3
- MEMCCQUMSXPDPE-UHFFFAOYSA-N 4-n-[3-(4-methylpiperazin-1-yl)propyl]benzene-1,4-diamine Chemical compound C1CN(C)CCN1CCCNC1=CC=C(N)C=C1 MEMCCQUMSXPDPE-UHFFFAOYSA-N 0.000 description 3
- 206010015866 Extravasation Diseases 0.000 description 3
- 102000009465 Growth Factor Receptors Human genes 0.000 description 3
- 108010009202 Growth Factor Receptors Proteins 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 230000036755 cellular response Effects 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000036251 extravasation Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 125000006413 ring segment Chemical group 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- CAKBAYWOHIUVHR-UHFFFAOYSA-N (4-nitrophenyl)-piperidin-1-ylmethanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)N1CCCCC1 CAKBAYWOHIUVHR-UHFFFAOYSA-N 0.000 description 2
- HLQQRQNEDYOBHS-UHFFFAOYSA-N 1-(2-(4-nitrophenoxy)ethyl)piperidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1OCCN1CCCCC1 HLQQRQNEDYOBHS-UHFFFAOYSA-N 0.000 description 2
- PAMJENUKCYUKLC-UHFFFAOYSA-N 1-(4-nitrobenzyl)piperidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCCCC1 PAMJENUKCYUKLC-UHFFFAOYSA-N 0.000 description 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 2
- NYPUAPKNWBOVQV-UHFFFAOYSA-N 1-[2-(4-nitrophenyl)ethyl]piperidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCN1CCCCC1 NYPUAPKNWBOVQV-UHFFFAOYSA-N 0.000 description 2
- JEVKRDOAGIIPGY-UHFFFAOYSA-N 1-[3-(4-nitrophenoxy)propyl]piperidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1OCCCN1CCCCC1 JEVKRDOAGIIPGY-UHFFFAOYSA-N 0.000 description 2
- IHLXQLQHIBFBOT-UHFFFAOYSA-N 1-[4-(4-nitrophenoxy)butyl]piperidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1OCCCCN1CCCCC1 IHLXQLQHIBFBOT-UHFFFAOYSA-N 0.000 description 2
- KYKOWCKYVHRPBL-UHFFFAOYSA-N 1-[4-(4-nitrophenyl)butyl]piperidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCCCN1CCCCC1 KYKOWCKYVHRPBL-UHFFFAOYSA-N 0.000 description 2
- UOXZPEGXZWCOPR-UHFFFAOYSA-N 1-fluoro-4-(3-methoxyphenyl)-2-nitrobenzene Chemical group COC1=CC=CC(C=2C=C(C(F)=CC=2)[N+]([O-])=O)=C1 UOXZPEGXZWCOPR-UHFFFAOYSA-N 0.000 description 2
- WUWUYBVFDFZIPS-UHFFFAOYSA-N 1-methyl-3-[(4-nitrophenoxy)methyl]piperidine Chemical compound C1N(C)CCCC1COC1=CC=C([N+]([O-])=O)C=C1 WUWUYBVFDFZIPS-UHFFFAOYSA-N 0.000 description 2
- XEWJEPSXWNILMA-UHFFFAOYSA-N 1-morpholin-4-yl-2-(4-nitrophenyl)ethanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1CC(=O)N1CCOCC1 XEWJEPSXWNILMA-UHFFFAOYSA-N 0.000 description 2
- QDIMLTACZGGYHK-UHFFFAOYSA-N 1-morpholin-4-yl-4-(4-nitrophenyl)butan-1-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCCC(=O)N1CCOCC1 QDIMLTACZGGYHK-UHFFFAOYSA-N 0.000 description 2
- FDMKTLRBJSCSDE-UHFFFAOYSA-N 2-(4-nitrophenyl)-1-piperidin-1-ylethanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1CC(=O)N1CCCCC1 FDMKTLRBJSCSDE-UHFFFAOYSA-N 0.000 description 2
- UHFXANYMAIRBOF-UHFFFAOYSA-N 2-[4-(3-methoxyphenyl)-2-nitrophenyl]acetic acid Chemical compound COC1=CC=CC(C=2C=C(C(CC(O)=O)=CC=2)[N+]([O-])=O)=C1 UHFXANYMAIRBOF-UHFFFAOYSA-N 0.000 description 2
- RZIYRKYHMDDHCK-UHFFFAOYSA-N 265654-77-1 Chemical compound C1=CC([N+](=O)[O-])=CC=C1OCCN1CCCC1 RZIYRKYHMDDHCK-UHFFFAOYSA-N 0.000 description 2
- WKCYFSZDBICRKL-UHFFFAOYSA-N 3-(diethylamino)propan-1-ol Chemical compound CCN(CC)CCCO WKCYFSZDBICRKL-UHFFFAOYSA-N 0.000 description 2
- CGZUYJPMUOAKAO-UHFFFAOYSA-N 3-[(4-hydroxyphenyl)iminomethyl]-1H-indol-2-ol Chemical compound OC1=CC=C(C=C1)N=CC1=C(NC2=CC=CC=C12)O CGZUYJPMUOAKAO-UHFFFAOYSA-N 0.000 description 2
- HKPYSBRBBCQYRD-UHFFFAOYSA-N 3-[[4-(2,6-dimethylmorpholin-4-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)OC(C)CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O HKPYSBRBBCQYRD-UHFFFAOYSA-N 0.000 description 2
- HQTMXZOMERSJCS-UHFFFAOYSA-N 3-[[4-(2,6-dimethylmorpholin-4-yl)-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1C(C)OC(C)CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O HQTMXZOMERSJCS-UHFFFAOYSA-N 0.000 description 2
- VVXBYIIKKZKTRE-UHFFFAOYSA-N 3-[[4-(2,6-dimethylmorpholin-4-yl)-3-(trifluoromethyl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1C(C)OC(C)CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O VVXBYIIKKZKTRE-UHFFFAOYSA-N 0.000 description 2
- ZCNLQPPKDMCQDH-UHFFFAOYSA-N 3-[[4-(2,6-dimethylmorpholin-4-yl)-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(C)OC(C)CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O ZCNLQPPKDMCQDH-UHFFFAOYSA-N 0.000 description 2
- YXDUSZGHZBEFSL-UHFFFAOYSA-N 3-[[4-(2,6-dimethylmorpholin-4-yl)-3-(trifluoromethyl)anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C(C)OC(C)CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O YXDUSZGHZBEFSL-UHFFFAOYSA-N 0.000 description 2
- IGZCSTXDSFHQEL-UHFFFAOYSA-N 3-[[4-(2,6-dimethylmorpholin-4-yl)-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1C(C)OC(C)CN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O IGZCSTXDSFHQEL-UHFFFAOYSA-N 0.000 description 2
- UQBJCQQFFGSOMS-UHFFFAOYSA-N 3-[[4-(2,6-dimethylmorpholin-4-yl)-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1C(C)OC(C)CN1C(C(=C1)F)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O UQBJCQQFFGSOMS-UHFFFAOYSA-N 0.000 description 2
- NVLIRQFALWXIQL-UHFFFAOYSA-N 3-[[4-(3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl)-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1CC2CCCCC2CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C(=O)NC2=C1C(F)=CC=C2 NVLIRQFALWXIQL-UHFFFAOYSA-N 0.000 description 2
- AZEPBLGPIZGKKV-UHFFFAOYSA-N 3-[[4-(3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl)-3-(trifluoromethyl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1CC2CCCCC2CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C(=O)NC2=C1C(C)=CC=C2 AZEPBLGPIZGKKV-UHFFFAOYSA-N 0.000 description 2
- NSEIIEVJXMMCQL-UHFFFAOYSA-N 3-[[4-(3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl)-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1CC2CCCCC2CN1C(C(F)=C1)=CC=C1NC=C1C(=O)NC2=C1C(C)=CC=C2 NSEIIEVJXMMCQL-UHFFFAOYSA-N 0.000 description 2
- GBBRVJQXJOTPNK-UHFFFAOYSA-N 3-[[4-(3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl)-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1CC2CCCCC2CN1C(C(F)=C1)=CC=C1NC=C1C(=O)NC2=CC=C(F)C=C21 GBBRVJQXJOTPNK-UHFFFAOYSA-N 0.000 description 2
- FJGNZSGDTJJWMK-UHFFFAOYSA-N 3-[[4-(3-chloropropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(OCCCCl)=CC=C1NC=C1C2=CC=CC=C2NC1=O FJGNZSGDTJJWMK-UHFFFAOYSA-N 0.000 description 2
- GXKGNNXECQRWFB-UHFFFAOYSA-N 3-[[4-(4-chlorobutoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(OCCCCCl)=CC=C1NC=C1C2=CC=CC=C2NC1=O GXKGNNXECQRWFB-UHFFFAOYSA-N 0.000 description 2
- SPOAVUKKYRDVLT-UHFFFAOYSA-N 3-[[4-(pyridin-2-ylmethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NCC1=CC=CC=N1 SPOAVUKKYRDVLT-UHFFFAOYSA-N 0.000 description 2
- KPKUPYPJGUTITK-UHFFFAOYSA-N 3-[[4-[2-[di(propan-2-yl)amino]ethylamino]-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCN(C(C)C)C(C)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O KPKUPYPJGUTITK-UHFFFAOYSA-N 0.000 description 2
- PBBACLJSTQDDAI-UHFFFAOYSA-N 3-[[4-[3-(3-fluoropyrrolidin-1-yl)propoxy]anilino]methylidene]-1-piperidin-4-ylindol-2-one Chemical compound C1C(F)CCN1CCCOC(C=C1)=CC=C1NC=C1C2=CC=CC=C2N(C2CCNCC2)C1=O PBBACLJSTQDDAI-UHFFFAOYSA-N 0.000 description 2
- OUHMHRLIJWSWME-UHFFFAOYSA-N 3-[[4-[3-(3-fluoropyrrolidin-1-yl)propoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(F)CCN1CCCOC(C=C1)=CC=C1NC=C1C2=CC=CC=C2NC1=O OUHMHRLIJWSWME-UHFFFAOYSA-N 0.000 description 2
- LZPODHNPQNTAPF-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propoxy]anilino]methylidene]-6-(3-methoxyphenyl)-1h-indol-2-one Chemical compound C1=CC(OCCCN(CC)CC)=CC=C1NC=C1C2=CC=C(C=3C=C(OC)C=CC=3)C=C2NC1=O LZPODHNPQNTAPF-UHFFFAOYSA-N 0.000 description 2
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 2
- INYFDQFEQGCBSN-UHFFFAOYSA-N 4-(4-nitrophenyl)-1-piperidin-1-ylbutan-1-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCCC(=O)N1CCCCC1 INYFDQFEQGCBSN-UHFFFAOYSA-N 0.000 description 2
- HYRUKAFUGSKHGD-UHFFFAOYSA-N 4-[(1-methylpiperidin-3-yl)methoxy]aniline;hydrochloride Chemical compound Cl.C1N(C)CCCC1COC1=CC=C(N)C=C1 HYRUKAFUGSKHGD-UHFFFAOYSA-N 0.000 description 2
- GFFZFWAUXAFCSY-UHFFFAOYSA-N 4-[2-(4-nitrophenyl)ethyl]morpholine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCN1CCOCC1 GFFZFWAUXAFCSY-UHFFFAOYSA-N 0.000 description 2
- LOLWRQUUOLPVOX-UHFFFAOYSA-N 4-[4-(4-nitrophenyl)butyl]morpholine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCCCN1CCOCC1 LOLWRQUUOLPVOX-UHFFFAOYSA-N 0.000 description 2
- UQEANKGXXSENNF-UHFFFAOYSA-N 4-bromo-1-fluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Br)=CC=C1F UQEANKGXXSENNF-UHFFFAOYSA-N 0.000 description 2
- USRZZPHRQZGXFH-UHFFFAOYSA-N 4-methyl-1,3-dihydroindol-2-one Chemical compound CC1=CC=CC2=C1CC(=O)N2 USRZZPHRQZGXFH-UHFFFAOYSA-N 0.000 description 2
- OZTJWFOJISVWJP-UHFFFAOYSA-N 4-methyl-3-[[4-[3-(4-methylpiperazin-1-yl)propylamino]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C)CCN1CCCNC(C=C1)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O OZTJWFOJISVWJP-UHFFFAOYSA-N 0.000 description 2
- IRQBUMYFAYXEGV-UHFFFAOYSA-N 6-(3-methoxyphenyl)-1,3-dihydroindol-2-one Chemical compound COC1=CC=CC(C=2C=C3NC(=O)CC3=CC=2)=C1 IRQBUMYFAYXEGV-UHFFFAOYSA-N 0.000 description 2
- KBZJQIQKWKKWER-UHFFFAOYSA-N 6-(3-methoxyphenyl)-3-[[4-(3-piperidin-1-ylpropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound COC1=CC=CC(C=2C=C3NC(=O)C(=CNC=4C=CC(OCCCN5CCCCC5)=CC=4)C3=CC=2)=C1 KBZJQIQKWKKWER-UHFFFAOYSA-N 0.000 description 2
- VWNBSDIFPUSDLK-UHFFFAOYSA-N 6-fluoro-3-[[4-(4-piperidin-1-ylbutyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1)=CC=C1CCCCN1CCCCC1 VWNBSDIFPUSDLK-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 229910006074 SO2NH2 Inorganic materials 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004280 Sodium formate Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 108020001778 catalytic domains Proteins 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- 238000006471 dimerization reaction Methods 0.000 description 2
- KEGXRXDQFPQJPZ-UHFFFAOYSA-N dimethyl 2-[4-(3-methoxyphenyl)-2-nitrophenyl]propanedioate Chemical compound C1=C([N+]([O-])=O)C(C(C(=O)OC)C(=O)OC)=CC=C1C1=CC=CC(OC)=C1 KEGXRXDQFPQJPZ-UHFFFAOYSA-N 0.000 description 2
- 230000007783 downstream signaling Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 208000005017 glioblastoma Diseases 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000004068 intracellular signaling Effects 0.000 description 2
- 229960002725 isoflurane Drugs 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- ZLZZAXUKBHFTHA-UHFFFAOYSA-N n,n-diethyl-2-(4-nitrophenoxy)ethanamine Chemical compound CCN(CC)CCOC1=CC=C([N+]([O-])=O)C=C1 ZLZZAXUKBHFTHA-UHFFFAOYSA-N 0.000 description 2
- GDLYTJHSJZNSPZ-UHFFFAOYSA-N n,n-diethyl-3-(2-fluoro-4-nitrophenoxy)propan-1-amine Chemical compound CCN(CC)CCCOC1=CC=C([N+]([O-])=O)C=C1F GDLYTJHSJZNSPZ-UHFFFAOYSA-N 0.000 description 2
- OFSUBZOEFLPRFA-UHFFFAOYSA-N n,n-diethyl-3-(4-nitrophenoxy)propan-1-amine Chemical compound CCN(CC)CCCOC1=CC=C([N+]([O-])=O)C=C1 OFSUBZOEFLPRFA-UHFFFAOYSA-N 0.000 description 2
- NWUVRJDVZZNZGH-UHFFFAOYSA-N n-(2-morpholin-4-ylethyl)-4-nitroaniline Chemical compound C1=CC([N+](=O)[O-])=CC=C1NCCN1CCOCC1 NWUVRJDVZZNZGH-UHFFFAOYSA-N 0.000 description 2
- JHPKICVISZEWHB-UHFFFAOYSA-N n-(3-morpholin-4-ylpropyl)-4-nitroaniline Chemical compound C1=CC([N+](=O)[O-])=CC=C1NCCCN1CCOCC1 JHPKICVISZEWHB-UHFFFAOYSA-N 0.000 description 2
- KBBUZGTXUQJPEZ-UHFFFAOYSA-N n-(piperidin-1-ylmethyl)aniline Chemical compound C1CCCCN1CNC1=CC=CC=C1 KBBUZGTXUQJPEZ-UHFFFAOYSA-N 0.000 description 2
- SPAQHUHOFHUIEV-UHFFFAOYSA-N n-[3-(4-methylpiperazin-1-yl)propyl]-4-nitroaniline Chemical compound C1CN(C)CCN1CCCNC1=CC=C([N+]([O-])=O)C=C1 SPAQHUHOFHUIEV-UHFFFAOYSA-N 0.000 description 2
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 125000004437 phosphorous atom Chemical group 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 125000004076 pyridyl group Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 2
- 235000019254 sodium formate Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- UGXQXVDTGJCQHR-UHFFFAOYSA-N (1-methylpiperidin-3-yl)methanol Chemical compound CN1CCCC(CO)C1 UGXQXVDTGJCQHR-UHFFFAOYSA-N 0.000 description 1
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 1
- RUBQQRMAWLSCCJ-UHFFFAOYSA-N 1,2-difluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C(F)=C1 RUBQQRMAWLSCCJ-UHFFFAOYSA-N 0.000 description 1
- CWWJJPJCPZUHPX-UHFFFAOYSA-N 1-[2-fluoro-4-[(4-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]piperidine-3-carboxamide Chemical compound C1C(C(=O)N)CCCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O CWWJJPJCPZUHPX-UHFFFAOYSA-N 0.000 description 1
- SHOACHLSUNLCNR-UHFFFAOYSA-N 1-[2-fluoro-4-[(4-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]piperidine-4-carboxamide Chemical compound C1CC(C(=O)N)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O SHOACHLSUNLCNR-UHFFFAOYSA-N 0.000 description 1
- RBCRORXJFFBRPN-UHFFFAOYSA-N 1-[2-fluoro-4-[(6-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]piperidine-3-carboxamide Chemical compound C1C(C(=O)N)CCCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O RBCRORXJFFBRPN-UHFFFAOYSA-N 0.000 description 1
- JANFCNJKKNPLFM-UHFFFAOYSA-N 1-[2-fluoro-4-[(6-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]piperidine-4-carboxamide Chemical compound C1CC(C(=O)N)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JANFCNJKKNPLFM-UHFFFAOYSA-N 0.000 description 1
- CMXTXKNMJWQRMQ-UHFFFAOYSA-N 1-[2-methyl-4-[(2-oxo-1h-indol-3-ylidene)methylamino]phenyl]piperidine-4-carboxamide Chemical compound CC1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1N1CCC(C(N)=O)CC1 CMXTXKNMJWQRMQ-UHFFFAOYSA-N 0.000 description 1
- UJVSHQYNGUNEGQ-UHFFFAOYSA-N 1-[4-[(2-oxo-1h-indol-3-ylidene)methylamino]-2-(trifluoromethyl)phenyl]piperidine-4-carboxamide Chemical compound C1CC(C(=O)N)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O UJVSHQYNGUNEGQ-UHFFFAOYSA-N 0.000 description 1
- GWCYQIZXIPTPGH-UHFFFAOYSA-N 1-[4-[(4-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]piperidine-3-carboxamide Chemical compound C1C(C(=O)N)CCCN1C(C=C1)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O GWCYQIZXIPTPGH-UHFFFAOYSA-N 0.000 description 1
- XQSCCSVCMKYVTR-UHFFFAOYSA-N 1-[4-[(4-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]piperidine-4-carboxamide Chemical compound C1CC(C(=O)N)CCN1C(C=C1)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O XQSCCSVCMKYVTR-UHFFFAOYSA-N 0.000 description 1
- GHBYIRDRDWMRMB-UHFFFAOYSA-N 1-[4-[(5-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]-2-methylphenyl]piperidine-3-carboxamide Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1N1CCCC(C(N)=O)C1 GHBYIRDRDWMRMB-UHFFFAOYSA-N 0.000 description 1
- AFJYZYSWHOQFFO-UHFFFAOYSA-N 1-[4-[(5-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]-2-methylphenyl]piperidine-4-carboxamide Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1N1CCC(C(N)=O)CC1 AFJYZYSWHOQFFO-UHFFFAOYSA-N 0.000 description 1
- ACSRITUDFQMLQG-UHFFFAOYSA-N 1-[4-[(6-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]-2-methylphenyl]piperidine-3-carboxamide Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1N1CCCC(C(N)=O)C1 ACSRITUDFQMLQG-UHFFFAOYSA-N 0.000 description 1
- LVHOCWFEWDXSBT-UHFFFAOYSA-N 1-[4-[(6-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]-2-methylphenyl]piperidine-4-carboxamide Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1N1CCC(C(N)=O)CC1 LVHOCWFEWDXSBT-UHFFFAOYSA-N 0.000 description 1
- NIDSRGCVYOEDFW-UHFFFAOYSA-N 1-bromo-4-chlorobutane Chemical compound ClCCCCBr NIDSRGCVYOEDFW-UHFFFAOYSA-N 0.000 description 1
- JQGBTOASISZOAG-KDWZCNHSSA-N 2,3,5,6-tetradeuterio-4-[(2-oxo-1h-indol-3-ylidene)methylamino]benzoic acid Chemical compound [2H]C1=C([2H])C(C(O)=O)=C([2H])C([2H])=C1NC=C1C2=CC=CC=C2NC1=O JQGBTOASISZOAG-KDWZCNHSSA-N 0.000 description 1
- ONUKJVAMEHIPPH-UHFFFAOYSA-N 2-(2,3-dihydropyrrol-1-yl)ethanol Chemical compound OCCN1CCC=C1 ONUKJVAMEHIPPH-UHFFFAOYSA-N 0.000 description 1
- KZTWONRVIPPDKH-UHFFFAOYSA-N 2-(piperidin-1-yl)ethanol Chemical compound OCCN1CCCCC1 KZTWONRVIPPDKH-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- RYCSNJCJOVQGBC-UHFFFAOYSA-N 3-(1-cyclopropyl-2h-pyridin-4-yl)-1h-quinolin-2-one Chemical class O=C1NC2=CC=CC=C2C=C1C(C=C1)=CCN1C1CC1 RYCSNJCJOVQGBC-UHFFFAOYSA-N 0.000 description 1
- RGUABPVONIGVAT-UHFFFAOYSA-N 3-(4-methylpiperazin-1-yl)propan-1-amine Chemical compound CN1CCN(CCCN)CC1 RGUABPVONIGVAT-UHFFFAOYSA-N 0.000 description 1
- BMNXNPLQPQEBFF-UHFFFAOYSA-N 3-(anilinomethylidene)-5-fluoro-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC1=CC=CC=C1 BMNXNPLQPQEBFF-UHFFFAOYSA-N 0.000 description 1
- MYVDRVAVJSPHNN-UHFFFAOYSA-N 3-[(1h-indol-6-ylamino)methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C2C=CNC2=CC(NC=C2C(=O)NC=3C=CC=C(C2=3)C)=C1 MYVDRVAVJSPHNN-UHFFFAOYSA-N 0.000 description 1
- ZJPUUKBMGQKQDY-UHFFFAOYSA-N 3-[(3-hydroxy-4-methoxyanilino)methylidene]-1h-indol-2-one;3-[(3-hydroxy-4-methylanilino)methylidene]-1h-indol-2-one Chemical compound C1=C(O)C(C)=CC=C1NC=C1C2=CC=CC=C2NC1=O.C1=C(O)C(OC)=CC=C1NC=C1C2=CC=CC=C2NC1=O ZJPUUKBMGQKQDY-UHFFFAOYSA-N 0.000 description 1
- OFFAZVPFZFWSMO-UHFFFAOYSA-N 3-[(4-ethoxyanilino)methylidene]-1h-indol-2-one Chemical compound C1=CC(OCC)=CC=C1NC=C1C2=CC=CC=C2NC1=O OFFAZVPFZFWSMO-UHFFFAOYSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- ALPLTVMWIUQKIK-UHFFFAOYSA-N 3-[4-[(5-chloro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]propanoic acid;3-[(3-ethylanilino)methylidene]-4-methyl-1h-indol-2-one Chemical compound CCC1=CC=CC(NC=C2C3=C(C)C=CC=C3NC2=O)=C1.C1=CC(CCC(=O)O)=CC=C1NC=C1C2=CC(Cl)=CC=C2NC1=O ALPLTVMWIUQKIK-UHFFFAOYSA-N 0.000 description 1
- RBDDAJVTIGNBHQ-UHFFFAOYSA-N 3-[[3-fluoro-4-(1-methoxybutan-2-ylamino)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(F)C(NC(COC)CC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O RBDDAJVTIGNBHQ-UHFFFAOYSA-N 0.000 description 1
- WSZIFIKCWPNVRL-UHFFFAOYSA-N 3-[[3-fluoro-4-(1-methoxypropan-2-ylamino)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(F)C(NC(C)COC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O WSZIFIKCWPNVRL-UHFFFAOYSA-N 0.000 description 1
- BLMAVXWEFNGPDD-UHFFFAOYSA-N 3-[[3-fluoro-4-(2-methoxyethylamino)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(F)C(NCCOC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O BLMAVXWEFNGPDD-UHFFFAOYSA-N 0.000 description 1
- BWAHBSVOYIEPMJ-UHFFFAOYSA-N 3-[[3-fluoro-4-(2-pyridin-4-ylethylamino)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCCC1=CC=NC=C1 BWAHBSVOYIEPMJ-UHFFFAOYSA-N 0.000 description 1
- ZELVTHZWDFERKN-UHFFFAOYSA-N 3-[[3-fluoro-4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCCCN1CCOCC1 ZELVTHZWDFERKN-UHFFFAOYSA-N 0.000 description 1
- QSJSAVJUJLYHJL-UHFFFAOYSA-N 3-[[3-fluoro-4-(3-pyridin-2-ylpyrrolidin-1-yl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N(C1)CCC1C1=CC=CC=N1 QSJSAVJUJLYHJL-UHFFFAOYSA-N 0.000 description 1
- AJEZSMPWTDTERK-UHFFFAOYSA-N 3-[[3-fluoro-4-(3-pyridin-4-ylpyrrolidin-1-yl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N(C1)CCC1C1=CC=NC=C1 AJEZSMPWTDTERK-UHFFFAOYSA-N 0.000 description 1
- QIVDTSNGDFIYMG-UHFFFAOYSA-N 3-[[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1CN(C)CCCN1C(C(=C1)F)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O QIVDTSNGDFIYMG-UHFFFAOYSA-N 0.000 description 1
- NYIPMCWLLCTGEN-UHFFFAOYSA-N 3-[[3-fluoro-4-(4-propylpiperidin-1-yl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1CC(CCC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O NYIPMCWLLCTGEN-UHFFFAOYSA-N 0.000 description 1
- WZJWWRNMRFIZLO-UHFFFAOYSA-N 3-[[3-fluoro-4-(4-pyrazin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound FC1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1N(CC1)CCN1C1=CN=CC=N1 WZJWWRNMRFIZLO-UHFFFAOYSA-N 0.000 description 1
- JLMKKXIGONUPOO-UHFFFAOYSA-N 3-[[3-fluoro-4-(4-pyrazin-2-ylpiperazin-1-yl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N(CC1)CCN1C1=CN=CC=N1 JLMKKXIGONUPOO-UHFFFAOYSA-N 0.000 description 1
- VDSXSBRZPJEOKJ-UHFFFAOYSA-N 3-[[3-fluoro-4-(4-pyrimidin-2-ylpiperazin-1-yl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N(CC1)CCN1C1=NC=CC=N1 VDSXSBRZPJEOKJ-UHFFFAOYSA-N 0.000 description 1
- GXOINBIYTWQNEP-UHFFFAOYSA-N 3-[[3-fluoro-4-(5-oxo-1,4-diazepan-1-yl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N1CCNC(=O)CC1 GXOINBIYTWQNEP-UHFFFAOYSA-N 0.000 description 1
- VANJHYJVUXSQLW-UHFFFAOYSA-N 3-[[3-fluoro-4-(oxan-4-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound FC1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NCC1CCOCC1 VANJHYJVUXSQLW-UHFFFAOYSA-N 0.000 description 1
- ZDVRZHPSNSAJKF-UHFFFAOYSA-N 3-[[3-fluoro-4-(oxan-4-ylmethylamino)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1CCOCC1 ZDVRZHPSNSAJKF-UHFFFAOYSA-N 0.000 description 1
- BYCJAYZTUHETMS-UHFFFAOYSA-N 3-[[3-fluoro-4-(oxolan-2-ylmethylamino)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1CCCO1 BYCJAYZTUHETMS-UHFFFAOYSA-N 0.000 description 1
- VLDRDWGMMVMLBD-UHFFFAOYSA-N 3-[[3-fluoro-4-(pyridin-2-ylmethylamino)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1=CC=CC=N1 VLDRDWGMMVMLBD-UHFFFAOYSA-N 0.000 description 1
- IXMPUCPTEPACBG-UHFFFAOYSA-N 3-[[3-fluoro-4-(pyridin-3-ylmethylamino)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1=CC=CN=C1 IXMPUCPTEPACBG-UHFFFAOYSA-N 0.000 description 1
- SERLESCMQZEPDH-UHFFFAOYSA-N 3-[[3-fluoro-4-(pyridin-4-ylmethylamino)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1=CC=NC=C1 SERLESCMQZEPDH-UHFFFAOYSA-N 0.000 description 1
- BIDXFHLRZVAEII-UHFFFAOYSA-N 3-[[3-fluoro-4-[(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1NC(C(=C1)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O BIDXFHLRZVAEII-UHFFFAOYSA-N 0.000 description 1
- PDMNCHPQPAYHQR-UHFFFAOYSA-N 3-[[3-fluoro-4-[(5-methylpyrazin-2-yl)methylamino]anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)F)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O PDMNCHPQPAYHQR-UHFFFAOYSA-N 0.000 description 1
- UYZKOGRLZJULCW-UHFFFAOYSA-N 3-[[3-fluoro-4-[2-methoxyethyl(propyl)amino]anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(F)C(N(CCOC)CCC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O UYZKOGRLZJULCW-UHFFFAOYSA-N 0.000 description 1
- FNUIYLFXRDXFER-UHFFFAOYSA-N 3-[[3-fluoro-4-[4-(2-methoxyethyl)piperazin-1-yl]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O FNUIYLFXRDXFER-UHFFFAOYSA-N 0.000 description 1
- BRHROYFTQNQCAY-UHFFFAOYSA-N 3-[[3-fluoro-4-[4-(2-methoxyethyl)piperazin-1-yl]anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O BRHROYFTQNQCAY-UHFFFAOYSA-N 0.000 description 1
- LDIGZGZBJIOUPU-UHFFFAOYSA-N 3-[[3-fluoro-4-[methyl(2-pyridin-2-ylethyl)amino]anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(C)C=CC=C3NC2=O)C=C(F)C=1N(C)CCC1=CC=CC=N1 LDIGZGZBJIOUPU-UHFFFAOYSA-N 0.000 description 1
- BAZHQYDMRNNFAP-UHFFFAOYSA-N 3-[[3-fluoro-4-[methyl(pyridin-3-ylmethyl)amino]anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(C)C=CC=C3NC2=O)C=C(F)C=1N(C)CC1=CC=CN=C1 BAZHQYDMRNNFAP-UHFFFAOYSA-N 0.000 description 1
- XOOCXCCMKKOGCD-UHFFFAOYSA-N 3-[[3-methyl-4-(oxan-4-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NCC1CCOCC1 XOOCXCCMKKOGCD-UHFFFAOYSA-N 0.000 description 1
- OXGYKDPXEUARIA-UHFFFAOYSA-N 3-[[3-methyl-4-[(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1NC(C(=C1)C)=CC=C1NC=C1C2=CC=CC=C2NC1=O OXGYKDPXEUARIA-UHFFFAOYSA-N 0.000 description 1
- ZBXIWPUBGKLYBJ-UHFFFAOYSA-N 3-[[3-methyl-4-[(5-methylpyrazin-2-yl)methylamino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)C)=CC=C1NC=C1C2=CC=CC=C2NC1=O ZBXIWPUBGKLYBJ-UHFFFAOYSA-N 0.000 description 1
- LCXCFOVSLVQLBG-UHFFFAOYSA-N 3-[[4-(1,3-dihydroisoindol-2-yl)-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1C2=CC=CC=C2CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C(=O)NC2=C1C(F)=CC=C2 LCXCFOVSLVQLBG-UHFFFAOYSA-N 0.000 description 1
- KGFZFAXXEGZOJQ-UHFFFAOYSA-N 3-[[4-(1,3-dihydroisoindol-2-yl)-3-(trifluoromethyl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1C2=CC=CC=C2CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C(=O)NC2=C1C(C)=CC=C2 KGFZFAXXEGZOJQ-UHFFFAOYSA-N 0.000 description 1
- QBEWHGXDHZSSAN-UHFFFAOYSA-N 3-[[4-(1,3-dihydroisoindol-2-yl)-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C2=CC=CC=C2CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C(=O)NC2=CC=C(F)C=C21 QBEWHGXDHZSSAN-UHFFFAOYSA-N 0.000 description 1
- AVMXITIANVBCDS-UHFFFAOYSA-N 3-[[4-(1,3-dihydroisoindol-2-yl)-3-(trifluoromethyl)anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C2=CC=CC=C2CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O AVMXITIANVBCDS-UHFFFAOYSA-N 0.000 description 1
- AAOOMGGBRHHGIS-UHFFFAOYSA-N 3-[[4-(1,3-dihydroisoindol-2-yl)-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C2=CC=CC=C2CN1C(C(F)=C1)=CC=C1NC=C1C(=O)NC2=CC=C(F)C=C21 AAOOMGGBRHHGIS-UHFFFAOYSA-N 0.000 description 1
- IEFZFYMGOOSIQL-UHFFFAOYSA-N 3-[[4-(1,3-dihydroisoindol-2-yl)-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C2=CC=CC=C2CN1C(C(F)=C1)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O IEFZFYMGOOSIQL-UHFFFAOYSA-N 0.000 description 1
- PXURPJMWAOXFAM-UHFFFAOYSA-N 3-[[4-(1,3-dihydroisoindol-2-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1C2=CC=CC=C2CN1C(C=C1)=CC=C1NC=C1C2=CC=CC=C2NC1=O PXURPJMWAOXFAM-UHFFFAOYSA-N 0.000 description 1
- JDGFRNPLBWVREV-UHFFFAOYSA-N 3-[[4-(1,3-dihydroisoindol-2-yl)anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C2=CC=CC=C2CN1C(C=C1)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JDGFRNPLBWVREV-UHFFFAOYSA-N 0.000 description 1
- CETHQFKFVREMRE-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-(trifluoromethyl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N(CC1)CCC21OCCO2 CETHQFKFVREMRE-UHFFFAOYSA-N 0.000 description 1
- JJNVPIONMUBPBI-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N(CC1)CCC21OCCO2 JJNVPIONMUBPBI-UHFFFAOYSA-N 0.000 description 1
- AJQPNVWNQMGWTI-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-fluoroanilino]methylidene]-1h-indol-2-one Chemical compound FC1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1N(CC1)CCC21OCCO2 AJQPNVWNQMGWTI-UHFFFAOYSA-N 0.000 description 1
- NAEJQTBYHZSSDR-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N(CC1)CCC21OCCO2 NAEJQTBYHZSSDR-UHFFFAOYSA-N 0.000 description 1
- DHHVZVPLHUXFTR-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N(CC1)CCC21OCCO2 DHHVZVPLHUXFTR-UHFFFAOYSA-N 0.000 description 1
- OUNXTIGUILCDPZ-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1N(CC1)CCC21OCCO2 OUNXTIGUILCDPZ-UHFFFAOYSA-N 0.000 description 1
- IQAYAFADYAZAJG-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1N(CC1)CCC21OCCO2 IQAYAFADYAZAJG-UHFFFAOYSA-N 0.000 description 1
- GCLPPVLPQJAQMN-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1N(CC1)CCC21OCCO2 GCLPPVLPQJAQMN-UHFFFAOYSA-N 0.000 description 1
- SESIWKRIRKSKEE-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1N(CC1)CCC21OCCO2 SESIWKRIRKSKEE-UHFFFAOYSA-N 0.000 description 1
- OGVDULSKZPDGHB-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1N(CC1)CCC21OCCO2 OGVDULSKZPDGHB-UHFFFAOYSA-N 0.000 description 1
- DEFNDXLCTUHTFX-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1N(CC1)CCC21OCCO2 DEFNDXLCTUHTFX-UHFFFAOYSA-N 0.000 description 1
- BDCTYIBGQWJWGW-UHFFFAOYSA-N 3-[[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1)=CC=C1N(CC1)CCC21OCCO2 BDCTYIBGQWJWGW-UHFFFAOYSA-N 0.000 description 1
- MHKNYYFILUSLBY-UHFFFAOYSA-N 3-[[4-(1-methoxybutan-2-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(COC)CC)=CC=C1NC=C1C2=CC=CC=C2NC1=O MHKNYYFILUSLBY-UHFFFAOYSA-N 0.000 description 1
- ALXHWSVSYFIGMX-UHFFFAOYSA-N 3-[[4-(1-methoxybutan-2-ylamino)-3-(trifluoromethyl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(COC)CC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O ALXHWSVSYFIGMX-UHFFFAOYSA-N 0.000 description 1
- UGHKFJNSLGFVBR-UHFFFAOYSA-N 3-[[4-(1-methoxybutan-2-ylamino)-3-methylanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C)C(NC(COC)CC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O UGHKFJNSLGFVBR-UHFFFAOYSA-N 0.000 description 1
- IIKHQGRTCVYPMT-UHFFFAOYSA-N 3-[[4-(1-methoxypropan-2-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(C)COC)=CC=C1NC=C1C2=CC=CC=C2NC1=O IIKHQGRTCVYPMT-UHFFFAOYSA-N 0.000 description 1
- AQQFUHVMXRPUKA-UHFFFAOYSA-N 3-[[4-(1-methoxypropan-2-ylamino)-3-methylanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C)C(NC(C)COC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O AQQFUHVMXRPUKA-UHFFFAOYSA-N 0.000 description 1
- XUJHUDHNZIBMFG-UHFFFAOYSA-N 3-[[4-(2,5-dihydropyrrol-1-yl)-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one;6-fluoro-3-[(3-fluoro-4-pyrrolidin-1-ylanilino)methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1N1CCCC1.O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1N1CC=CC1 XUJHUDHNZIBMFG-UHFFFAOYSA-N 0.000 description 1
- MLBZTTFLFMYBRC-UHFFFAOYSA-N 3-[[4-(2,6-dimethylmorpholin-4-yl)-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(C)OC(C)CN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O MLBZTTFLFMYBRC-UHFFFAOYSA-N 0.000 description 1
- CBNNWTZVEKUNHK-UHFFFAOYSA-N 3-[[4-(2-hydroxyethyl)anilino]methylidene]-1h-indol-2-one;3-[[4-(hydroxymethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(CO)=CC=C1NC=C1C2=CC=CC=C2NC1=O.C1=CC(CCO)=CC=C1NC=C1C2=CC=CC=C2NC1=O CBNNWTZVEKUNHK-UHFFFAOYSA-N 0.000 description 1
- XHTZGDIDBNMYTC-UHFFFAOYSA-N 3-[[4-(2-hydroxyethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCO)=CC=C1NC=C1C2=CC=CC=C2NC1=O XHTZGDIDBNMYTC-UHFFFAOYSA-N 0.000 description 1
- DJTSOPOQJZPUMX-UHFFFAOYSA-N 3-[[4-(2-methoxyethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCOC)=CC=C1NC=C1C2=CC=CC=C2NC1=O DJTSOPOQJZPUMX-UHFFFAOYSA-N 0.000 description 1
- WSJZWGRWWJRDLC-UHFFFAOYSA-N 3-[[4-(2-methoxyethylamino)-3-(trifluoromethyl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCOC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O WSJZWGRWWJRDLC-UHFFFAOYSA-N 0.000 description 1
- COTCKGHPPJCVHE-UHFFFAOYSA-N 3-[[4-(2-morpholin-4-ylethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1CCN1CCOCC1 COTCKGHPPJCVHE-UHFFFAOYSA-N 0.000 description 1
- UAGVRPRQOAYTFU-UHFFFAOYSA-N 3-[[4-(2-morpholin-4-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NCCN1CCOCC1 UAGVRPRQOAYTFU-UHFFFAOYSA-N 0.000 description 1
- FPSYFVCWNVAQSG-UHFFFAOYSA-N 3-[[4-(2-morpholin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1NCCN1CCOCC1 FPSYFVCWNVAQSG-UHFFFAOYSA-N 0.000 description 1
- PAARMLVXHHVCEA-UHFFFAOYSA-N 3-[[4-(2-piperidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1OCCN1CCCCC1 PAARMLVXHHVCEA-UHFFFAOYSA-N 0.000 description 1
- BTPJQUFYXQIVBZ-UHFFFAOYSA-N 3-[[4-(2-piperidin-1-ylethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1CCN1CCCCC1 BTPJQUFYXQIVBZ-UHFFFAOYSA-N 0.000 description 1
- HCDFEANQKIJRIJ-UHFFFAOYSA-N 3-[[4-(2-piperidin-1-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NCCN1CCCCC1 HCDFEANQKIJRIJ-UHFFFAOYSA-N 0.000 description 1
- MOODPGPVCXELAD-UHFFFAOYSA-N 3-[[4-(2-pyridin-2-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NCCC1=CC=CC=N1 MOODPGPVCXELAD-UHFFFAOYSA-N 0.000 description 1
- IYYCPELOCLIXMA-UHFFFAOYSA-N 3-[[4-(2-pyridin-3-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NCCC1=CC=CN=C1 IYYCPELOCLIXMA-UHFFFAOYSA-N 0.000 description 1
- HWGLLISUGFIOBT-UHFFFAOYSA-N 3-[[4-(2-pyridin-4-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NCCC1=CC=NC=C1 HWGLLISUGFIOBT-UHFFFAOYSA-N 0.000 description 1
- ZACZXMTWNBFQGP-UHFFFAOYSA-N 3-[[4-(2-pyrrolidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1OCCN1CCCC1 ZACZXMTWNBFQGP-UHFFFAOYSA-N 0.000 description 1
- GFCVYTISURHJNG-UHFFFAOYSA-N 3-[[4-(3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CC2CCCCC2CN1C1=CC=C(NC=C2C3=CC=CC=C3NC2=O)C=C1C(F)(F)F GFCVYTISURHJNG-UHFFFAOYSA-N 0.000 description 1
- GGDMERIZPKCWSM-UHFFFAOYSA-N 3-[[4-(3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl)-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1CC2CCCCC2CN1C(C(F)=C1)=CC=C1NC=C1C(=O)NC2=C1C(F)=CC=C2 GGDMERIZPKCWSM-UHFFFAOYSA-N 0.000 description 1
- BPUNEKCGHYJNLZ-UHFFFAOYSA-N 3-[[4-(3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl)-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1CC2CCCCC2CN1C(C(F)=C1)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O BPUNEKCGHYJNLZ-UHFFFAOYSA-N 0.000 description 1
- STPYJXGXYRKBSD-UHFFFAOYSA-N 3-[[4-(3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-2-yl)-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1CC2CCCCC2CN1C1=CC=C(NC=C2C3=CC(F)=CC=C3NC2=O)C=C1C STPYJXGXYRKBSD-UHFFFAOYSA-N 0.000 description 1
- PNXVOQKMMXGIPU-UHFFFAOYSA-N 3-[[4-(3,5-dimethylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1C(C)NC(C)CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O PNXVOQKMMXGIPU-UHFFFAOYSA-N 0.000 description 1
- JGQNEWKLJDFEFF-UHFFFAOYSA-N 3-[[4-(3,5-dimethylpiperazin-1-yl)-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1C(C)NC(C)CN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O JGQNEWKLJDFEFF-UHFFFAOYSA-N 0.000 description 1
- ZPDOYZOMMAKXSL-UHFFFAOYSA-N 3-[[4-(3,5-dimethylpiperazin-1-yl)-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(C)NC(C)CN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O ZPDOYZOMMAKXSL-UHFFFAOYSA-N 0.000 description 1
- PRPONEBNNVSTHM-UHFFFAOYSA-N 3-[[4-(3,5-dimethylpiperazin-1-yl)-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C(C)NC(C)CN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O PRPONEBNNVSTHM-UHFFFAOYSA-N 0.000 description 1
- IBHDPNQMFLTNFQ-UHFFFAOYSA-N 3-[[4-(3,5-dimethylpiperidin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)CC(C)CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O IBHDPNQMFLTNFQ-UHFFFAOYSA-N 0.000 description 1
- PRAWOVPEMAJOMA-UHFFFAOYSA-N 3-[[4-(3,5-dimethylpiperidin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(C)CC(C)CN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O PRAWOVPEMAJOMA-UHFFFAOYSA-N 0.000 description 1
- LHUHFNOURZICLJ-UHFFFAOYSA-N 3-[[4-(3,5-dimethylpiperidin-1-yl)-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1C(C)CC(C)CN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O LHUHFNOURZICLJ-UHFFFAOYSA-N 0.000 description 1
- FRDRPCUNWYIXTB-UHFFFAOYSA-N 3-[[4-(3,5-dimethylpiperidin-1-yl)-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(C)CC(C)CN1C(C(=C1)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O FRDRPCUNWYIXTB-UHFFFAOYSA-N 0.000 description 1
- UPEHRAUQTCDLCB-UHFFFAOYSA-N 3-[[4-(3,5-dimethylpiperidin-1-yl)-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C(C)CC(C)CN1C(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O UPEHRAUQTCDLCB-UHFFFAOYSA-N 0.000 description 1
- YMCHIOFFWGDJHY-UHFFFAOYSA-N 3-[[4-(3,6-dihydro-2h-pyridin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N1CCC=CC1 YMCHIOFFWGDJHY-UHFFFAOYSA-N 0.000 description 1
- OLANSJVSBDDMPT-UHFFFAOYSA-N 3-[[4-(3-imidazol-1-ylpropylamino)-3-methylanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C)=CC=C1NCCCN1C=CN=C1 OLANSJVSBDDMPT-UHFFFAOYSA-N 0.000 description 1
- PZEVDCPDTDUACB-UHFFFAOYSA-N 3-[[4-(3-methylpiperidin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)CCCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O PZEVDCPDTDUACB-UHFFFAOYSA-N 0.000 description 1
- RGZBLIAZNWLGIN-UHFFFAOYSA-N 3-[[4-(3-morpholin-4-ylpropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1OCCCN1CCOCC1 RGZBLIAZNWLGIN-UHFFFAOYSA-N 0.000 description 1
- UZHGNFKLWBUQCL-UHFFFAOYSA-N 3-[[4-(3-morpholin-4-ylpropylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NCCCN1CCOCC1 UZHGNFKLWBUQCL-UHFFFAOYSA-N 0.000 description 1
- IQRIDXOGQVVVDE-UHFFFAOYSA-N 3-[[4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1NCCCN1CCOCC1 IQRIDXOGQVVVDE-UHFFFAOYSA-N 0.000 description 1
- FMWSPBSMGYJKFT-UHFFFAOYSA-N 3-[[4-(3-piperidin-1-ylpropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1OCCCN1CCCCC1 FMWSPBSMGYJKFT-UHFFFAOYSA-N 0.000 description 1
- GRQAYCFOLJCVGP-UHFFFAOYSA-N 3-[[4-(3-pyrrolidin-1-ylpropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1OCCCN1CCCC1 GRQAYCFOLJCVGP-UHFFFAOYSA-N 0.000 description 1
- WMLQUFFZMLDDON-UHFFFAOYSA-N 3-[[4-(3-thiomorpholin-4-ylpropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1OCCCN1CCSCC1 WMLQUFFZMLDDON-UHFFFAOYSA-N 0.000 description 1
- NHQJZIIIDSPQKU-UHFFFAOYSA-N 3-[[4-(4-acetyl-1,4-diazepan-1-yl)-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1CN(C(=O)C)CCCN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O NHQJZIIIDSPQKU-UHFFFAOYSA-N 0.000 description 1
- DVWDQOFFNDAXNN-UHFFFAOYSA-N 3-[[4-(4-acetylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C(=O)C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O DVWDQOFFNDAXNN-UHFFFAOYSA-N 0.000 description 1
- OOWBLRATEKWPKG-UHFFFAOYSA-N 3-[[4-(4-acetylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1CN(C(=O)C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O OOWBLRATEKWPKG-UHFFFAOYSA-N 0.000 description 1
- ZCIUFSZKVNOMLB-UHFFFAOYSA-N 3-[[4-(4-acetylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1CN(C(=O)C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O ZCIUFSZKVNOMLB-UHFFFAOYSA-N 0.000 description 1
- RCJWGLMAUYNPFB-UHFFFAOYSA-N 3-[[4-(4-acetylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1CN(C(=O)C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O RCJWGLMAUYNPFB-UHFFFAOYSA-N 0.000 description 1
- GSRXGMJTSZBYIT-UHFFFAOYSA-N 3-[[4-(4-acetylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1CN(C(=O)C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O GSRXGMJTSZBYIT-UHFFFAOYSA-N 0.000 description 1
- KEAPTJJJUJKIJH-UHFFFAOYSA-N 3-[[4-(4-acetylpiperazin-1-yl)-3-fluoroanilino]methylidene]-1h-indol-2-one;n-[1-[2-fluoro-4-[(2-oxo-1h-indol-3-ylidene)methylamino]phenyl]pyrrolidin-3-yl]acetamide Chemical compound C1C(NC(=O)C)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O.C1CN(C(=O)C)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O KEAPTJJJUJKIJH-UHFFFAOYSA-N 0.000 description 1
- DGOJFFKZWLXJBT-UHFFFAOYSA-N 3-[[4-(4-acetylpiperazin-1-yl)-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1CN(C(=O)C)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O DGOJFFKZWLXJBT-UHFFFAOYSA-N 0.000 description 1
- DUGAZVUWQGKYNG-UHFFFAOYSA-N 3-[[4-(4-acetylpiperazin-1-yl)-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1CN(C(=O)C)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O DUGAZVUWQGKYNG-UHFFFAOYSA-N 0.000 description 1
- MYCMGHPKQVCKJO-UHFFFAOYSA-N 3-[[4-(4-acetylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one;n-[1-[4-[(2-oxo-1h-indol-3-ylidene)methylamino]phenyl]pyrrolidin-3-yl]acetamide Chemical compound C1C(NC(=O)C)CCN1C(C=C1)=CC=C1NC=C1C2=CC=CC=C2NC1=O.C1CN(C(=O)C)CCN1C(C=C1)=CC=C1NC=C1C2=CC=CC=C2NC1=O MYCMGHPKQVCKJO-UHFFFAOYSA-N 0.000 description 1
- QOQZJJCEBGPLNA-UHFFFAOYSA-N 3-[[4-(4-butan-2-ylpiperazin-1-yl)-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1CN(C(C)CC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O QOQZJJCEBGPLNA-UHFFFAOYSA-N 0.000 description 1
- CIDZBNPLNVWRCN-UHFFFAOYSA-N 3-[[4-(4-butan-2-ylpiperazin-1-yl)-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1CN(C(C)CC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O CIDZBNPLNVWRCN-UHFFFAOYSA-N 0.000 description 1
- JDWXBGLDVJVCDC-UHFFFAOYSA-N 3-[[4-(4-butan-2-ylpiperazin-1-yl)-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1CN(C(C)CC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JDWXBGLDVJVCDC-UHFFFAOYSA-N 0.000 description 1
- HTSQRWKMEMDOOG-UHFFFAOYSA-N 3-[[4-(4-butan-2-ylpiperazin-1-yl)-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1CN(C(C)CC)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O HTSQRWKMEMDOOG-UHFFFAOYSA-N 0.000 description 1
- ZWSGBYGTQRSVGG-UHFFFAOYSA-N 3-[[4-(4-butan-2-ylpiperazin-1-yl)-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1CN(C(C)CC)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O ZWSGBYGTQRSVGG-UHFFFAOYSA-N 0.000 description 1
- GTMNDLLUASOFJG-UHFFFAOYSA-N 3-[[4-(4-butylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1CN(CCCC)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O GTMNDLLUASOFJG-UHFFFAOYSA-N 0.000 description 1
- QAYKHIVCYBJQPA-UHFFFAOYSA-N 3-[[4-(4-butylpiperazin-1-yl)-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1CN(CCCC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O QAYKHIVCYBJQPA-UHFFFAOYSA-N 0.000 description 1
- QFRXSPTXDWVFLZ-UHFFFAOYSA-N 3-[[4-(4-butylpiperazin-1-yl)-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1CN(CCCC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O QFRXSPTXDWVFLZ-UHFFFAOYSA-N 0.000 description 1
- FXWRPABSTYNXCJ-UHFFFAOYSA-N 3-[[4-(4-butylpiperazin-1-yl)-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1CN(CCCC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O FXWRPABSTYNXCJ-UHFFFAOYSA-N 0.000 description 1
- FNOJJZMNMXVGGX-UHFFFAOYSA-N 3-[[4-(4-butylpiperazin-1-yl)-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1CN(CCCC)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O FNOJJZMNMXVGGX-UHFFFAOYSA-N 0.000 description 1
- OARDQQBBPUQMKJ-UHFFFAOYSA-N 3-[[4-(4-ethylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1CN(CC)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O OARDQQBBPUQMKJ-UHFFFAOYSA-N 0.000 description 1
- LHBRJJGGIXLHPN-UHFFFAOYSA-N 3-[[4-(4-ethylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1CN(CC)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O LHBRJJGGIXLHPN-UHFFFAOYSA-N 0.000 description 1
- DOFOMFUEKOEHRW-UHFFFAOYSA-N 3-[[4-(4-ethylpiperazin-1-yl)-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O DOFOMFUEKOEHRW-UHFFFAOYSA-N 0.000 description 1
- KRBLXTGOFZRTHV-UHFFFAOYSA-N 3-[[4-(4-ethylpiperazin-1-yl)-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O KRBLXTGOFZRTHV-UHFFFAOYSA-N 0.000 description 1
- FIEVNCVNPLJWHK-UHFFFAOYSA-N 3-[[4-(4-ethylpiperazin-1-yl)-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O FIEVNCVNPLJWHK-UHFFFAOYSA-N 0.000 description 1
- NRUNIHPUDPVRSO-UHFFFAOYSA-N 3-[[4-(4-morpholin-4-ylbutoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1OCCCCN1CCOCC1 NRUNIHPUDPVRSO-UHFFFAOYSA-N 0.000 description 1
- RRDYWTMDVBPHSP-UHFFFAOYSA-N 3-[[4-(4-morpholin-4-ylbutyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1CCCCN1CCOCC1 RRDYWTMDVBPHSP-UHFFFAOYSA-N 0.000 description 1
- NRGBFARFHAGCHB-UHFFFAOYSA-N 3-[[4-(4-piperidin-1-ylbutoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1OCCCCN1CCCCC1 NRGBFARFHAGCHB-UHFFFAOYSA-N 0.000 description 1
- BQTLZTHKGACVKR-UHFFFAOYSA-N 3-[[4-(4-piperidin-1-ylbutyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1CCCCN1CCCCC1 BQTLZTHKGACVKR-UHFFFAOYSA-N 0.000 description 1
- AVZPFLLRLMKXFW-UHFFFAOYSA-N 3-[[4-(4-pyrimidin-2-ylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1N(CC1)CCN1C1=NC=CC=N1 AVZPFLLRLMKXFW-UHFFFAOYSA-N 0.000 description 1
- LXCLZZYHKHWRRN-UHFFFAOYSA-N 3-[[4-(4-pyrimidin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1N(CC1)CCN1C1=NC=CC=N1 LXCLZZYHKHWRRN-UHFFFAOYSA-N 0.000 description 1
- RGSVWLBPTBQRCJ-UHFFFAOYSA-N 3-[[4-(4-pyrrolidin-1-ylbutoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1OCCCCN1CCCC1 RGSVWLBPTBQRCJ-UHFFFAOYSA-N 0.000 description 1
- UDKNIDORPQYVES-UHFFFAOYSA-N 3-[[4-(4-thiomorpholin-4-ylbutoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1OCCCCN1CCSCC1 UDKNIDORPQYVES-UHFFFAOYSA-N 0.000 description 1
- MWLFCQZUDGBSQY-UHFFFAOYSA-N 3-[[4-(azepan-1-yl)-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N1CCCCCC1 MWLFCQZUDGBSQY-UHFFFAOYSA-N 0.000 description 1
- WMKRIMFWQNDVOF-UHFFFAOYSA-N 3-[[4-(azepan-1-yl)-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N1CCCCCC1 WMKRIMFWQNDVOF-UHFFFAOYSA-N 0.000 description 1
- ZACYNTCJTKREJA-UHFFFAOYSA-N 3-[[4-(azocan-1-yl)-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N1CCCCCCC1 ZACYNTCJTKREJA-UHFFFAOYSA-N 0.000 description 1
- SZDYCJCJEJPDRT-UHFFFAOYSA-N 3-[[4-(diethylamino)-3-fluoroanilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(N(CC)CC)=CC=C1NC=C1C2=CC=CC=C2NC1=O SZDYCJCJEJPDRT-UHFFFAOYSA-N 0.000 description 1
- DYLGLKGQMDTGPO-UHFFFAOYSA-N 3-[[4-(dipropylamino)-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(N(CCC)CCC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O DYLGLKGQMDTGPO-UHFFFAOYSA-N 0.000 description 1
- CEIAGUWINUCEJO-UHFFFAOYSA-N 3-[[4-(morpholin-4-ylmethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1CN1CCOCC1 CEIAGUWINUCEJO-UHFFFAOYSA-N 0.000 description 1
- IYNJNNTVNCRGSS-UHFFFAOYSA-N 3-[[4-(oxan-4-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NC1CCOCC1 IYNJNNTVNCRGSS-UHFFFAOYSA-N 0.000 description 1
- RHPFDTMOMQPPNY-UHFFFAOYSA-N 3-[[4-(oxolan-2-ylmethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NCC1CCCO1 RHPFDTMOMQPPNY-UHFFFAOYSA-N 0.000 description 1
- FJBMLMLGTYOKIE-UHFFFAOYSA-N 3-[[4-(piperidin-1-ylmethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1CN1CCCCC1 FJBMLMLGTYOKIE-UHFFFAOYSA-N 0.000 description 1
- DJXBRTRODICYGA-UHFFFAOYSA-N 3-[[4-[(1-benzylpyrrolidin-3-yl)amino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound FC(F)(F)C1=CC(NC=C2C3=CC=CC=C3NC2=O)=CC=C1NC(C1)CCN1CC1=CC=CC=C1 DJXBRTRODICYGA-UHFFFAOYSA-N 0.000 description 1
- IOCAQQWWOISLKK-UHFFFAOYSA-N 3-[[4-[(1-benzylpyrrolidin-3-yl)amino]-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NC(C1)CCN1CC1=CC=CC=C1 IOCAQQWWOISLKK-UHFFFAOYSA-N 0.000 description 1
- QBYKFZSBSRZLHO-UHFFFAOYSA-N 3-[[4-[(1-benzylpyrrolidin-3-yl)amino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NC(C1)CCN1CC1=CC=CC=C1 QBYKFZSBSRZLHO-UHFFFAOYSA-N 0.000 description 1
- VVWPWLQACLYFPI-UHFFFAOYSA-N 3-[[4-[(1-benzylpyrrolidin-3-yl)amino]-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1NC(C1)CCN1CC1=CC=CC=C1 VVWPWLQACLYFPI-UHFFFAOYSA-N 0.000 description 1
- NKTHASLKNVMAIE-UHFFFAOYSA-N 3-[[4-[(1-benzylpyrrolidin-3-yl)amino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NC(C1)CCN1CC1=CC=CC=C1 NKTHASLKNVMAIE-UHFFFAOYSA-N 0.000 description 1
- DWGUEFFPJGRUJP-UHFFFAOYSA-N 3-[[4-[(1-benzylpyrrolidin-3-yl)amino]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1NC(C1)CCN1CC1=CC=CC=C1 DWGUEFFPJGRUJP-UHFFFAOYSA-N 0.000 description 1
- UGFWEQHCIWVHGV-UHFFFAOYSA-N 3-[[4-[(1-methylpiperidin-3-yl)methoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1N(C)CCCC1COC(C=C1)=CC=C1NC=C1C2=CC=CC=C2NC1=O UGFWEQHCIWVHGV-UHFFFAOYSA-N 0.000 description 1
- NIWGXVQJRXCSGJ-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O1C(C)(C)OCC1CNC(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O NIWGXVQJRXCSGJ-UHFFFAOYSA-N 0.000 description 1
- VRRHMBXJGRUJTA-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound O1C(C)(C)OCC1CNC(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O VRRHMBXJGRUJTA-UHFFFAOYSA-N 0.000 description 1
- XTNMXGZUONNKCV-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-(trifluoromethyl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NCC1COC(C)(C)O1 XTNMXGZUONNKCV-UHFFFAOYSA-N 0.000 description 1
- TZKBTZOSVLFKSF-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-fluoroanilino]methylidene]-1h-indol-2-one Chemical compound O1C(C)(C)OCC1CNC(C(=C1)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O TZKBTZOSVLFKSF-UHFFFAOYSA-N 0.000 description 1
- JSKQRLHFFJBZSP-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound O1C(C)(C)OCC1CNC(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O JSKQRLHFFJBZSP-UHFFFAOYSA-N 0.000 description 1
- UCGAEMHWKPFQEX-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1COC(C)(C)O1 UCGAEMHWKPFQEX-UHFFFAOYSA-N 0.000 description 1
- WTGZHZLKGHBPDY-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound O1C(C)(C)OCC1CNC(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O WTGZHZLKGHBPDY-UHFFFAOYSA-N 0.000 description 1
- FSUIPHRIMLOBMK-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound O1C(C)(C)OCC1CNC(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O FSUIPHRIMLOBMK-UHFFFAOYSA-N 0.000 description 1
- CRLPHKSJPMACIS-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-methylanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NCC1COC(C)(C)O1 CRLPHKSJPMACIS-UHFFFAOYSA-N 0.000 description 1
- VLBXKHWCGHSWKN-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1NCC1COC(C)(C)O1 VLBXKHWCGHSWKN-UHFFFAOYSA-N 0.000 description 1
- TVZIVYIENCFIFE-UHFFFAOYSA-N 3-[[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methylamino]-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1NCC1COC(C)(C)O1 TVZIVYIENCFIFE-UHFFFAOYSA-N 0.000 description 1
- PPJZPQOAYORLRB-UHFFFAOYSA-N 3-[[4-[(5-methylpyrazin-2-yl)methylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O PPJZPQOAYORLRB-UHFFFAOYSA-N 0.000 description 1
- RZWSKUIPOGSXJD-UHFFFAOYSA-N 3-[[4-[1,3-dioxolan-2-ylmethyl(methyl)amino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC=CC=C3NC2=O)C=C(C(F)(F)F)C=1N(C)CC1OCCO1 RZWSKUIPOGSXJD-UHFFFAOYSA-N 0.000 description 1
- RVEDOMPZBBXIKV-UHFFFAOYSA-N 3-[[4-[1,3-dioxolan-2-ylmethyl(methyl)amino]-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(F)C=CC=C3NC2=O)C=C(C(F)(F)F)C=1N(C)CC1OCCO1 RVEDOMPZBBXIKV-UHFFFAOYSA-N 0.000 description 1
- FNKRCCDZKAXSOU-UHFFFAOYSA-N 3-[[4-[1,3-dioxolan-2-ylmethyl(methyl)amino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(F)C=CC=C3NC2=O)C=C(F)C=1N(C)CC1OCCO1 FNKRCCDZKAXSOU-UHFFFAOYSA-N 0.000 description 1
- AMIRYCPIYFGNIH-UHFFFAOYSA-N 3-[[4-[1,3-dioxolan-2-ylmethyl(methyl)amino]-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(C)C=CC=C3NC2=O)C=C(F)C=1N(C)CC1OCCO1 AMIRYCPIYFGNIH-UHFFFAOYSA-N 0.000 description 1
- MBWQIIIJDOKHIH-UHFFFAOYSA-N 3-[[4-[1,3-dioxolan-2-ylmethyl(methyl)amino]-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC(F)=CC=C3NC2=O)C=C(F)C=1N(C)CC1OCCO1 MBWQIIIJDOKHIH-UHFFFAOYSA-N 0.000 description 1
- OQGFFUKHHZEVPC-UHFFFAOYSA-N 3-[[4-[1,3-dioxolan-2-ylmethyl(methyl)amino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC=C(F)C=C3NC2=O)C=C(F)C=1N(C)CC1OCCO1 OQGFFUKHHZEVPC-UHFFFAOYSA-N 0.000 description 1
- YQASXFNIDMSKAP-UHFFFAOYSA-N 3-[[4-[1,3-dioxolan-2-ylmethyl(methyl)amino]anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(F)C=CC=C3NC2=O)C=CC=1N(C)CC1OCCO1 YQASXFNIDMSKAP-UHFFFAOYSA-N 0.000 description 1
- GOJRBWUECUKSEU-UHFFFAOYSA-N 3-[[4-[1,3-dioxolan-2-ylmethyl(methyl)amino]anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC(F)=CC=C3NC2=O)C=CC=1N(C)CC1OCCO1 GOJRBWUECUKSEU-UHFFFAOYSA-N 0.000 description 1
- ILWSVOLVALULGR-UHFFFAOYSA-N 3-[[4-[1-(diethylamino)propan-2-ylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(C)CN(CC)CC)=CC=C1NC=C1C2=CC=CC=C2NC1=O ILWSVOLVALULGR-UHFFFAOYSA-N 0.000 description 1
- MIRMBDFDLXIHBP-UHFFFAOYSA-N 3-[[4-[1-(diethylamino)propan-2-ylamino]-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(C)CN(CC)CC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O MIRMBDFDLXIHBP-UHFFFAOYSA-N 0.000 description 1
- LMMAFTOGKLRGGD-UHFFFAOYSA-N 3-[[4-[1-(diethylamino)propan-2-ylamino]-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(C)CN(CC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O LMMAFTOGKLRGGD-UHFFFAOYSA-N 0.000 description 1
- AUEAZNKUMOEDAV-UHFFFAOYSA-N 3-[[4-[1-(diethylamino)propan-2-ylamino]-3-(trifluoromethyl)anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(C)CN(CC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O AUEAZNKUMOEDAV-UHFFFAOYSA-N 0.000 description 1
- FBEWZMBNNINDHE-UHFFFAOYSA-N 3-[[4-[1-(diethylamino)propan-2-ylamino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NC(C)CN(CC)CC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O FBEWZMBNNINDHE-UHFFFAOYSA-N 0.000 description 1
- BOTROPWBSNSCFX-UHFFFAOYSA-N 3-[[4-[1-(diethylamino)propan-2-ylamino]-3-methylanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NC(C)CN(CC)CC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O BOTROPWBSNSCFX-UHFFFAOYSA-N 0.000 description 1
- LDUAYUQRMHVQMK-UHFFFAOYSA-N 3-[[4-[1-(diethylamino)propan-2-ylamino]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NC(C)CN(CC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O LDUAYUQRMHVQMK-UHFFFAOYSA-N 0.000 description 1
- MBFGQEHXHIWJJD-UHFFFAOYSA-N 3-[[4-[1-(dimethylamino)propan-2-ylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(CN(C)C)C)=CC=C1NC=C1C2=CC=CC=C2NC1=O MBFGQEHXHIWJJD-UHFFFAOYSA-N 0.000 description 1
- YRWICMVOFBYLJN-UHFFFAOYSA-N 3-[[4-[1-(dimethylamino)propan-2-ylamino]-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(CN(C)C)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O YRWICMVOFBYLJN-UHFFFAOYSA-N 0.000 description 1
- PNHFUKDOMIXSIV-UHFFFAOYSA-N 3-[[4-[1-(dimethylamino)propan-2-ylamino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NC(CN(C)C)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O PNHFUKDOMIXSIV-UHFFFAOYSA-N 0.000 description 1
- BNFGWPNKBZQUQS-UHFFFAOYSA-N 3-[[4-[1-(dimethylamino)propan-2-ylamino]-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(F)C(NC(CN(C)C)C)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O BNFGWPNKBZQUQS-UHFFFAOYSA-N 0.000 description 1
- YCKRYJJKFPBDNY-UHFFFAOYSA-N 3-[[4-[1-(dimethylamino)propan-2-ylamino]-3-methylanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C)C(NC(CN(C)C)C)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O YCKRYJJKFPBDNY-UHFFFAOYSA-N 0.000 description 1
- WCVAAGRFZWGKRG-UHFFFAOYSA-N 3-[[4-[1-(dimethylamino)propan-2-ylamino]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NC(CN(C)C)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O WCVAAGRFZWGKRG-UHFFFAOYSA-N 0.000 description 1
- QYLXABXNAOPSSJ-UHFFFAOYSA-N 3-[[4-[2-(1,3-dioxolan-2-yl)ethyl-methylamino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(F)C=CC=C3NC2=O)C=C(F)C=1N(C)CCC1OCCO1 QYLXABXNAOPSSJ-UHFFFAOYSA-N 0.000 description 1
- KAMANDKAMMFLEF-UHFFFAOYSA-N 3-[[4-[2-(1,3-dioxolan-2-yl)ethyl-methylamino]-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(C)C=CC=C3NC2=O)C=C(F)C=1N(C)CCC1OCCO1 KAMANDKAMMFLEF-UHFFFAOYSA-N 0.000 description 1
- HIIOERUSBPKIMB-UHFFFAOYSA-N 3-[[4-[2-(1,3-dioxolan-2-yl)ethyl-methylamino]-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC(F)=CC=C3NC2=O)C=C(F)C=1N(C)CCC1OCCO1 HIIOERUSBPKIMB-UHFFFAOYSA-N 0.000 description 1
- DNBIULFGWCKIQN-UHFFFAOYSA-N 3-[[4-[2-(1,3-dioxolan-2-yl)ethyl-methylamino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC=C(F)C=C3NC2=O)C=C(F)C=1N(C)CCC1OCCO1 DNBIULFGWCKIQN-UHFFFAOYSA-N 0.000 description 1
- BEEARNBAKDQVJP-UHFFFAOYSA-N 3-[[4-[2-(1,3-dioxolan-2-yl)ethyl-methylamino]-3-methylanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(C)C=CC=C3NC2=O)C=C(C)C=1N(C)CCC1OCCO1 BEEARNBAKDQVJP-UHFFFAOYSA-N 0.000 description 1
- GCMOOCWGNLPUPY-UHFFFAOYSA-N 3-[[4-[2-(1,3-dioxolan-2-yl)ethyl-methylamino]-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC=C(F)C=C3NC2=O)C=C(C)C=1N(C)CCC1OCCO1 GCMOOCWGNLPUPY-UHFFFAOYSA-N 0.000 description 1
- NNFKCGIFRJLMST-UHFFFAOYSA-N 3-[[4-[2-(1,3-dioxolan-2-yl)ethyl-methylamino]anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(C)C=CC=C3NC2=O)C=CC=1N(C)CCC1OCCO1 NNFKCGIFRJLMST-UHFFFAOYSA-N 0.000 description 1
- BZMYHUZAMALEFC-UHFFFAOYSA-N 3-[[4-[2-(1,3-dioxolan-2-yl)ethyl-methylamino]anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC(F)=CC=C3NC2=O)C=CC=1N(C)CCC1OCCO1 BZMYHUZAMALEFC-UHFFFAOYSA-N 0.000 description 1
- MQSRQFOWXMEUJL-UHFFFAOYSA-N 3-[[4-[2-(1,3-dioxolan-2-yl)ethyl-methylamino]anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC=C(F)C=C3NC2=O)C=CC=1N(C)CCC1OCCO1 MQSRQFOWXMEUJL-UHFFFAOYSA-N 0.000 description 1
- WMXUKSRKBANKSY-UHFFFAOYSA-N 3-[[4-[2-(3-fluoropyrrolidin-1-yl)ethoxy]anilino]methylidene]-1-piperidin-4-ylindol-2-one Chemical compound C1C(F)CCN1CCOC(C=C1)=CC=C1NC=C1C2=CC=CC=C2N(C2CCNCC2)C1=O WMXUKSRKBANKSY-UHFFFAOYSA-N 0.000 description 1
- KHKIIRHEHVDACO-UHFFFAOYSA-N 3-[[4-[2-(3-fluoropyrrolidin-1-yl)ethoxy]anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1OCCN1CCC(F)C1 KHKIIRHEHVDACO-UHFFFAOYSA-N 0.000 description 1
- YMQJVKRJULMLSC-UHFFFAOYSA-N 3-[[4-[2-(diethylamino)ethoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(OCCN(CC)CC)=CC=C1NC=C1C2=CC=CC=C2NC1=O YMQJVKRJULMLSC-UHFFFAOYSA-N 0.000 description 1
- NAKCSSKBTPYNKW-UHFFFAOYSA-N 3-[[4-[2-(diethylamino)ethoxy]anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=CC(OCCN(CC)CC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O NAKCSSKBTPYNKW-UHFFFAOYSA-N 0.000 description 1
- ZNMCVJOAUSZYQL-UHFFFAOYSA-N 3-[[4-[2-(diethylamino)ethoxy]anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=CC(OCCN(CC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O ZNMCVJOAUSZYQL-UHFFFAOYSA-N 0.000 description 1
- FUUFTZSSRKZPAN-UHFFFAOYSA-N 3-[[4-[2-(diethylamino)ethylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCN(CC)CC)=CC=C1NC=C1C2=CC=CC=C2NC1=O FUUFTZSSRKZPAN-UHFFFAOYSA-N 0.000 description 1
- XZYDJYQTZYNNDJ-UHFFFAOYSA-N 3-[[4-[2-(diethylamino)ethylamino]-3-(trifluoromethyl)anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCN(CC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O XZYDJYQTZYNNDJ-UHFFFAOYSA-N 0.000 description 1
- LRMKFANJOBNEGC-UHFFFAOYSA-N 3-[[4-[2-(diethylamino)ethylamino]-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NCCN(CC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O LRMKFANJOBNEGC-UHFFFAOYSA-N 0.000 description 1
- JRNCFQRNENCHRU-UHFFFAOYSA-N 3-[[4-[2-(diethylamino)ethylamino]-3-methylanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(CC)CC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O JRNCFQRNENCHRU-UHFFFAOYSA-N 0.000 description 1
- NDKFUPUHTHMELC-UHFFFAOYSA-N 3-[[4-[2-(diethylamino)ethylamino]-3-methylanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(CC)CC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O NDKFUPUHTHMELC-UHFFFAOYSA-N 0.000 description 1
- PPZBJPVQURCWBS-UHFFFAOYSA-N 3-[[4-[2-(diethylamino)ethylamino]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(CC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O PPZBJPVQURCWBS-UHFFFAOYSA-N 0.000 description 1
- XPSWSOLAEOAREB-UHFFFAOYSA-N 3-[[4-[2-(diethylamino)ethylamino]-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(CC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O XPSWSOLAEOAREB-UHFFFAOYSA-N 0.000 description 1
- XCZHGWPRVHRQGE-UHFFFAOYSA-N 3-[[4-[2-(dimethylamino)ethylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCN(C)C)=CC=C1NC=C1C2=CC=CC=C2NC1=O XCZHGWPRVHRQGE-UHFFFAOYSA-N 0.000 description 1
- WTVCIMQIRHDDJQ-UHFFFAOYSA-N 3-[[4-[2-(dimethylamino)ethylamino]-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCN(C)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O WTVCIMQIRHDDJQ-UHFFFAOYSA-N 0.000 description 1
- VDMIPWFBFZXLPJ-UHFFFAOYSA-N 3-[[4-[2-(dimethylamino)ethylamino]-3-(trifluoromethyl)anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCN(C)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O VDMIPWFBFZXLPJ-UHFFFAOYSA-N 0.000 description 1
- SXVRMQZTHPYOGO-UHFFFAOYSA-N 3-[[4-[2-(dimethylamino)ethylamino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NCCN(C)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O SXVRMQZTHPYOGO-UHFFFAOYSA-N 0.000 description 1
- RFJLJHAXRIEXMP-UHFFFAOYSA-N 3-[[4-[2-(dimethylamino)ethylamino]-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(F)C(NCCN(C)C)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O RFJLJHAXRIEXMP-UHFFFAOYSA-N 0.000 description 1
- KUUBSPXAGOALRR-UHFFFAOYSA-N 3-[[4-[2-(dimethylamino)ethylamino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NCCN(C)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O KUUBSPXAGOALRR-UHFFFAOYSA-N 0.000 description 1
- IWTAFOSIUMVPDM-UHFFFAOYSA-N 3-[[4-[2-(dimethylamino)ethylamino]-3-methylanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(C)C)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O IWTAFOSIUMVPDM-UHFFFAOYSA-N 0.000 description 1
- UWBHXDPEJRDNKP-UHFFFAOYSA-N 3-[[4-[2-(dimethylamino)ethylamino]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(C)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O UWBHXDPEJRDNKP-UHFFFAOYSA-N 0.000 description 1
- UACCBFNVRNSOAS-UHFFFAOYSA-N 3-[[4-[2-(dimethylamino)ethylamino]-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(C)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O UACCBFNVRNSOAS-UHFFFAOYSA-N 0.000 description 1
- GYXWRBHTQSMIMG-UHFFFAOYSA-N 3-[[4-[2-[di(propan-2-yl)amino]ethylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCN(C(C)C)C(C)C)=CC=C1NC=C1C2=CC=CC=C2NC1=O GYXWRBHTQSMIMG-UHFFFAOYSA-N 0.000 description 1
- MYMWXOGPUHQTOI-UHFFFAOYSA-N 3-[[4-[2-[di(propan-2-yl)amino]ethylamino]-3-(trifluoromethyl)anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCN(C(C)C)C(C)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O MYMWXOGPUHQTOI-UHFFFAOYSA-N 0.000 description 1
- YGXBCTZFXVYYJD-UHFFFAOYSA-N 3-[[4-[2-[di(propan-2-yl)amino]ethylamino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NCCN(C(C)C)C(C)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O YGXBCTZFXVYYJD-UHFFFAOYSA-N 0.000 description 1
- FIUQUQYERJIUIE-UHFFFAOYSA-N 3-[[4-[2-[di(propan-2-yl)amino]ethylamino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NCCN(C(C)C)C(C)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O FIUQUQYERJIUIE-UHFFFAOYSA-N 0.000 description 1
- SBYAWNSWDOEWPB-UHFFFAOYSA-N 3-[[4-[2-[di(propan-2-yl)amino]ethylamino]-3-methylanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(C(C)C)C(C)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O SBYAWNSWDOEWPB-UHFFFAOYSA-N 0.000 description 1
- ILRGTMITZLLXBF-UHFFFAOYSA-N 3-[[4-[2-[di(propan-2-yl)amino]ethylamino]-3-methylanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(C(C)C)C(C)C)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O ILRGTMITZLLXBF-UHFFFAOYSA-N 0.000 description 1
- PXQFSSQGYZFWTP-UHFFFAOYSA-N 3-[[4-[2-[di(propan-2-yl)amino]ethylamino]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(C(C)C)C(C)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O PXQFSSQGYZFWTP-UHFFFAOYSA-N 0.000 description 1
- QZLNEDGBBDJKAR-UHFFFAOYSA-N 3-[[4-[2-[di(propan-2-yl)amino]ethylamino]-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCN(C(C)C)C(C)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O QZLNEDGBBDJKAR-UHFFFAOYSA-N 0.000 description 1
- FRYLCOQSOVBYBV-UHFFFAOYSA-N 3-[[4-[2-methoxyethyl(methyl)amino]-3-(trifluoromethyl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(N(C)CCOC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O FRYLCOQSOVBYBV-UHFFFAOYSA-N 0.000 description 1
- KKHRYGRFFXXIFT-UHFFFAOYSA-N 3-[[4-[2-methoxyethyl(propyl)amino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(N(CCOC)CCC)=CC=C1NC=C1C2=CC=CC=C2NC1=O KKHRYGRFFXXIFT-UHFFFAOYSA-N 0.000 description 1
- LAYMMYZEGWTKTE-UHFFFAOYSA-N 3-[[4-[3-(2-methylpiperidin-1-yl)propylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound CC1CCCCN1CCCNC(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O LAYMMYZEGWTKTE-UHFFFAOYSA-N 0.000 description 1
- FEDRYHYBRMVIGY-UHFFFAOYSA-N 3-[[4-[3-(3-fluoropyrrolidin-1-yl)propoxy]anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1OCCCN1CCC(F)C1 FEDRYHYBRMVIGY-UHFFFAOYSA-N 0.000 description 1
- HGTAZPJHFKGZDP-UHFFFAOYSA-N 3-[[4-[3-(4-methylpiperazin-1-yl)propylamino]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C)CCN1CCCNC(C=C1)=CC=C1NC=C1C2=CC=CC=C2NC1=O HGTAZPJHFKGZDP-UHFFFAOYSA-N 0.000 description 1
- JSPRHACJIOOOKT-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propoxy]-3-fluoroanilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(OCCCN(CC)CC)=CC=C1NC=C1C2=CC=CC=C2NC1=O JSPRHACJIOOOKT-UHFFFAOYSA-N 0.000 description 1
- NWJJNCUEEMMHHY-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propoxy]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(OCCCN(CC)CC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O NWJJNCUEEMMHHY-UHFFFAOYSA-N 0.000 description 1
- SZSLQSPSICDSMY-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propoxy]-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(F)C(OCCCN(CC)CC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O SZSLQSPSICDSMY-UHFFFAOYSA-N 0.000 description 1
- JUFQHPCLUQCIEN-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propoxy]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(OCCCN(CC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JUFQHPCLUQCIEN-UHFFFAOYSA-N 0.000 description 1
- DRHODTYJSVXWGP-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(OCCCN(CC)CC)=CC=C1NC=C1C2=CC=CC=C2NC1=O DRHODTYJSVXWGP-UHFFFAOYSA-N 0.000 description 1
- SQYOTAUYXKLCLY-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propoxy]anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=CC(OCCCN(CC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O SQYOTAUYXKLCLY-UHFFFAOYSA-N 0.000 description 1
- YRTTVVQMKXQJLN-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propoxy]anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=CC(OCCCN(CC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O YRTTVVQMKXQJLN-UHFFFAOYSA-N 0.000 description 1
- SJMFNBAHKXGIAU-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCCN(CC)CC)=CC=C1NC=C1C2=CC=CC=C2NC1=O SJMFNBAHKXGIAU-UHFFFAOYSA-N 0.000 description 1
- NTBVZQLPAYTKLU-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propylamino]-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCCN(CC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O NTBVZQLPAYTKLU-UHFFFAOYSA-N 0.000 description 1
- AGLTVHREDXKZQX-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propylamino]-3-(trifluoromethyl)anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCCN(CC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O AGLTVHREDXKZQX-UHFFFAOYSA-N 0.000 description 1
- XWGNDCKSNQXLMB-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propylamino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NCCCN(CC)CC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O XWGNDCKSNQXLMB-UHFFFAOYSA-N 0.000 description 1
- BMOVAMOTHKSUQD-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propylamino]-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NCCCN(CC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O BMOVAMOTHKSUQD-UHFFFAOYSA-N 0.000 description 1
- DVHIQOAZMVOWJQ-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propylamino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NCCCN(CC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O DVHIQOAZMVOWJQ-UHFFFAOYSA-N 0.000 description 1
- WEVNVJZFKZFPEN-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propylamino]-3-methylanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCCN(CC)CC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O WEVNVJZFKZFPEN-UHFFFAOYSA-N 0.000 description 1
- RSANIIVFTFENMG-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propylamino]-3-methylanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C)C(NCCCN(CC)CC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O RSANIIVFTFENMG-UHFFFAOYSA-N 0.000 description 1
- LQGLITFAHBGSIZ-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propylamino]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCCN(CC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O LQGLITFAHBGSIZ-UHFFFAOYSA-N 0.000 description 1
- HYQJIEOZDGGVJA-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)propylamino]-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCCN(CC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O HYQJIEOZDGGVJA-UHFFFAOYSA-N 0.000 description 1
- PTVVDWUHUAPARO-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)pyrrolidin-1-yl]-3-fluoroanilino]methylidene]-1h-indol-2-one Chemical compound C1C(N(CC)CC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O PTVVDWUHUAPARO-UHFFFAOYSA-N 0.000 description 1
- YFZUPTREQAEHEW-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)pyrrolidin-1-yl]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1C(N(CC)CC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O YFZUPTREQAEHEW-UHFFFAOYSA-N 0.000 description 1
- SZEDXLKJDFTMRC-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)pyrrolidin-1-yl]-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(N(CC)CC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O SZEDXLKJDFTMRC-UHFFFAOYSA-N 0.000 description 1
- XYLASYLWALBHBL-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)pyrrolidin-1-yl]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C(N(CC)CC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O XYLASYLWALBHBL-UHFFFAOYSA-N 0.000 description 1
- YEQILHTUIWOIFI-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)pyrrolidin-1-yl]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(N(CC)CC)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O YEQILHTUIWOIFI-UHFFFAOYSA-N 0.000 description 1
- XHLCTCZTPJZSJX-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)pyrrolidin-1-yl]-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C(N(CC)CC)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O XHLCTCZTPJZSJX-UHFFFAOYSA-N 0.000 description 1
- ASFYJNVAZROEBF-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)pyrrolidin-1-yl]anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1C(N(CC)CC)CCN1C(C=C1)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O ASFYJNVAZROEBF-UHFFFAOYSA-N 0.000 description 1
- JJEJTHQXZWYYKW-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)pyrrolidin-1-yl]anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(N(CC)CC)CCN1C(C=C1)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O JJEJTHQXZWYYKW-UHFFFAOYSA-N 0.000 description 1
- AJWBHRQIZLXFBD-UHFFFAOYSA-N 3-[[4-[3-(diethylamino)pyrrolidin-1-yl]anilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C(N(CC)CC)CCN1C(C=C1)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O AJWBHRQIZLXFBD-UHFFFAOYSA-N 0.000 description 1
- NGAYCWGNVCPGGA-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)propylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCCN(C)C)=CC=C1NC=C1C2=CC=CC=C2NC1=O NGAYCWGNVCPGGA-UHFFFAOYSA-N 0.000 description 1
- HUBSIYAGOIHNNK-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)propylamino]-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCCN(C)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O HUBSIYAGOIHNNK-UHFFFAOYSA-N 0.000 description 1
- KJTOIAKFUZGUIS-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)propylamino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NCCCN(C)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O KJTOIAKFUZGUIS-UHFFFAOYSA-N 0.000 description 1
- ZSMFFDZDFKMFPM-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)propylamino]-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(F)C(NCCCN(C)C)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O ZSMFFDZDFKMFPM-UHFFFAOYSA-N 0.000 description 1
- WJFGQWFUZIKAGH-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)propylamino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(NCCCN(C)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O WJFGQWFUZIKAGH-UHFFFAOYSA-N 0.000 description 1
- CODPCBCSPSOTAV-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)propylamino]-3-methylanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCCN(C)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O CODPCBCSPSOTAV-UHFFFAOYSA-N 0.000 description 1
- DDDZXXKUXUTRHQ-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)propylamino]-3-methylanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C)C(NCCCN(C)C)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O DDDZXXKUXUTRHQ-UHFFFAOYSA-N 0.000 description 1
- CTLOFOJAYLXVMY-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)propylamino]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCCN(C)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O CTLOFOJAYLXVMY-UHFFFAOYSA-N 0.000 description 1
- WOHYNAOHPQRZSJ-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)propylamino]-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(C)C(NCCCN(C)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O WOHYNAOHPQRZSJ-UHFFFAOYSA-N 0.000 description 1
- GLJMKGDPMDGEFU-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)pyrrolidin-1-yl]-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(N(C)C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O GLJMKGDPMDGEFU-UHFFFAOYSA-N 0.000 description 1
- HKKPIUVKTKSTCN-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)pyrrolidin-1-yl]-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1C(N(C)C)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O HKKPIUVKTKSTCN-UHFFFAOYSA-N 0.000 description 1
- LVWUEXQEAVSZOA-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)pyrrolidin-1-yl]-3-fluoroanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(N(C)C)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O LVWUEXQEAVSZOA-UHFFFAOYSA-N 0.000 description 1
- DCUOXPDZYAAYEW-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)pyrrolidin-1-yl]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C(N(C)C)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O DCUOXPDZYAAYEW-UHFFFAOYSA-N 0.000 description 1
- BGCMJTNFBOSJJU-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)pyrrolidin-1-yl]-3-methylanilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1C(N(C)C)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O BGCMJTNFBOSJJU-UHFFFAOYSA-N 0.000 description 1
- UDGFHORTCJSIPX-UHFFFAOYSA-N 3-[[4-[3-(dimethylamino)pyrrolidin-1-yl]-3-methylanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1C(N(C)C)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O UDGFHORTCJSIPX-UHFFFAOYSA-N 0.000 description 1
- JFYZMTDWMKUAIH-UHFFFAOYSA-N 3-[[4-[4-(2-methoxyethyl)piperazin-1-yl]anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C=C1)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O JFYZMTDWMKUAIH-UHFFFAOYSA-N 0.000 description 1
- OTQONTFKLIDBFJ-UHFFFAOYSA-N 3-[[4-[4-(4-methylpiperazin-1-yl)butoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C)CCN1CCCCOC(C=C1)=CC=C1NC=C1C2=CC=CC=C2NC1=O OTQONTFKLIDBFJ-UHFFFAOYSA-N 0.000 description 1
- PUEQQNCSHCZGOU-UHFFFAOYSA-N 3-[[4-[4-(diethylamino)butoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(OCCCCN(CC)CC)=CC=C1NC=C1C2=CC=CC=C2NC1=O PUEQQNCSHCZGOU-UHFFFAOYSA-N 0.000 description 1
- SUIWUCKGMYUMNW-UHFFFAOYSA-N 3-[[4-[butyl(ethyl)amino]-3-(trifluoromethyl)anilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(N(CC)CCCC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O SUIWUCKGMYUMNW-UHFFFAOYSA-N 0.000 description 1
- CQRNBAHPYCBSNL-UHFFFAOYSA-N 3-[[4-[butyl(ethyl)amino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(N(CC)CCCC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O CQRNBAHPYCBSNL-UHFFFAOYSA-N 0.000 description 1
- ZHVGZCQCLVHEOY-UHFFFAOYSA-N 3-[[4-[butyl(ethyl)amino]-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(F)C(N(CC)CCCC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O ZHVGZCQCLVHEOY-UHFFFAOYSA-N 0.000 description 1
- HURWSKXQBDLIMY-UHFFFAOYSA-N 3-[[4-[butyl(propyl)amino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(N(CCC)CCCC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O HURWSKXQBDLIMY-UHFFFAOYSA-N 0.000 description 1
- BXIMPBCLGNZTKO-UHFFFAOYSA-N 3-[[4-[butyl(propyl)amino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(N(CCC)CCCC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O BXIMPBCLGNZTKO-UHFFFAOYSA-N 0.000 description 1
- GYPXBXVTDUEUIG-UHFFFAOYSA-N 3-[[4-[cyclopropylmethyl(propyl)amino]-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC(F)=CC=C3NC2=O)C=C(C(F)(F)F)C=1N(CCC)CC1CC1 GYPXBXVTDUEUIG-UHFFFAOYSA-N 0.000 description 1
- NPOXLJYEPLEREV-UHFFFAOYSA-N 3-[[4-[cyclopropylmethyl(propyl)amino]-3-fluoroanilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(F)C=CC=C3NC2=O)C=C(F)C=1N(CCC)CC1CC1 NPOXLJYEPLEREV-UHFFFAOYSA-N 0.000 description 1
- WKQGKVGABBYGKB-UHFFFAOYSA-N 3-[[4-[cyclopropylmethyl(propyl)amino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC=C(F)C=C3NC2=O)C=C(F)C=1N(CCC)CC1CC1 WKQGKVGABBYGKB-UHFFFAOYSA-N 0.000 description 1
- XNNRRSXTQFGEMQ-UHFFFAOYSA-N 3-[[4-[ethyl(2-methoxyethyl)amino]-3-(trifluoromethyl)anilino]methylidene]-4-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(N(CCOC)CC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O XNNRRSXTQFGEMQ-UHFFFAOYSA-N 0.000 description 1
- SSFZSQPVARRVES-UHFFFAOYSA-N 3-[[4-[ethyl(2-methoxyethyl)amino]-3-(trifluoromethyl)anilino]methylidene]-5-fluoro-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(N(CCOC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O SSFZSQPVARRVES-UHFFFAOYSA-N 0.000 description 1
- IFMYMMZEXFAAQD-UHFFFAOYSA-N 3-[[4-[ethyl(2-methoxyethyl)amino]-3-fluoroanilino]methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=C(F)C(N(CCOC)CC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O IFMYMMZEXFAAQD-UHFFFAOYSA-N 0.000 description 1
- ZRBLODLRIFMISJ-UHFFFAOYSA-N 3-[[4-[ethyl(2-methoxyethyl)amino]-3-fluoroanilino]methylidene]-6-fluoro-1h-indol-2-one Chemical compound C1=C(F)C(N(CCOC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O ZRBLODLRIFMISJ-UHFFFAOYSA-N 0.000 description 1
- PVLWGGUWOKKNRX-UHFFFAOYSA-N 3-[[4-[methyl(pyridin-3-ylmethyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC=CC=C3NC2=O)C=CC=1N(C)CC1=CC=CN=C1 PVLWGGUWOKKNRX-UHFFFAOYSA-N 0.000 description 1
- DHYHYLGCQVVLOQ-UHFFFAOYSA-N 3-bromoaniline Chemical compound NC1=CC=CC(Br)=C1 DHYHYLGCQVVLOQ-UHFFFAOYSA-N 0.000 description 1
- LENYOXXELREKGZ-UHFFFAOYSA-N 3-fluoropyrrolidine;hydron;chloride Chemical compound Cl.FC1CCNC1 LENYOXXELREKGZ-UHFFFAOYSA-N 0.000 description 1
- PLRXAFVBCHEMGD-UHFFFAOYSA-N 3-piperidin-1-ylpropan-1-ol Chemical compound OCCCN1CCCCC1 PLRXAFVBCHEMGD-UHFFFAOYSA-N 0.000 description 1
- YMUMJMDUWDSZTK-UHFFFAOYSA-N 4-[4-[(4-methyl-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]butanoic acid Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC1=CC=C(CCCC(O)=O)C=C1 YMUMJMDUWDSZTK-UHFFFAOYSA-N 0.000 description 1
- LBRWWZUWAYJCHM-UHFFFAOYSA-N 4-[4-[(5-chloro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]butanoic acid;3-[(4-ethylanilino)methylidene]-4-methyl-1h-indol-2-one Chemical compound C1=CC(CC)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O.C1=CC(CCCC(=O)O)=CC=C1NC=C1C2=CC(Cl)=CC=C2NC1=O LBRWWZUWAYJCHM-UHFFFAOYSA-N 0.000 description 1
- OUZPDRBYJWKZQO-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(1-methoxypropan-2-ylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(NC(C)COC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O OUZPDRBYJWKZQO-UHFFFAOYSA-N 0.000 description 1
- UHPIJLSPPDLENM-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(2-hydroxyethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(NCCO)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O UHPIJLSPPDLENM-UHFFFAOYSA-N 0.000 description 1
- WUJXNXMGVDMSIL-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(2-methoxyethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(NCCOC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O WUJXNXMGVDMSIL-UHFFFAOYSA-N 0.000 description 1
- QACYESHTCZAABH-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(2-morpholin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCCN1CCOCC1 QACYESHTCZAABH-UHFFFAOYSA-N 0.000 description 1
- DPLJBMIVYNUHOA-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(2-piperidin-1-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCCN1CCCCC1 DPLJBMIVYNUHOA-UHFFFAOYSA-N 0.000 description 1
- BJFVGUFGHFNMNA-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(2-pyridin-2-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCCC1=CC=CC=N1 BJFVGUFGHFNMNA-UHFFFAOYSA-N 0.000 description 1
- IDIZQCMTWOTREH-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(2-pyridin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCCC1=CC=NC=C1 IDIZQCMTWOTREH-UHFFFAOYSA-N 0.000 description 1
- IDXFDTCHRUGTHZ-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(3-imidazol-1-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCCCN1C=CN=C1 IDXFDTCHRUGTHZ-UHFFFAOYSA-N 0.000 description 1
- ALQRCXABEIWOMF-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCCCN1CCOCC1 ALQRCXABEIWOMF-UHFFFAOYSA-N 0.000 description 1
- NFWAILRTYALENX-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(3-pyridin-2-ylpyrrolidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N(C1)CCC1C1=CC=CC=N1 NFWAILRTYALENX-UHFFFAOYSA-N 0.000 description 1
- ROOCWOHCMOZBHN-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(3-pyridin-4-ylpyrrolidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N(C1)CCC1C1=CC=NC=C1 ROOCWOHCMOZBHN-UHFFFAOYSA-N 0.000 description 1
- ZSDPLWFHFFYRKU-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C)CCCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O ZSDPLWFHFFYRKU-UHFFFAOYSA-N 0.000 description 1
- AFXDOJRPZYPDPD-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(4-propan-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C(C)C)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O AFXDOJRPZYPDPD-UHFFFAOYSA-N 0.000 description 1
- WXUWIQJCXJGUEE-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(4-propylpiperidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CC(CCC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O WXUWIQJCXJGUEE-UHFFFAOYSA-N 0.000 description 1
- KAQMZKYEFKKYOU-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(4-pyrazin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N(CC1)CCN1C1=CN=CC=N1 KAQMZKYEFKKYOU-UHFFFAOYSA-N 0.000 description 1
- MXKJGCKONUULFV-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(4-pyrimidin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N(CC1)CCN1C1=NC=CC=N1 MXKJGCKONUULFV-UHFFFAOYSA-N 0.000 description 1
- PDRQQHVFQAHHKJ-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(5-oxo-1,4-diazepan-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N1CCNC(=O)CC1 PDRQQHVFQAHHKJ-UHFFFAOYSA-N 0.000 description 1
- AKAPAGYVLPDKIY-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(oxan-4-ylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NC1CCOCC1 AKAPAGYVLPDKIY-UHFFFAOYSA-N 0.000 description 1
- KHTWOYAORWYVHP-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(oxan-4-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1CCOCC1 KHTWOYAORWYVHP-UHFFFAOYSA-N 0.000 description 1
- XXHWJWOVFZGXNL-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(oxolan-2-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1CCCO1 XXHWJWOVFZGXNL-UHFFFAOYSA-N 0.000 description 1
- DFENXBNZNCXVAZ-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-(pyridin-4-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1=CC=NC=C1 DFENXBNZNCXVAZ-UHFFFAOYSA-N 0.000 description 1
- NQQQMHDKVWNYKT-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-[(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1NC(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O NQQQMHDKVWNYKT-UHFFFAOYSA-N 0.000 description 1
- KWIHKZTUWXESCA-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-[(5-methylpyrazin-2-yl)methylamino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O KWIHKZTUWXESCA-UHFFFAOYSA-N 0.000 description 1
- HYUZNLKXWPCMPZ-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-[2-methoxyethyl(propyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(N(CCOC)CCC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O HYUZNLKXWPCMPZ-UHFFFAOYSA-N 0.000 description 1
- VSSIJZOPVQCYFW-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-[3-(2-methylpiperidin-1-yl)propylamino]anilino]methylidene]-1h-indol-2-one Chemical compound CC1CCCCN1CCCNC(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O VSSIJZOPVQCYFW-UHFFFAOYSA-N 0.000 description 1
- ZXRXTSJAVHIRPE-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-[4-(2-methoxyethyl)piperazin-1-yl]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O ZXRXTSJAVHIRPE-UHFFFAOYSA-N 0.000 description 1
- QJJWSJOQMWVSML-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-[methyl(2-pyridin-2-ylethyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(F)C=CC=C3NC2=O)C=C(F)C=1N(C)CCC1=CC=CC=N1 QJJWSJOQMWVSML-UHFFFAOYSA-N 0.000 description 1
- NMGNXASJWWSKOQ-UHFFFAOYSA-N 4-fluoro-3-[[3-fluoro-4-[methyl(pyridin-3-ylmethyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(F)C=CC=C3NC2=O)C=C(F)C=1N(C)CC1=CC=CN=C1 NMGNXASJWWSKOQ-UHFFFAOYSA-N 0.000 description 1
- ATXKYOUYUJVYLK-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-(2-piperidin-1-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NCCN1CCCCC1 ATXKYOUYUJVYLK-UHFFFAOYSA-N 0.000 description 1
- CEPDJLSFFDXOIS-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-(2-pyridin-2-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NCCC1=CC=CC=N1 CEPDJLSFFDXOIS-UHFFFAOYSA-N 0.000 description 1
- ZUGCRAWVRUMFAJ-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-(2-pyridin-3-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NCCC1=CC=CN=C1 ZUGCRAWVRUMFAJ-UHFFFAOYSA-N 0.000 description 1
- RCKNSMDAYLYARU-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-(2-pyridin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NCCC1=CC=NC=C1 RCKNSMDAYLYARU-UHFFFAOYSA-N 0.000 description 1
- YBVHDMDPBWSQSC-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NCCCN1CCOCC1 YBVHDMDPBWSQSC-UHFFFAOYSA-N 0.000 description 1
- YNGOJPZPSGZNSJ-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-(oxan-4-ylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NC1CCOCC1 YNGOJPZPSGZNSJ-UHFFFAOYSA-N 0.000 description 1
- OBGDPVDSNDGETK-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-(oxan-4-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NCC1CCOCC1 OBGDPVDSNDGETK-UHFFFAOYSA-N 0.000 description 1
- JFDVGQVECPSCTJ-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-(pyridin-2-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NCC1=CC=CC=N1 JFDVGQVECPSCTJ-UHFFFAOYSA-N 0.000 description 1
- MULJHHSDSVBNTD-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-(pyridin-3-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NCC1=CC=CN=C1 MULJHHSDSVBNTD-UHFFFAOYSA-N 0.000 description 1
- GPDWFUHCGKXRSS-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-[(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1NC(C(=C1)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O GPDWFUHCGKXRSS-UHFFFAOYSA-N 0.000 description 1
- YTUYAICPVRZPNR-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-[(5-methylpyrazin-2-yl)methylamino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O YTUYAICPVRZPNR-UHFFFAOYSA-N 0.000 description 1
- HFXYHTOSXLZZHG-UHFFFAOYSA-N 4-fluoro-3-[[3-methyl-4-[3-(2-methylpiperidin-1-yl)propylamino]anilino]methylidene]-1h-indol-2-one Chemical compound CC1CCCCN1CCCNC(C(=C1)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O HFXYHTOSXLZZHG-UHFFFAOYSA-N 0.000 description 1
- VVLPDEKCSZROQJ-UHFFFAOYSA-N 4-fluoro-3-[[4-(1-methoxybutan-2-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(COC)CC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O VVLPDEKCSZROQJ-UHFFFAOYSA-N 0.000 description 1
- LBVVXQVULSOFBW-UHFFFAOYSA-N 4-fluoro-3-[[4-(1-methoxybutan-2-ylamino)-3-methylanilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C)C(NC(COC)CC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O LBVVXQVULSOFBW-UHFFFAOYSA-N 0.000 description 1
- VOCBYFMSHWEMOB-UHFFFAOYSA-N 4-fluoro-3-[[4-(1-methoxypropan-2-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(C)COC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O VOCBYFMSHWEMOB-UHFFFAOYSA-N 0.000 description 1
- OEYIPVUHZDWDPO-UHFFFAOYSA-N 4-fluoro-3-[[4-(1-methoxypropan-2-ylamino)-3-methylanilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C)C(NC(C)COC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O OEYIPVUHZDWDPO-UHFFFAOYSA-N 0.000 description 1
- AUNPZVGEHSDNCV-UHFFFAOYSA-N 4-fluoro-3-[[4-(2-hydroxyethylamino)-3-methylanilino]methylidene]-1h-indol-2-one Chemical compound C1=C(NCCO)C(C)=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=C1 AUNPZVGEHSDNCV-UHFFFAOYSA-N 0.000 description 1
- DYQUPTSMDMELCD-UHFFFAOYSA-N 4-fluoro-3-[[4-(2-methoxyethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCOC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O DYQUPTSMDMELCD-UHFFFAOYSA-N 0.000 description 1
- YFNBGCHZACDAFC-UHFFFAOYSA-N 4-fluoro-3-[[4-(2-piperidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1OCCN1CCCCC1 YFNBGCHZACDAFC-UHFFFAOYSA-N 0.000 description 1
- WSNSMASALYSROS-UHFFFAOYSA-N 4-fluoro-3-[[4-(2-piperidin-1-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NCCN1CCCCC1 WSNSMASALYSROS-UHFFFAOYSA-N 0.000 description 1
- DUSRYZZNKQKPQG-UHFFFAOYSA-N 4-fluoro-3-[[4-(2-pyridin-4-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NCCC1=CC=NC=C1 DUSRYZZNKQKPQG-UHFFFAOYSA-N 0.000 description 1
- WQJRHLLNUPNAEY-UHFFFAOYSA-N 4-fluoro-3-[[4-(2-pyrrolidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1OCCN1CCCC1 WQJRHLLNUPNAEY-UHFFFAOYSA-N 0.000 description 1
- PYCQGCMNEZWHDA-UHFFFAOYSA-N 4-fluoro-3-[[4-(3-methylpiperidin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)CCCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O PYCQGCMNEZWHDA-UHFFFAOYSA-N 0.000 description 1
- HUKGOONEBLOBEW-UHFFFAOYSA-N 4-fluoro-3-[[4-(3-piperidin-1-ylpropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1OCCCN1CCCCC1 HUKGOONEBLOBEW-UHFFFAOYSA-N 0.000 description 1
- NKESIEGDZXCREA-UHFFFAOYSA-N 4-fluoro-3-[[4-(3-pyridin-2-ylpyrrolidin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N(C1)CCC1C1=CC=CC=N1 NKESIEGDZXCREA-UHFFFAOYSA-N 0.000 description 1
- BHAQFABNGZWLJT-UHFFFAOYSA-N 4-fluoro-3-[[4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O BHAQFABNGZWLJT-UHFFFAOYSA-N 0.000 description 1
- YIUHEINGPQSCCC-UHFFFAOYSA-N 4-fluoro-3-[[4-(4-methylpiperidin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CC(C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O YIUHEINGPQSCCC-UHFFFAOYSA-N 0.000 description 1
- YNVZSYJGAXYBDC-UHFFFAOYSA-N 4-fluoro-3-[[4-(4-piperidin-1-ylbutyl)anilino]methylidene]-1h-indol-2-one;5-fluoro-3-[[4-(4-piperidin-1-ylbutyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1CCCCN1CCCCC1.C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1CCCCN1CCCCC1 YNVZSYJGAXYBDC-UHFFFAOYSA-N 0.000 description 1
- BJTOVXLTYTZHHB-UHFFFAOYSA-N 4-fluoro-3-[[4-(4-propan-2-ylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C(C)C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O BJTOVXLTYTZHHB-UHFFFAOYSA-N 0.000 description 1
- ZVUMUKZVDKRCEO-UHFFFAOYSA-N 4-fluoro-3-[[4-(4-propylpiperidin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CC(CCC)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O ZVUMUKZVDKRCEO-UHFFFAOYSA-N 0.000 description 1
- JEQOYTPBAJVORG-UHFFFAOYSA-N 4-fluoro-3-[[4-(4-pyrimidin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1N(CC1)CCN1C1=NC=CC=N1 JEQOYTPBAJVORG-UHFFFAOYSA-N 0.000 description 1
- PYIJPXORLXJHTN-UHFFFAOYSA-N 4-fluoro-3-[[4-(oxan-4-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NC1CCOCC1 PYIJPXORLXJHTN-UHFFFAOYSA-N 0.000 description 1
- KMAJELRXIBVKEM-UHFFFAOYSA-N 4-fluoro-3-[[4-(oxan-4-ylmethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NCC1CCOCC1 KMAJELRXIBVKEM-UHFFFAOYSA-N 0.000 description 1
- CWENORWPIGUQHM-UHFFFAOYSA-N 4-fluoro-3-[[4-(oxolan-2-ylmethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NCC1CCCO1 CWENORWPIGUQHM-UHFFFAOYSA-N 0.000 description 1
- URFWSVSJICUUDQ-UHFFFAOYSA-N 4-fluoro-3-[[4-[(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1NC(C=C1)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O URFWSVSJICUUDQ-UHFFFAOYSA-N 0.000 description 1
- GAHOUGLIKVXQDE-UHFFFAOYSA-N 4-fluoro-3-[[4-[(1-methylpiperidin-3-yl)methoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1N(C)CCCC1COC(C=C1)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O GAHOUGLIKVXQDE-UHFFFAOYSA-N 0.000 description 1
- XYIJSHFDVLTYHK-UHFFFAOYSA-N 4-fluoro-3-[[4-[(5-methylpyrazin-2-yl)methylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O XYIJSHFDVLTYHK-UHFFFAOYSA-N 0.000 description 1
- ZZBIIXZICLBTEE-UHFFFAOYSA-N 4-fluoro-3-[[4-[2-(3-fluoropyrrolidin-1-yl)ethoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(F)CCN1CCOC(C=C1)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O ZZBIIXZICLBTEE-UHFFFAOYSA-N 0.000 description 1
- RXJPASMSAHPXSV-UHFFFAOYSA-N 4-fluoro-3-[[4-[2-methoxyethyl(propyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(N(CCOC)CCC)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O RXJPASMSAHPXSV-UHFFFAOYSA-N 0.000 description 1
- GNLGCDNPKCCRFX-UHFFFAOYSA-N 4-fluoro-3-[[4-[3-(2-methylpiperidin-1-yl)propylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound CC1CCCCN1CCCNC(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O GNLGCDNPKCCRFX-UHFFFAOYSA-N 0.000 description 1
- TUGCONLUIDPXQF-UHFFFAOYSA-N 4-fluoro-3-[[4-[3-(3-fluoropyrrolidin-1-yl)propoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(F)CCN1CCCOC(C=C1)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O TUGCONLUIDPXQF-UHFFFAOYSA-N 0.000 description 1
- KZSSWIVMJKQXHE-UHFFFAOYSA-N 4-fluoro-3-[[4-[4-(2-methoxyethyl)piperazin-1-yl]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O KZSSWIVMJKQXHE-UHFFFAOYSA-N 0.000 description 1
- GMGLIMNJLBZOND-UHFFFAOYSA-N 4-fluoro-3-[[4-[4-(2-methoxyethyl)piperazin-1-yl]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C=C1)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O GMGLIMNJLBZOND-UHFFFAOYSA-N 0.000 description 1
- IDJZWUYDEIKERW-UHFFFAOYSA-N 4-fluoro-3-[[4-[methyl(2-pyridin-2-ylethyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(F)C=CC=C3NC2=O)C=CC=1N(C)CCC1=CC=CC=N1 IDJZWUYDEIKERW-UHFFFAOYSA-N 0.000 description 1
- DALRQMDRVSGFQN-UHFFFAOYSA-N 4-fluoro-3-[[4-morpholin-4-yl-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N1CCOCC1 DALRQMDRVSGFQN-UHFFFAOYSA-N 0.000 description 1
- MSNKJKQLLPAXHT-UHFFFAOYSA-N 4-fluoro-3-[[4-thiomorpholin-4-yl-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N1CCSCC1 MSNKJKQLLPAXHT-UHFFFAOYSA-N 0.000 description 1
- QYBDRNQHBZSOFP-UHFFFAOYSA-N 4-methyl-3-[[3-methyl-4-(2-morpholin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C)=CC=C1NCCN1CCOCC1 QYBDRNQHBZSOFP-UHFFFAOYSA-N 0.000 description 1
- MOQQPHVZZKXEOI-UHFFFAOYSA-N 4-methyl-3-[[3-methyl-4-(2-piperidin-1-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C)=CC=C1NCCN1CCCCC1 MOQQPHVZZKXEOI-UHFFFAOYSA-N 0.000 description 1
- KVNOUUNLNHUTBF-UHFFFAOYSA-N 4-methyl-3-[[3-methyl-4-(2-pyridin-2-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C)=CC=C1NCCC1=CC=CC=N1 KVNOUUNLNHUTBF-UHFFFAOYSA-N 0.000 description 1
- DBFZHJGLXHTCIX-UHFFFAOYSA-N 4-methyl-3-[[3-methyl-4-(2-pyridin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C)=CC=C1NCCC1=CC=NC=C1 DBFZHJGLXHTCIX-UHFFFAOYSA-N 0.000 description 1
- FUBLHJHHHNHOJE-UHFFFAOYSA-N 4-methyl-3-[[3-methyl-4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C)=CC=C1NCCCN1CCOCC1 FUBLHJHHHNHOJE-UHFFFAOYSA-N 0.000 description 1
- DTROYMPZJHEPEK-UHFFFAOYSA-N 4-methyl-3-[[3-methyl-4-(3-pyridin-2-ylpyrrolidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C)=CC=C1N(C1)CCC1C1=CC=CC=N1 DTROYMPZJHEPEK-UHFFFAOYSA-N 0.000 description 1
- XNXBLBXMAANUJQ-UHFFFAOYSA-N 4-methyl-3-[[3-methyl-4-[methyl(2-pyridin-2-ylethyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=C(C)C=CC=C3NC2=O)C=C(C)C=1N(C)CCC1=CC=CC=N1 XNXBLBXMAANUJQ-UHFFFAOYSA-N 0.000 description 1
- XJROAKSXZVMWIF-UHFFFAOYSA-N 4-methyl-3-[[4-(2-morpholin-4-ylethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1CCN1CCOCC1 XJROAKSXZVMWIF-UHFFFAOYSA-N 0.000 description 1
- FONMBASZACUQTB-UHFFFAOYSA-N 4-methyl-3-[[4-(2-piperidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1OCCN1CCCCC1 FONMBASZACUQTB-UHFFFAOYSA-N 0.000 description 1
- YLHBPQSRXNJCQI-UHFFFAOYSA-N 4-methyl-3-[[4-(2-piperidin-1-ylethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1CCN1CCCCC1 YLHBPQSRXNJCQI-UHFFFAOYSA-N 0.000 description 1
- JWGTTZCJNFINQO-UHFFFAOYSA-N 4-methyl-3-[[4-(2-pyridin-2-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NCCC1=CC=CC=N1 JWGTTZCJNFINQO-UHFFFAOYSA-N 0.000 description 1
- VOFMPGFBZYRJNF-UHFFFAOYSA-N 4-methyl-3-[[4-(2-pyridin-4-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NCCC1=CC=NC=C1 VOFMPGFBZYRJNF-UHFFFAOYSA-N 0.000 description 1
- MLKBOULKHGMPGQ-UHFFFAOYSA-N 4-methyl-3-[[4-(2-pyrrolidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1OCCN1CCCC1 MLKBOULKHGMPGQ-UHFFFAOYSA-N 0.000 description 1
- MGYNJNGAOYFAJH-UHFFFAOYSA-N 4-methyl-3-[[4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1NCCCN1CCOCC1 MGYNJNGAOYFAJH-UHFFFAOYSA-N 0.000 description 1
- NYOIGDHSYVCKPF-UHFFFAOYSA-N 4-methyl-3-[[4-(3-piperidin-1-ylpropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1OCCCN1CCCCC1 NYOIGDHSYVCKPF-UHFFFAOYSA-N 0.000 description 1
- DKIUNTXZADLHQP-UHFFFAOYSA-N 4-methyl-3-[[4-(3-pyridin-2-ylpyrrolidin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N(C1)CCC1C1=CC=CC=N1 DKIUNTXZADLHQP-UHFFFAOYSA-N 0.000 description 1
- TXPUQRAPHQVBFJ-UHFFFAOYSA-N 4-methyl-3-[[4-(4-morpholin-4-ylbutyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1CCCCN1CCOCC1 TXPUQRAPHQVBFJ-UHFFFAOYSA-N 0.000 description 1
- STSCXRCWOXJCIG-UHFFFAOYSA-N 4-methyl-3-[[4-(4-piperidin-1-ylbutoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1OCCCCN1CCCCC1 STSCXRCWOXJCIG-UHFFFAOYSA-N 0.000 description 1
- DFUUSWYLFYYCKM-UHFFFAOYSA-N 4-methyl-3-[[4-(4-piperidin-1-ylbutyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1CCCCN1CCCCC1 DFUUSWYLFYYCKM-UHFFFAOYSA-N 0.000 description 1
- WFKKGJJWPBWCSF-UHFFFAOYSA-N 4-methyl-3-[[4-(morpholin-4-ylmethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1CN1CCOCC1 WFKKGJJWPBWCSF-UHFFFAOYSA-N 0.000 description 1
- WPOVVNVSHNHNLY-UHFFFAOYSA-N 4-methyl-3-[[4-(morpholine-4-carbothioyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1C(=S)N1CCOCC1 WPOVVNVSHNHNLY-UHFFFAOYSA-N 0.000 description 1
- KVWXZTYCRYPHPK-UHFFFAOYSA-N 4-methyl-3-[[4-(oxan-4-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NC1CCOCC1 KVWXZTYCRYPHPK-UHFFFAOYSA-N 0.000 description 1
- DHDBELQWEIEBCG-UHFFFAOYSA-N 4-methyl-3-[[4-(piperidin-1-ylmethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1CN1CCCCC1 DHDBELQWEIEBCG-UHFFFAOYSA-N 0.000 description 1
- NGNKVHBPBGOSQQ-UHFFFAOYSA-N 4-methyl-3-[[4-[(1-methylpiperidin-3-yl)methoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1N(C)CCCC1COC(C=C1)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O NGNKVHBPBGOSQQ-UHFFFAOYSA-N 0.000 description 1
- AUATXGKIBGISMA-UHFFFAOYSA-N 4-methyl-3-[[4-pyrrolidin-1-yl-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N1CCCC1 AUATXGKIBGISMA-UHFFFAOYSA-N 0.000 description 1
- PHNDZBFLOPIMSM-UHFFFAOYSA-N 4-morpholin-4-ylaniline Chemical compound C1=CC(N)=CC=C1N1CCOCC1 PHNDZBFLOPIMSM-UHFFFAOYSA-N 0.000 description 1
- YRISKTNAYHHICR-UHFFFAOYSA-N 4-piperidin-1-ylbutan-1-ol Chemical compound OCCCCN1CCCCC1 YRISKTNAYHHICR-UHFFFAOYSA-N 0.000 description 1
- IHJSCMUMZZQSPU-UHFFFAOYSA-N 5-chloro-3-[[4-(2-piperidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1OCCN1CCCCC1 IHJSCMUMZZQSPU-UHFFFAOYSA-N 0.000 description 1
- UTUGWSZLDRHYRJ-UHFFFAOYSA-N 5-chloro-3-[[4-(2-pyrrolidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1OCCN1CCCC1 UTUGWSZLDRHYRJ-UHFFFAOYSA-N 0.000 description 1
- UFOYSUAHBJOOGO-UHFFFAOYSA-N 5-chloro-3-[[4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-1h-indol-2-one;5-fluoro-3-[[4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1NCCCN1CCOCC1.C12=CC(Cl)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1NCCCN1CCOCC1 UFOYSUAHBJOOGO-UHFFFAOYSA-N 0.000 description 1
- KBCXFFJRJZTOSO-UHFFFAOYSA-N 5-chloro-3-[[4-(3-piperidin-1-ylpropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1OCCCN1CCCCC1 KBCXFFJRJZTOSO-UHFFFAOYSA-N 0.000 description 1
- VIXYSKLPXQJZGK-UHFFFAOYSA-N 5-chloro-3-[[4-(4-morpholin-4-ylbutyl)anilino]methylidene]-1h-indol-2-one;4-methyl-3-[[4-(4-morpholin-4-ylbutyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1CCCCN1CCOCC1.C12=CC(Cl)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1CCCCN1CCOCC1 VIXYSKLPXQJZGK-UHFFFAOYSA-N 0.000 description 1
- XGWXAKRBKDBXMH-UHFFFAOYSA-N 5-chloro-3-[[4-[(1-methylpiperidin-3-yl)methoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1N(C)CCCC1COC(C=C1)=CC=C1NC=C1C2=CC(Cl)=CC=C2NC1=O XGWXAKRBKDBXMH-UHFFFAOYSA-N 0.000 description 1
- MJPJENQXHWTJDF-UHFFFAOYSA-N 5-chloro-3-[[4-[(1-methylpiperidin-3-yl)methoxy]anilino]methylidene]-1h-indol-2-one;3-[[4-(2-piperidin-1-ylethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=CNC(C=C1)=CC=C1CCN1CCCCC1.C1N(C)CCCC1COC(C=C1)=CC=C1NC=C1C2=CC(Cl)=CC=C2NC1=O MJPJENQXHWTJDF-UHFFFAOYSA-N 0.000 description 1
- CTGGMXRUIVZTKX-UHFFFAOYSA-N 5-chloro-3-[[4-[2-(3-fluoropyrrolidin-1-yl)ethoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(F)CCN1CCOC(C=C1)=CC=C1NC=C1C2=CC(Cl)=CC=C2NC1=O CTGGMXRUIVZTKX-UHFFFAOYSA-N 0.000 description 1
- KVSAVNTXBINCRI-UHFFFAOYSA-N 5-chloro-3-[[4-[3-(3-fluoropyrrolidin-1-yl)propoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(F)CCN1CCCOC(C=C1)=CC=C1NC=C1C2=CC(Cl)=CC=C2NC1=O KVSAVNTXBINCRI-UHFFFAOYSA-N 0.000 description 1
- LOPGUOHJCQVSQX-UHFFFAOYSA-N 5-chloro-3-[[4-[3-(diethylamino)propoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(OCCCN(CC)CC)=CC=C1NC=C1C2=CC(Cl)=CC=C2NC1=O LOPGUOHJCQVSQX-UHFFFAOYSA-N 0.000 description 1
- JDEXGIVTMVDOIY-UHFFFAOYSA-N 5-fluoro-3-(hydroxymethylidene)-1h-indol-2-one Chemical compound C1=C(F)C=C2C(=CO)C(=O)NC2=C1 JDEXGIVTMVDOIY-UHFFFAOYSA-N 0.000 description 1
- BOXGYGUVXMVPMS-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(1-methoxybutan-2-ylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(NC(COC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O BOXGYGUVXMVPMS-UHFFFAOYSA-N 0.000 description 1
- PKEWVYMOQOEYCA-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(1-methoxypropan-2-ylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(NC(C)COC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O PKEWVYMOQOEYCA-UHFFFAOYSA-N 0.000 description 1
- LMZBEUCQGQOZQG-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(2-methoxyethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(NCCOC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O LMZBEUCQGQOZQG-UHFFFAOYSA-N 0.000 description 1
- RDUKVKLRNSMFOQ-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(2-pyridin-3-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1NCCC1=CC=CN=C1 RDUKVKLRNSMFOQ-UHFFFAOYSA-N 0.000 description 1
- QRSZDPQWCMBYII-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(2-pyridin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1NCCC1=CC=NC=C1 QRSZDPQWCMBYII-UHFFFAOYSA-N 0.000 description 1
- SOYNUNMCNBMNJJ-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(3-imidazol-1-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1NCCCN1C=CN=C1 SOYNUNMCNBMNJJ-UHFFFAOYSA-N 0.000 description 1
- CEMTVHHLZAENQK-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1NCCCN1CCOCC1 CEMTVHHLZAENQK-UHFFFAOYSA-N 0.000 description 1
- MOPQGOKTPULHHN-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(3-pyridin-2-ylpyrrolidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1N(C1)CCC1C1=CC=CC=N1 MOPQGOKTPULHHN-UHFFFAOYSA-N 0.000 description 1
- WBVRRHUGLIJUHB-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(3-pyridin-4-ylpyrrolidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1N(C1)CCC1C1=CC=NC=C1 WBVRRHUGLIJUHB-UHFFFAOYSA-N 0.000 description 1
- PHTLZWQJFOEDDR-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(4-methyl-1,4-diazepan-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C)CCCN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O PHTLZWQJFOEDDR-UHFFFAOYSA-N 0.000 description 1
- BTFQUHXSWNIBLT-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(4-propan-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C(C)C)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O BTFQUHXSWNIBLT-UHFFFAOYSA-N 0.000 description 1
- PRMYGVHANNGWLP-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(4-pyrazin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1N(CC1)CCN1C1=CN=CC=N1 PRMYGVHANNGWLP-UHFFFAOYSA-N 0.000 description 1
- BYSQTPNHVGTNKG-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(oxan-4-ylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1NC1CCOCC1 BYSQTPNHVGTNKG-UHFFFAOYSA-N 0.000 description 1
- HHYNBPYARUVXDJ-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(oxan-4-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1CCOCC1 HHYNBPYARUVXDJ-UHFFFAOYSA-N 0.000 description 1
- RPMLBNVMTPXCJA-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-(oxolan-2-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1F)=CC=C1NCC1CCCO1 RPMLBNVMTPXCJA-UHFFFAOYSA-N 0.000 description 1
- GLUQKIACRONPGB-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-[(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1NC(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O GLUQKIACRONPGB-UHFFFAOYSA-N 0.000 description 1
- NFWYOJSZJRTIKF-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-[(5-methylpyrazin-2-yl)methylamino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O NFWYOJSZJRTIKF-UHFFFAOYSA-N 0.000 description 1
- PFUNZCQWGALAKD-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-[2-methoxyethyl(methyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(N(C)CCOC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O PFUNZCQWGALAKD-UHFFFAOYSA-N 0.000 description 1
- PYYDKGYXLYRSOT-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-[2-methoxyethyl(propyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(N(CCOC)CCC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O PYYDKGYXLYRSOT-UHFFFAOYSA-N 0.000 description 1
- LCOOUEMQZCSKFZ-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-[4-(2-methoxyethyl)piperazin-1-yl]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O LCOOUEMQZCSKFZ-UHFFFAOYSA-N 0.000 description 1
- ZERWFBWDPHQHKY-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-[methyl(2-pyridin-2-ylethyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC(F)=CC=C3NC2=O)C=C(F)C=1N(C)CCC1=CC=CC=N1 ZERWFBWDPHQHKY-UHFFFAOYSA-N 0.000 description 1
- TZDDRNNPANMFCD-UHFFFAOYSA-N 5-fluoro-3-[[3-fluoro-4-[methyl(pyridin-3-ylmethyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC(F)=CC=C3NC2=O)C=C(F)C=1N(C)CC1=CC=CN=C1 TZDDRNNPANMFCD-UHFFFAOYSA-N 0.000 description 1
- CTXPBUVUHKPYLX-UHFFFAOYSA-N 5-fluoro-3-[[3-methyl-4-(2-morpholin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1NCCN1CCOCC1 CTXPBUVUHKPYLX-UHFFFAOYSA-N 0.000 description 1
- JDQAWHULDYIOBM-UHFFFAOYSA-N 5-fluoro-3-[[3-methyl-4-(2-piperidin-1-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1NCCN1CCCCC1 JDQAWHULDYIOBM-UHFFFAOYSA-N 0.000 description 1
- RETSIYIWIWRMIO-UHFFFAOYSA-N 5-fluoro-3-[[3-methyl-4-(2-pyridin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1NCCC1=CC=NC=C1 RETSIYIWIWRMIO-UHFFFAOYSA-N 0.000 description 1
- XZDZMNAKBAEQSZ-UHFFFAOYSA-N 5-fluoro-3-[[3-methyl-4-(3-pyridin-2-ylpyrrolidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1N(C1)CCC1C1=CC=CC=N1 XZDZMNAKBAEQSZ-UHFFFAOYSA-N 0.000 description 1
- ROTUCOSVVMZGGG-UHFFFAOYSA-N 5-fluoro-3-[[3-methyl-4-(3-pyridin-4-ylpyrrolidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1N(C1)CCC1C1=CC=NC=C1 ROTUCOSVVMZGGG-UHFFFAOYSA-N 0.000 description 1
- GTWLDWCPYKNTBX-UHFFFAOYSA-N 5-fluoro-3-[[3-methyl-4-(4-propylpiperidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CC(CCC)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O GTWLDWCPYKNTBX-UHFFFAOYSA-N 0.000 description 1
- JCJSQZACIUPOIP-UHFFFAOYSA-N 5-fluoro-3-[[3-methyl-4-(oxan-4-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1NCC1CCOCC1 JCJSQZACIUPOIP-UHFFFAOYSA-N 0.000 description 1
- RSTBMNDCPBZRTB-UHFFFAOYSA-N 5-fluoro-3-[[3-methyl-4-[(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1NC(C(=C1)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O RSTBMNDCPBZRTB-UHFFFAOYSA-N 0.000 description 1
- JBFWFSNHQJZRTL-UHFFFAOYSA-N 5-fluoro-3-[[3-methyl-4-[(5-methylpyrazin-2-yl)methylamino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O JBFWFSNHQJZRTL-UHFFFAOYSA-N 0.000 description 1
- FSLAJYFKXSOFRC-UHFFFAOYSA-N 5-fluoro-3-[[3-methyl-4-[3-(2-methylpiperidin-1-yl)propylamino]anilino]methylidene]-1h-indol-2-one Chemical compound CC1CCCCN1CCCNC(C(=C1)C)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O FSLAJYFKXSOFRC-UHFFFAOYSA-N 0.000 description 1
- YZUGCFVKXGWGMO-UHFFFAOYSA-N 5-fluoro-3-[[4-(1-methoxybutan-2-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(COC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O YZUGCFVKXGWGMO-UHFFFAOYSA-N 0.000 description 1
- VELMUZNLNTYEIP-UHFFFAOYSA-N 5-fluoro-3-[[4-(1-methoxybutan-2-ylamino)-3-methylanilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C)C(NC(COC)CC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O VELMUZNLNTYEIP-UHFFFAOYSA-N 0.000 description 1
- RVXWXPATQNSQCF-UHFFFAOYSA-N 5-fluoro-3-[[4-(1-methoxypropan-2-ylamino)-3-methylanilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C)C(NC(C)COC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O RVXWXPATQNSQCF-UHFFFAOYSA-N 0.000 description 1
- SXRIJLOUJWRETL-UHFFFAOYSA-N 5-fluoro-3-[[4-(2-methoxyethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCOC)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O SXRIJLOUJWRETL-UHFFFAOYSA-N 0.000 description 1
- ARFCNYZDKSEEAX-UHFFFAOYSA-N 5-fluoro-3-[[4-(2-morpholin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1NCCN1CCOCC1 ARFCNYZDKSEEAX-UHFFFAOYSA-N 0.000 description 1
- XKLKJBDKORZZDT-UHFFFAOYSA-N 5-fluoro-3-[[4-(2-piperidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1OCCN1CCCCC1 XKLKJBDKORZZDT-UHFFFAOYSA-N 0.000 description 1
- GYVOTXNIZKXFQY-UHFFFAOYSA-N 5-fluoro-3-[[4-(2-piperidin-1-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NCCN1CCCCC1 GYVOTXNIZKXFQY-UHFFFAOYSA-N 0.000 description 1
- HJKABFJALKOZLQ-UHFFFAOYSA-N 5-fluoro-3-[[4-(2-pyrrolidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1OCCN1CCCC1 HJKABFJALKOZLQ-UHFFFAOYSA-N 0.000 description 1
- CZAXOECFSPJPCB-UHFFFAOYSA-N 5-fluoro-3-[[4-(3-imidazol-1-ylpropylamino)-3-methylanilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1NCCCN1C=CN=C1 CZAXOECFSPJPCB-UHFFFAOYSA-N 0.000 description 1
- UKTNWJHBGCWDPV-UHFFFAOYSA-N 5-fluoro-3-[[4-(3-morpholin-4-ylpropylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NCCCN1CCOCC1 UKTNWJHBGCWDPV-UHFFFAOYSA-N 0.000 description 1
- XZHGKPNCXOKBIS-UHFFFAOYSA-N 5-fluoro-3-[[4-(3-piperidin-1-ylpropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1OCCCN1CCCCC1 XZHGKPNCXOKBIS-UHFFFAOYSA-N 0.000 description 1
- DMEXUXWVXPZHEV-UHFFFAOYSA-N 5-fluoro-3-[[4-(4-methyl-1,4-diazepan-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C)CCCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O DMEXUXWVXPZHEV-UHFFFAOYSA-N 0.000 description 1
- UUWUNIYUOKPAEZ-UHFFFAOYSA-N 5-fluoro-3-[[4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O UUWUNIYUOKPAEZ-UHFFFAOYSA-N 0.000 description 1
- WVQFRSSWSOFRHB-UHFFFAOYSA-N 5-fluoro-3-[[4-(4-pyrazin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1N(CC1)CCN1C1=CN=CC=N1 WVQFRSSWSOFRHB-UHFFFAOYSA-N 0.000 description 1
- OSQMGNBCDMJJGQ-UHFFFAOYSA-N 5-fluoro-3-[[4-(4-pyrimidin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1)=CC=C1N(CC1)CCN1C1=NC=CC=N1 OSQMGNBCDMJJGQ-UHFFFAOYSA-N 0.000 description 1
- OZIYDEWMKVYLQH-UHFFFAOYSA-N 5-fluoro-3-[[4-(5-oxo-1,4-diazepan-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1N1CCNC(=O)CC1 OZIYDEWMKVYLQH-UHFFFAOYSA-N 0.000 description 1
- FTJVRDJOIAITBH-UHFFFAOYSA-N 5-fluoro-3-[[4-(oxan-4-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NC1CCOCC1 FTJVRDJOIAITBH-UHFFFAOYSA-N 0.000 description 1
- MBBCFHFXVMPYKZ-UHFFFAOYSA-N 5-fluoro-3-[[4-(oxan-4-ylmethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC(F)=CC=C2NC(=O)C1=CNC(C=C1C(F)(F)F)=CC=C1NCC1CCOCC1 MBBCFHFXVMPYKZ-UHFFFAOYSA-N 0.000 description 1
- FEGAURYEPGEQJR-UHFFFAOYSA-N 5-fluoro-3-[[4-[(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1NC(C=C1)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O FEGAURYEPGEQJR-UHFFFAOYSA-N 0.000 description 1
- AXOAOKQAQZWKAE-UHFFFAOYSA-N 5-fluoro-3-[[4-[(1-methylpiperidin-3-yl)methoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1N(C)CCCC1COC(C=C1)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O AXOAOKQAQZWKAE-UHFFFAOYSA-N 0.000 description 1
- HTMBBXNBUKCUIY-UHFFFAOYSA-N 5-fluoro-3-[[4-[(5-methylpyrazin-2-yl)methylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O HTMBBXNBUKCUIY-UHFFFAOYSA-N 0.000 description 1
- XKMJPCLGONIEAY-UHFFFAOYSA-N 5-fluoro-3-[[4-[2-(1h-imidazol-5-yl)ethylamino]-3-methylanilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1NCCC1=CNC=N1 XKMJPCLGONIEAY-UHFFFAOYSA-N 0.000 description 1
- KCGZATCJOTZIAL-UHFFFAOYSA-N 5-fluoro-3-[[4-[2-(3-fluoropyrrolidin-1-yl)ethoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(F)CCN1CCOC(C=C1)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O KCGZATCJOTZIAL-UHFFFAOYSA-N 0.000 description 1
- JIQGYCFBDSWWDO-UHFFFAOYSA-N 5-fluoro-3-[[4-[3-(3-fluoropyrrolidin-1-yl)propoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(F)CCN1CCCOC(C=C1)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O JIQGYCFBDSWWDO-UHFFFAOYSA-N 0.000 description 1
- FKXNEWVGGVOEHF-UHFFFAOYSA-N 5-fluoro-3-[[4-[4-(2-methoxyethyl)piperazin-1-yl]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C=C1)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O FKXNEWVGGVOEHF-UHFFFAOYSA-N 0.000 description 1
- PPWVJESRNADNPO-UHFFFAOYSA-N 5-fluoro-3-[[4-[methyl(2-pyridin-2-ylethyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC(F)=CC=C3NC2=O)C=CC=1N(C)CCC1=CC=CC=N1 PPWVJESRNADNPO-UHFFFAOYSA-N 0.000 description 1
- FUFZNHHSSMCXCZ-UHFFFAOYSA-N 5-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole Chemical compound FC(F)(F)C1=CC=CC(C=2N=C(ON=2)C2CCNCC2)=C1 FUFZNHHSSMCXCZ-UHFFFAOYSA-N 0.000 description 1
- RPQIMJHYSQRUJW-UHFFFAOYSA-N 6-(3-methoxyphenyl)-3-[[4-(4-methylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound COC1=CC=CC(C=2C=C3NC(=O)C(=CNC=4C=CC(=CC=4)N4CCN(C)CC4)C3=CC=2)=C1 RPQIMJHYSQRUJW-UHFFFAOYSA-N 0.000 description 1
- PKQNTFAOZIVXCE-UHFFFAOYSA-N 6-fluoro-1,3-dihydroindol-2-one Chemical compound FC1=CC=C2CC(=O)NC2=C1 PKQNTFAOZIVXCE-UHFFFAOYSA-N 0.000 description 1
- WVPSSLGKRDLSGS-UHFFFAOYSA-N 6-fluoro-3-[(4-morpholin-4-ylanilino)methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1)=CC=C1N1CCOCC1 WVPSSLGKRDLSGS-UHFFFAOYSA-N 0.000 description 1
- CUAWTQWXAYDPQC-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(1-methoxybutan-2-ylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(NC(COC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O CUAWTQWXAYDPQC-UHFFFAOYSA-N 0.000 description 1
- CXQPPMFPJKJRHZ-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(1-methoxypropan-2-ylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(NC(C)COC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O CXQPPMFPJKJRHZ-UHFFFAOYSA-N 0.000 description 1
- YJHIJWAAJMAPBB-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(2-hydroxyethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(NCCO)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O YJHIJWAAJMAPBB-UHFFFAOYSA-N 0.000 description 1
- SWBSOBSQCAMUGV-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(2-methoxyethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(NCCOC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O SWBSOBSQCAMUGV-UHFFFAOYSA-N 0.000 description 1
- NKVOHONPASMMKR-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(2-morpholin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NCCN1CCOCC1 NKVOHONPASMMKR-UHFFFAOYSA-N 0.000 description 1
- IZBDUGVHZNHHOK-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(2-piperidin-1-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NCCN1CCCCC1 IZBDUGVHZNHHOK-UHFFFAOYSA-N 0.000 description 1
- ATCDIIQBAJGLDJ-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(2-pyridin-2-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NCCC1=CC=CC=N1 ATCDIIQBAJGLDJ-UHFFFAOYSA-N 0.000 description 1
- VHDMDDRDYZCLJG-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(2-pyridin-3-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NCCC1=CC=CN=C1 VHDMDDRDYZCLJG-UHFFFAOYSA-N 0.000 description 1
- ZQRDAJGMIIXNDL-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(2-pyridin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NCCC1=CC=NC=C1 ZQRDAJGMIIXNDL-UHFFFAOYSA-N 0.000 description 1
- FXULEFYIUYWVQB-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NCCCN1CCOCC1 FXULEFYIUYWVQB-UHFFFAOYSA-N 0.000 description 1
- APORINONFOTEKM-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(3-pyridin-2-ylpyrrolidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1N(C1)CCC1C1=CC=CC=N1 APORINONFOTEKM-UHFFFAOYSA-N 0.000 description 1
- SDCKVXWXSJDTFY-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(3-pyridin-4-ylpyrrolidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1N(C1)CCC1C1=CC=NC=C1 SDCKVXWXSJDTFY-UHFFFAOYSA-N 0.000 description 1
- SITJULOOKKIGGR-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(4-propan-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C(C)C)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O SITJULOOKKIGGR-UHFFFAOYSA-N 0.000 description 1
- JLDUZCQUPJQWBX-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(4-propylpiperidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CC(CCC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JLDUZCQUPJQWBX-UHFFFAOYSA-N 0.000 description 1
- YAPNNQHLUDMDNF-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(4-pyrazin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1N(CC1)CCN1C1=CN=CC=N1 YAPNNQHLUDMDNF-UHFFFAOYSA-N 0.000 description 1
- KPFGLSVLHSNRDT-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(4-pyrimidin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1N(CC1)CCN1C1=NC=CC=N1 KPFGLSVLHSNRDT-UHFFFAOYSA-N 0.000 description 1
- NTSCLBXYELHTPH-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(5-oxo-1,4-diazepan-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1N1CCNC(=O)CC1 NTSCLBXYELHTPH-UHFFFAOYSA-N 0.000 description 1
- JMQZEBUVBYPENE-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(oxan-4-ylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NC1CCOCC1 JMQZEBUVBYPENE-UHFFFAOYSA-N 0.000 description 1
- GZHCVPUDMZBYFS-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(oxan-4-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NCC1CCOCC1 GZHCVPUDMZBYFS-UHFFFAOYSA-N 0.000 description 1
- KKXNLMMJPYCAAP-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(oxolan-2-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NCC1CCCO1 KKXNLMMJPYCAAP-UHFFFAOYSA-N 0.000 description 1
- PPLWJZDCAVSUKO-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-(pyridin-3-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1NCC1=CC=CN=C1 PPLWJZDCAVSUKO-UHFFFAOYSA-N 0.000 description 1
- FWMCKPADLJPXRL-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-[(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1NC(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O FWMCKPADLJPXRL-UHFFFAOYSA-N 0.000 description 1
- KFDDVEGGMDQABG-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-[(5-methylpyrazin-2-yl)methylamino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O KFDDVEGGMDQABG-UHFFFAOYSA-N 0.000 description 1
- SXBXLWOMFJYTKY-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-[2-methoxyethyl(methyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(N(C)CCOC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O SXBXLWOMFJYTKY-UHFFFAOYSA-N 0.000 description 1
- IAXQCUDQFXATFR-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-[2-methoxyethyl(propyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(F)C(N(CCOC)CCC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O IAXQCUDQFXATFR-UHFFFAOYSA-N 0.000 description 1
- MTZOPFQJSVSPSY-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-[4-(2-methoxyethyl)piperazin-1-yl]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O MTZOPFQJSVSPSY-UHFFFAOYSA-N 0.000 description 1
- RCQWVCMUSUSCCI-UHFFFAOYSA-N 6-fluoro-3-[[3-fluoro-4-[methyl(pyridin-3-ylmethyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC=C(F)C=C3NC2=O)C=C(F)C=1N(C)CC1=CC=CN=C1 RCQWVCMUSUSCCI-UHFFFAOYSA-N 0.000 description 1
- IFSQNBWDUFCFQF-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-(2-morpholin-4-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1NCCN1CCOCC1 IFSQNBWDUFCFQF-UHFFFAOYSA-N 0.000 description 1
- MEOGHHJSIFEKOO-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-(2-piperidin-1-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1NCCN1CCCCC1 MEOGHHJSIFEKOO-UHFFFAOYSA-N 0.000 description 1
- RZBBFKKOUPMODM-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-(2-pyridin-2-ylethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1NCCC1=CC=CC=N1 RZBBFKKOUPMODM-UHFFFAOYSA-N 0.000 description 1
- WXJYRHKJTQWPMA-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-(3-morpholin-4-ylpropylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1NCCCN1CCOCC1 WXJYRHKJTQWPMA-UHFFFAOYSA-N 0.000 description 1
- OWTSXKMEXFWIEG-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-(4-methylpiperidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CC(C)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O OWTSXKMEXFWIEG-UHFFFAOYSA-N 0.000 description 1
- UAHVUMOTRAXUNH-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-(4-propylpiperidin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CC(CCC)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O UAHVUMOTRAXUNH-UHFFFAOYSA-N 0.000 description 1
- HZIPWMOPVNRBBN-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-(4-pyrazin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1N(CC1)CCN1C1=CN=CC=N1 HZIPWMOPVNRBBN-UHFFFAOYSA-N 0.000 description 1
- CEGKJNOUXWGLPL-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-(oxan-4-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1NCC1CCOCC1 CEGKJNOUXWGLPL-UHFFFAOYSA-N 0.000 description 1
- ZCYQVJATHDMDOI-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-(pyridin-2-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1NCC1=CC=CC=N1 ZCYQVJATHDMDOI-UHFFFAOYSA-N 0.000 description 1
- PIUGNUGVYMCCCT-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-(pyridin-4-ylmethylamino)anilino]methylidene]-1h-indol-2-one Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1NCC1=CC=NC=C1 PIUGNUGVYMCCCT-UHFFFAOYSA-N 0.000 description 1
- JUDBBYICQSZHIY-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-[(1,2,2,6,6-pentamethylpiperidin-4-yl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(C)(C)N(C)C(C)(C)CC1NC(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JUDBBYICQSZHIY-UHFFFAOYSA-N 0.000 description 1
- LDWLSEQVZQEPBB-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-[(5-methylpyrazin-2-yl)methylamino]anilino]methylidene]-1h-indol-2-one Chemical compound C1=NC(C)=CN=C1CNC(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O LDWLSEQVZQEPBB-UHFFFAOYSA-N 0.000 description 1
- FHGMPFJHMFZGTP-UHFFFAOYSA-N 6-fluoro-3-[[3-methyl-4-[3-(2-methylpiperidin-1-yl)propylamino]anilino]methylidene]-1h-indol-2-one Chemical compound CC1CCCCN1CCCNC(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O FHGMPFJHMFZGTP-UHFFFAOYSA-N 0.000 description 1
- CWXNBQLAMLWREO-UHFFFAOYSA-N 6-fluoro-3-[[4-(1-methoxybutan-2-ylamino)-3-methylanilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C)C(NC(COC)CC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O CWXNBQLAMLWREO-UHFFFAOYSA-N 0.000 description 1
- WNAXMAMRBBNPMR-UHFFFAOYSA-N 6-fluoro-3-[[4-(1-methoxypropan-2-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NC(C)COC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O WNAXMAMRBBNPMR-UHFFFAOYSA-N 0.000 description 1
- AZCSLNHHHLJYQQ-UHFFFAOYSA-N 6-fluoro-3-[[4-(1-methoxypropan-2-ylamino)-3-methylanilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C)C(NC(C)COC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O AZCSLNHHHLJYQQ-UHFFFAOYSA-N 0.000 description 1
- VOLDQNMUVJIONM-UHFFFAOYSA-N 6-fluoro-3-[[4-(2-methoxyethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=C(C(F)(F)F)C(NCCOC)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O VOLDQNMUVJIONM-UHFFFAOYSA-N 0.000 description 1
- OOARYXZMCDUFHB-UHFFFAOYSA-N 6-fluoro-3-[[4-(2-piperidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1)=CC=C1OCCN1CCCCC1 OOARYXZMCDUFHB-UHFFFAOYSA-N 0.000 description 1
- XZJXWPFNTGVVFR-UHFFFAOYSA-N 6-fluoro-3-[[4-(2-piperidin-1-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1C(F)(F)F)=CC=C1NCCN1CCCCC1 XZJXWPFNTGVVFR-UHFFFAOYSA-N 0.000 description 1
- XARWNJKWSVNYKS-UHFFFAOYSA-N 6-fluoro-3-[[4-(2-pyridin-2-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1C(F)(F)F)=CC=C1NCCC1=CC=CC=N1 XARWNJKWSVNYKS-UHFFFAOYSA-N 0.000 description 1
- TZMWDBIZTGAEGG-UHFFFAOYSA-N 6-fluoro-3-[[4-(2-pyridin-3-ylethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1C(F)(F)F)=CC=C1NCCC1=CC=CN=C1 TZMWDBIZTGAEGG-UHFFFAOYSA-N 0.000 description 1
- GSRJARIWHBZJCC-UHFFFAOYSA-N 6-fluoro-3-[[4-(2-pyrrolidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1)=CC=C1OCCN1CCCC1 GSRJARIWHBZJCC-UHFFFAOYSA-N 0.000 description 1
- VNBTVWYNHNEQQK-UHFFFAOYSA-N 6-fluoro-3-[[4-(2-pyrrolidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one;4-methyl-3-[[4-(2-pyrrolidin-1-ylethoxy)anilino]methylidene]-1h-indol-2-one Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1)=CC=C1OCCN1CCCC1.O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1)=CC=C1OCCN1CCCC1 VNBTVWYNHNEQQK-UHFFFAOYSA-N 0.000 description 1
- JFLPHCGNFCMGBZ-UHFFFAOYSA-N 6-fluoro-3-[[4-(3-methylsulfonylpyrrolidin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1C(S(=O)(=O)C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JFLPHCGNFCMGBZ-UHFFFAOYSA-N 0.000 description 1
- XEFMNYAFMZLVSH-UHFFFAOYSA-N 6-fluoro-3-[[4-(3-piperidin-1-ylpropoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1)=CC=C1OCCCN1CCCCC1 XEFMNYAFMZLVSH-UHFFFAOYSA-N 0.000 description 1
- JPWYWWAYNGZJQZ-UHFFFAOYSA-N 6-fluoro-3-[[4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JPWYWWAYNGZJQZ-UHFFFAOYSA-N 0.000 description 1
- SCUZODLFXBXKGO-UHFFFAOYSA-N 6-fluoro-3-[[4-(4-piperidin-1-ylbutoxy)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1)=CC=C1OCCCCN1CCCCC1 SCUZODLFXBXKGO-UHFFFAOYSA-N 0.000 description 1
- QQCWOOHUVOXNMI-UHFFFAOYSA-N 6-fluoro-3-[[4-(4-pyrazin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1)=CC=C1N(CC1)CCN1C1=CN=CC=N1 QQCWOOHUVOXNMI-UHFFFAOYSA-N 0.000 description 1
- JTOSMNXCKYJRMY-UHFFFAOYSA-N 6-fluoro-3-[[4-(4-pyrimidin-2-ylpiperazin-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1)=CC=C1N(CC1)CCN1C1=NC=CC=N1 JTOSMNXCKYJRMY-UHFFFAOYSA-N 0.000 description 1
- JVXWALVIJDZGDP-UHFFFAOYSA-N 6-fluoro-3-[[4-(oxan-4-ylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1C(F)(F)F)=CC=C1NC1CCOCC1 JVXWALVIJDZGDP-UHFFFAOYSA-N 0.000 description 1
- DEFXCQPHHJZVFI-UHFFFAOYSA-N 6-fluoro-3-[[4-(oxan-4-ylmethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1C(F)(F)F)=CC=C1NCC1CCOCC1 DEFXCQPHHJZVFI-UHFFFAOYSA-N 0.000 description 1
- IRRRJZVDZKUILE-UHFFFAOYSA-N 6-fluoro-3-[[4-(pyridin-2-ylmethylamino)-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1C(F)(F)F)=CC=C1NCC1=CC=CC=N1 IRRRJZVDZKUILE-UHFFFAOYSA-N 0.000 description 1
- AJTREDHBNCNUDS-UHFFFAOYSA-N 6-fluoro-3-[[4-[(1-methylpiperidin-3-yl)methoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1N(C)CCCC1COC(C=C1)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O AJTREDHBNCNUDS-UHFFFAOYSA-N 0.000 description 1
- JPHZOKZQUAUKMZ-UHFFFAOYSA-N 6-fluoro-3-[[4-[3-(2-methylpiperidin-1-yl)propylamino]-3-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound CC1CCCCN1CCCNC(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JPHZOKZQUAUKMZ-UHFFFAOYSA-N 0.000 description 1
- NTFJCKKQYYXXMX-UHFFFAOYSA-N 6-fluoro-3-[[4-[3-(2-methylpiperidin-1-yl)propylamino]anilino]methylidene]-1h-indol-2-one Chemical compound CC1CCCCN1CCCNC(C=C1)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O NTFJCKKQYYXXMX-UHFFFAOYSA-N 0.000 description 1
- VHCPHEKFXOKYGP-UHFFFAOYSA-N 6-fluoro-3-[[4-[3-(3-fluoropyrrolidin-1-yl)propoxy]anilino]methylidene]-1h-indol-2-one Chemical compound C1C(F)CCN1CCCOC(C=C1)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O VHCPHEKFXOKYGP-UHFFFAOYSA-N 0.000 description 1
- JAXHTPVITMGZIQ-UHFFFAOYSA-N 6-fluoro-3-[[4-[3-(4-methylpiperazin-1-yl)propylamino]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(C)CCN1CCCNC(C=C1)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JAXHTPVITMGZIQ-UHFFFAOYSA-N 0.000 description 1
- UUIIAAVGIVPMMN-UHFFFAOYSA-N 6-fluoro-3-[[4-[4-(2-methoxyethyl)piperazin-1-yl]-3-methylanilino]methylidene]-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C(=C1)C)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O UUIIAAVGIVPMMN-UHFFFAOYSA-N 0.000 description 1
- AIWXACLCJZNOSV-UHFFFAOYSA-N 6-fluoro-3-[[4-[4-(2-methoxyethyl)piperazin-1-yl]anilino]methylidene]-1h-indol-2-one Chemical compound C1CN(CCOC)CCN1C(C=C1)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O AIWXACLCJZNOSV-UHFFFAOYSA-N 0.000 description 1
- OQRLBSGTCXIQKE-UHFFFAOYSA-N 6-fluoro-3-[[4-[methyl(2-pyridin-2-ylethyl)amino]anilino]methylidene]-1h-indol-2-one Chemical compound C=1C=C(NC=C2C3=CC=C(F)C=C3NC2=O)C=CC=1N(C)CCC1=CC=CC=N1 OQRLBSGTCXIQKE-UHFFFAOYSA-N 0.000 description 1
- 102000007299 Amphiregulin Human genes 0.000 description 1
- 108010033760 Amphiregulin Proteins 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- OGBVRMYSNSKIEF-UHFFFAOYSA-N Benzylphosphonic acid Chemical class OP(O)(=O)CC1=CC=CC=C1 OGBVRMYSNSKIEF-UHFFFAOYSA-N 0.000 description 1
- 102000056058 Betacellulin Human genes 0.000 description 1
- 101800001382 Betacellulin Proteins 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- WNPNGMJZEVNKKN-UHFFFAOYSA-N BrC1=CC=C(C=C1)NCC1C(NC2=CC=CC=C12)=O.BrC=1C=C(C=CC1)NC=C1C(NC2=CC=CC=C12)=O.C1(=CC=CC=C1)NC=C1C(NC2=CC=CC=C12)=O Chemical compound BrC1=CC=C(C=C1)NCC1C(NC2=CC=CC=C12)=O.BrC=1C=C(C=CC1)NC=C1C(NC2=CC=CC=C12)=O.C1(=CC=CC=C1)NC=C1C(NC2=CC=CC=C12)=O WNPNGMJZEVNKKN-UHFFFAOYSA-N 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- JCEIRSDBOGVMFX-UHFFFAOYSA-N C(=O)OCC.C1(=CC=CC=C1)NC=C1C(NC2=CC=CC=C12)=O Chemical compound C(=O)OCC.C1(=CC=CC=C1)NC=C1C(NC2=CC=CC=C12)=O JCEIRSDBOGVMFX-UHFFFAOYSA-N 0.000 description 1
- MNTAONJGDVFDPD-UHFFFAOYSA-N C(C)C1=CC=C(C=C1)NC=C1C(NC2=CC=CC=C12)=O.BrC=1C=C(C=CC1)NCC1C(NC2=CC=CC=C12)=O Chemical compound C(C)C1=CC=C(C=C1)NC=C1C(NC2=CC=CC=C12)=O.BrC=1C=C(C=CC1)NCC1C(NC2=CC=CC=C12)=O MNTAONJGDVFDPD-UHFFFAOYSA-N 0.000 description 1
- QFPLVRHIEXEFJI-UHFFFAOYSA-N C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N1CCN(C=O)CC1 Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N1CCN(C=O)CC1 QFPLVRHIEXEFJI-UHFFFAOYSA-N 0.000 description 1
- QFSJFJPORDQXIX-UHFFFAOYSA-N C1=2C(C)=CC=CC=2NC(=O)C1=CNC1=CC=CC(CO)=C1.C1=CC(NC(=O)OC(C)(C)C)=CC=C1NC=C1C2=CC=CC=C2NC1=O Chemical compound C1=2C(C)=CC=CC=2NC(=O)C1=CNC1=CC=CC(CO)=C1.C1=CC(NC(=O)OC(C)(C)C)=CC=C1NC=C1C2=CC=CC=C2NC1=O QFSJFJPORDQXIX-UHFFFAOYSA-N 0.000 description 1
- FAZGFVDGIRTETR-UHFFFAOYSA-N C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N1CCN(C=O)CC1 Chemical compound C1=2C(F)=CC=CC=2NC(=O)C1=CNC(C=C1F)=CC=C1N1CCN(C=O)CC1 FAZGFVDGIRTETR-UHFFFAOYSA-N 0.000 description 1
- RTDRYVLWRHNMQZ-UHFFFAOYSA-N C1=C2N=CSC2=CC(NC=C2C(=O)NC3=CC=C(C=C32)F)=C1.C1=CC(CC(=O)O)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O Chemical compound C1=C2N=CSC2=CC(NC=C2C(=O)NC3=CC=C(C=C32)F)=C1.C1=CC(CC(=O)O)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O RTDRYVLWRHNMQZ-UHFFFAOYSA-N 0.000 description 1
- LAHGMBDJDKUDNT-UHFFFAOYSA-N C1=CC(CO)=CC=C1NC=C1C2=CC(Cl)=CC=C2NC1=O.C1=C2NC=CC2=CC(NC=C2C(=O)NC3=CC=C(C=C32)Cl)=C1 Chemical compound C1=CC(CO)=CC=C1NC=C1C2=CC(Cl)=CC=C2NC1=O.C1=C2NC=CC2=CC(NC=C2C(=O)NC3=CC=C(C=C32)Cl)=C1 LAHGMBDJDKUDNT-UHFFFAOYSA-N 0.000 description 1
- QHCDLGMQXRZXCV-UHFFFAOYSA-N C1=CC(OC(F)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O Chemical compound C1=CC(OC(F)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O QHCDLGMQXRZXCV-UHFFFAOYSA-N 0.000 description 1
- JIFLPTUSBGDLBA-UHFFFAOYSA-N CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1N1CCN(C=O)CC1 Chemical compound CC1=CC(NC=C2C3=CC(F)=CC=C3NC2=O)=CC=C1N1CCN(C=O)CC1 JIFLPTUSBGDLBA-UHFFFAOYSA-N 0.000 description 1
- OAJLFPDXCLVCQC-UHFFFAOYSA-N CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1N1CCN(C=O)CC1 Chemical compound CC1=CC(NC=C2C3=CC=C(F)C=C3NC2=O)=CC=C1N1CCN(C=O)CC1 OAJLFPDXCLVCQC-UHFFFAOYSA-N 0.000 description 1
- LFVDGYMXWJRMNJ-UHFFFAOYSA-N CN(CC(C)NC1=C(C=C(C=C1)NC=C1C(N(C2=CC=CC=C12)F)=O)F)C Chemical compound CN(CC(C)NC1=C(C=C(C=C1)NC=C1C(N(C2=CC=CC=C12)F)=O)F)C LFVDGYMXWJRMNJ-UHFFFAOYSA-N 0.000 description 1
- 101100381481 Caenorhabditis elegans baz-2 gene Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 1
- 208000005590 Choroidal Neovascularization Diseases 0.000 description 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 102000004626 Colony-Stimulating Factor Receptors Human genes 0.000 description 1
- 108010003384 Colony-Stimulating Factor Receptors Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- UJXZHXAWHANPBY-UHFFFAOYSA-N FC1=C(C=CC(=C1)NC=C1C(NC2=CC=CC(=C12)C)=O)NC1CN(CC1)C(=O)O Chemical compound FC1=C(C=CC(=C1)NC=C1C(NC2=CC=CC(=C12)C)=O)NC1CN(CC1)C(=O)O UJXZHXAWHANPBY-UHFFFAOYSA-N 0.000 description 1
- UWNLXAXOWFXAEF-UHFFFAOYSA-N FC1=C2C(C(NC2=CC=C1)=O)=CNC1=CC=C(C=C1)N1CC2CCCCC2CC1.FC1=C2C(C(NC2=CC=C1)=O)=CNC1=CC=C(C=C1)N1CC2CCCCC2CC1 Chemical compound FC1=C2C(C(NC2=CC=C1)=O)=CNC1=CC=C(C=C1)N1CC2CCCCC2CC1.FC1=C2C(C(NC2=CC=C1)=O)=CNC1=CC=C(C=C1)N1CC2CCCCC2CC1 UWNLXAXOWFXAEF-UHFFFAOYSA-N 0.000 description 1
- KYDALJJDEVTJPW-UHFFFAOYSA-N FC=1C=C2C(C(NC2=CC1)=O)=CNC1=CC=C(C=C1)CCCCN1CCOCC1.FC1=C2C(C(NC2=CC=C1)=O)=CNC1=CC=C(C=C1)CCCCN1CCOCC1 Chemical compound FC=1C=C2C(C(NC2=CC1)=O)=CNC1=CC=C(C=C1)CCCCN1CCOCC1.FC1=C2C(C(NC2=CC=C1)=O)=CNC1=CC=C(C=C1)CCCCN1CCOCC1 KYDALJJDEVTJPW-UHFFFAOYSA-N 0.000 description 1
- 108091008794 FGF receptors Proteins 0.000 description 1
- BMGUVTZCLJKXDL-UHFFFAOYSA-N FOC1=CC=CC2=C1C=CN2 Chemical compound FOC1=CC=CC2=C1C=CN2 BMGUVTZCLJKXDL-UHFFFAOYSA-N 0.000 description 1
- 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 1
- 101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 1
- 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 1
- 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 description 1
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 1
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 1
- 102100027844 Fibroblast growth factor receptor 4 Human genes 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- OUVXYXNWSVIOSJ-UHFFFAOYSA-N Fluo-4 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)N(CC(O)=O)CC(O)=O)=C1 OUVXYXNWSVIOSJ-UHFFFAOYSA-N 0.000 description 1
- YSWHPLCDIMUKFE-QWRGUYRKSA-N Glu-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 YSWHPLCDIMUKFE-QWRGUYRKSA-N 0.000 description 1
- 102000018710 Heparin-binding EGF-like Growth Factor Human genes 0.000 description 1
- 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000917134 Homo sapiens Fibroblast growth factor receptor 4 Proteins 0.000 description 1
- 101001005128 Homo sapiens LIM domain kinase 1 Proteins 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 description 1
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 102100026023 LIM domain kinase 1 Human genes 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- 101100268066 Mus musculus Zap70 gene Proteins 0.000 description 1
- 208000007727 Muscle Tissue Neoplasms Diseases 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- CFTPMOJXNAGYHS-UHFFFAOYSA-N NC=1C=C(C=CC1C)NC=C1C(NC2=CC=CC=C12)=O.NC=1C=C(C=CC1)NC=C1C(NC2=CC=CC=C12)=O Chemical compound NC=1C=C(C=CC1C)NC=C1C(NC2=CC=CC=C12)=O.NC=1C=C(C=CC1)NC=C1C(NC2=CC=CC=C12)=O CFTPMOJXNAGYHS-UHFFFAOYSA-N 0.000 description 1
- 102400000058 Neuregulin-1 Human genes 0.000 description 1
- 108090000556 Neuregulin-1 Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- MWBCMACPSOEMFO-UHFFFAOYSA-N O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1N1CCN(C=O)CC1 Chemical compound O=C1NC2=CC(F)=CC=C2C1=CNC(C=C1F)=CC=C1N1CCN(C=O)CC1 MWBCMACPSOEMFO-UHFFFAOYSA-N 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 102000001393 Platelet-Derived Growth Factor alpha Receptor Human genes 0.000 description 1
- 108010068588 Platelet-Derived Growth Factor alpha Receptor Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
- 101100372762 Rattus norvegicus Flt1 gene Proteins 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 1
- 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 description 1
- 102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 description 1
- 101710100963 Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 101100263588 Sus scrofa VEGFA gene Proteins 0.000 description 1
- 102000006747 Transforming Growth Factor alpha Human genes 0.000 description 1
- 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
- BGDKAVGWHJFAGW-UHFFFAOYSA-N Tropicamide Chemical compound C=1C=CC=CC=1C(CO)C(=O)N(CC)CC1=CC=NC=C1 BGDKAVGWHJFAGW-UHFFFAOYSA-N 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 108091008605 VEGF receptors Proteins 0.000 description 1
- 108010053096 Vascular Endothelial Growth Factor Receptor-1 Proteins 0.000 description 1
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 1
- 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RIIWUGSYXOBDMC-UHFFFAOYSA-N benzene-1,2-diamine;hydron;dichloride Chemical compound Cl.Cl.NC1=CC=CC=C1N RIIWUGSYXOBDMC-UHFFFAOYSA-N 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 125000005841 biaryl group Chemical group 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 108091071773 flk family Proteins 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 102000058223 human VEGFA Human genes 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000000521 hyperimmunizing effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 238000000021 kinase assay Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 206010027191 meningioma Diseases 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- IFFFJWIZBCCHES-UHFFFAOYSA-N methyl 1-[4-[(4-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]-2-methylphenyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OC)CCN1C(C(=C1)C)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O IFFFJWIZBCCHES-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- HCVYBVPZNZDZJR-UHFFFAOYSA-N n-[1-[2-fluoro-4-[(4-methyl-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]pyrrolidin-3-yl]-n-methylacetamide Chemical compound C1C(N(C)C(C)=O)CCN1C(C(=C1)F)=CC=C1NC=C1C2=C(C)C=CC=C2NC1=O HCVYBVPZNZDZJR-UHFFFAOYSA-N 0.000 description 1
- YELBIACUIBDANM-UHFFFAOYSA-N n-[1-[2-fluoro-4-[(5-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]pyrrolidin-3-yl]-n-methylacetamide Chemical compound C1C(N(C)C(C)=O)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O YELBIACUIBDANM-UHFFFAOYSA-N 0.000 description 1
- QWCYNVSGYFJXSM-UHFFFAOYSA-N n-[1-[2-fluoro-4-[(6-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]pyrrolidin-3-yl]-n-methylacetamide Chemical compound C1C(N(C)C(C)=O)CCN1C(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O QWCYNVSGYFJXSM-UHFFFAOYSA-N 0.000 description 1
- FUZUUERKBYOGDN-UHFFFAOYSA-N n-[1-[4-[(5-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]phenyl]pyrrolidin-3-yl]-n-methylacetamide Chemical compound C1C(N(C)C(C)=O)CCN1C(C=C1)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O FUZUUERKBYOGDN-UHFFFAOYSA-N 0.000 description 1
- JPJJTTBHIAWRMZ-UHFFFAOYSA-N n-[1-[4-[(6-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]-2-(trifluoromethyl)phenyl]pyrrolidin-3-yl]acetamide Chemical compound C1C(NC(=O)C)CCN1C(C(=C1)C(F)(F)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O JPJJTTBHIAWRMZ-UHFFFAOYSA-N 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008196 pharmacological composition Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000007981 phosphate-citrate buffer Substances 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000006514 pyridin-2-ylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000001210 retinal vessel Anatomy 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- WNYCCNZVFYIECA-UHFFFAOYSA-N tert-butyl 3-[2-fluoro-4-[(2-oxo-1h-indol-3-ylidene)methylamino]anilino]pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1NC(C(=C1)F)=CC=C1NC=C1C2=CC=CC=C2NC1=O WNYCCNZVFYIECA-UHFFFAOYSA-N 0.000 description 1
- CSXYBYKUTJBQFW-UHFFFAOYSA-N tert-butyl 3-[2-fluoro-4-[(4-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]anilino]pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1NC(C(=C1)F)=CC=C1NC=C1C2=C(F)C=CC=C2NC1=O CSXYBYKUTJBQFW-UHFFFAOYSA-N 0.000 description 1
- GJPKUXDQCQKMEC-UHFFFAOYSA-N tert-butyl 3-[2-fluoro-4-[(5-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]anilino]pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1NC(C(=C1)F)=CC=C1NC=C1C2=CC(F)=CC=C2NC1=O GJPKUXDQCQKMEC-UHFFFAOYSA-N 0.000 description 1
- ROWPFKFCQPRBAR-UHFFFAOYSA-N tert-butyl 3-[2-fluoro-4-[(6-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]anilino]pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1NC(C(=C1)F)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O ROWPFKFCQPRBAR-UHFFFAOYSA-N 0.000 description 1
- KYHHOMOFYMXMSZ-UHFFFAOYSA-N tert-butyl 3-[4-[(4-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]-2-methylanilino]pyrrolidine-1-carboxylate Chemical compound CC1=CC(NC=C2C3=C(F)C=CC=C3NC2=O)=CC=C1NC1CCN(C(=O)OC(C)(C)C)C1 KYHHOMOFYMXMSZ-UHFFFAOYSA-N 0.000 description 1
- ZBCYCKCCSFAIHR-UHFFFAOYSA-N tert-butyl 3-[4-[(6-fluoro-2-oxo-1h-indol-3-ylidene)methylamino]anilino]pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1NC(C=C1)=CC=C1NC=C1C2=CC=C(F)C=C2NC1=O ZBCYCKCCSFAIHR-UHFFFAOYSA-N 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- 125000004953 trihalomethyl group Chemical group 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 229960004791 tropicamide Drugs 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
- 229960001600 xylazine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32581901P | 2001-09-27 | 2001-09-27 | |
| US32581501P | 2001-09-27 | 2001-09-27 | |
| PCT/US2002/030882 WO2003027102A1 (en) | 2001-09-27 | 2002-09-27 | 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010013326A Division JP2010116411A (ja) | 2001-09-27 | 2010-01-25 | キナーゼ阻害物質としての３−（アリールアミノ）メチレン−１，３−ジヒドロ−２ｈ−インドール−２−オン類 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508336A true JP2005508336A (ja) | 2005-03-31 |
| JP2005508336A5 JP2005508336A5 (enExample) | 2006-01-12 |
Family
ID=26985125
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003530690A Pending JP2005508336A (ja) | 2001-09-27 | 2002-09-27 | キナーゼ阻害物質としての３−（アリールアミノ）メチレン−１，３−ジヒドロ−２ｈ−インドール−２−オン類 |
| JP2010013326A Pending JP2010116411A (ja) | 2001-09-27 | 2010-01-25 | キナーゼ阻害物質としての３−（アリールアミノ）メチレン−１，３−ジヒドロ−２ｈ−インドール−２−オン類 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010013326A Pending JP2010116411A (ja) | 2001-09-27 | 2010-01-25 | キナーゼ阻害物質としての３−（アリールアミノ）メチレン−１，３−ジヒドロ−２ｈ−インドール−２−オン類 |
Country Status (6)
| Country | Link |
|---|---|
| US (7) | US6765012B2 (enExample) |
| EP (1) | EP1430048A1 (enExample) |
| JP (2) | JP2005508336A (enExample) |
| AU (1) | AU2002341881B2 (enExample) |
| CA (1) | CA2461812C (enExample) |
| WO (1) | WO2003027102A1 (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009057299A (ja) * | 2007-08-30 | 2009-03-19 | Nippon Soda Co Ltd | 置換フェノキシアザビシクロオクタン誘導体およびその製造方法 |
| JP2010530401A (ja) * | 2007-06-21 | 2010-09-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | インドリン−２−オンおよびアザ−インドリン−２−オン |
| JP2016505549A (ja) * | 2012-12-06 | 2016-02-25 | 山東亨利醫藥科技有限責任公司 | チロシンキナーゼ阻害剤としてのインドリノン誘導体 |
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998046588A2 (en) * | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| US20030153015A1 (en) * | 2000-01-20 | 2003-08-14 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| HU230302B1 (hu) | 2000-10-20 | 2015-12-28 | Eisai R&D Management Co., Ltd. | Nitrogéntartalmú aromás származékok és ezeket tartalmazó gyógyászati készítmények |
| EP1430048A1 (en) * | 2001-09-27 | 2004-06-23 | Allergan, Inc. | 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| PE20040701A1 (es) * | 2002-07-23 | 2004-11-30 | Boehringer Ingelheim Pharma | Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos |
| DE10233366A1 (de) * | 2002-07-23 | 2004-02-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US7514468B2 (en) | 2002-07-23 | 2009-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions |
| US7169936B2 (en) | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
| CN101337930B (zh) | 2003-11-11 | 2010-09-08 | 卫材R&D管理有限公司 | 脲衍生物的制备方法 |
| US20050101582A1 (en) * | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
| US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
| AU2005209201B2 (en) | 2004-01-20 | 2010-06-03 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
| US7338536B2 (en) | 2004-02-27 | 2008-03-04 | L'oreal S. A. | N-alkylamino secondary para-phenylenediamine, composition for dyeing keratin fibers comprising such a para-phenylenediamine, processes using this composition and uses thereof |
| FR2866879A1 (fr) * | 2004-02-27 | 2005-09-02 | Oreal | Para-phenylenediamine secondaire n-alkylaminee, composition de teinture des fibres keratiniques contenant une telle para-phenylenediamine, procedes mettant en oeuvre cette composition et utilisations |
| KR100629713B1 (ko) * | 2004-04-10 | 2006-09-29 | (주)아모레퍼시픽 | 펜타에리스리톨 유도체와 이의 제조방법, 및 이를포함하는 액정베이스 |
| US8425929B2 (en) | 2004-04-30 | 2013-04-23 | Allergan, Inc. | Sustained release intraocular implants and methods for preventing retinal dysfunction |
| US20050244461A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Controlled release drug delivery systems and methods for treatment of an eye |
| US20050244462A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Devices and methods for treating a mammalian eye |
| WO2005110374A1 (en) * | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
| US8591885B2 (en) * | 2004-04-30 | 2013-11-26 | Allergan, Inc. | Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems |
| US20050244478A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Anti-excititoxic sustained release intraocular implants and related methods |
| US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
| US8673341B2 (en) | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
| US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
| US9498457B2 (en) | 2004-04-30 | 2016-11-22 | Allergan, Inc. | Hypotensive prostamide-containing biodegradable intraocular implants and related implants |
| US20050244463A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular vasculopathies |
| US7771742B2 (en) | 2004-04-30 | 2010-08-10 | Allergan, Inc. | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
| US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| WO2005107708A1 (en) | 2004-04-30 | 2005-11-17 | Allergan, Inc. | Biodegradable intravitreal tyrosine kinase inhibitors implants |
| US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
| US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
| US20070059336A1 (en) * | 2004-04-30 | 2007-03-15 | Allergan, Inc. | Anti-angiogenic sustained release intraocular implants and related methods |
| US20050244466A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Photodynamic therapy in conjunction with intraocular implants |
| US20050244471A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Estradiol derivative and estratopone containing sustained release intraocular implants and related methods |
| US8147865B2 (en) * | 2004-04-30 | 2012-04-03 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
| US8455656B2 (en) * | 2004-04-30 | 2013-06-04 | Allergan, Inc. | Kinase inhibitors |
| EP1797881B1 (en) | 2004-09-17 | 2009-04-15 | Eisai R&D Management Co., Ltd. | Medicinal composition with improved stability and reduced gelation properties |
| TW200640443A (en) * | 2005-02-23 | 2006-12-01 | Alcon Inc | Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors |
| US7749530B2 (en) | 2005-07-13 | 2010-07-06 | Allergan, Inc. | Kinase inhibitors |
| US7309787B2 (en) * | 2005-07-13 | 2007-12-18 | Allergan, Inc. | Kinase inhibitors |
| CA2602453A1 (en) * | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Kinase inhibitors |
| AU2006268265A1 (en) | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Kinase inhibitors |
| WO2007015578A1 (ja) | 2005-08-02 | 2007-02-08 | Eisai R & D Management Co., Ltd. | 血管新生阻害物質の効果を検定する方法 |
| WO2007087419A2 (en) | 2006-01-24 | 2007-08-02 | Allergan, Inc. | Substituted 3-(5-membered unsaturated heterocyclyl) -1, 3-dihydro-indol-2-one derivatives as tyrosine kinase inhibitors for the treatment of cancer |
| US7977351B2 (en) | 2006-03-22 | 2011-07-12 | Allergan, Inc. | Heteroaryl dihydroindolones as kinase inhibitors |
| ES2556173T3 (es) | 2006-05-18 | 2016-01-13 | Eisai R&D Management Co., Ltd. | Agente antitumoral para un cáncer de tiroides |
| WO2008022013A1 (en) * | 2006-08-11 | 2008-02-21 | Allergan, Inc. | Kinase inhibitors |
| CN101511793B (zh) | 2006-08-28 | 2011-08-03 | 卫材R&D管理有限公司 | 针对未分化型胃癌的抗肿瘤剂 |
| US8143410B2 (en) | 2006-11-16 | 2012-03-27 | Allergan, Inc. | Kinase inhibitors |
| US8558002B2 (en) | 2006-11-16 | 2013-10-15 | Allergan, Inc. | Sulfoximines as kinase inhibitors |
| US8969415B2 (en) | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
| KR101445892B1 (ko) | 2007-01-29 | 2014-09-29 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 미분화형 위암 치료용 조성물 |
| US8642067B2 (en) | 2007-04-02 | 2014-02-04 | Allergen, Inc. | Methods and compositions for intraocular administration to treat ocular conditions |
| US7911053B2 (en) * | 2007-04-19 | 2011-03-22 | Marvell World Trade Ltd. | Semiconductor packaging with internal wiring bus |
| CN101848895B (zh) | 2007-11-09 | 2013-10-23 | 卫材R&D管理有限公司 | 血管新生抑制物质和抗肿瘤性铂络合物的组合使用 |
| US9340555B2 (en) | 2009-09-03 | 2016-05-17 | Allergan, Inc. | Compounds as tyrosine kinase modulators |
| JP5868855B2 (ja) | 2009-09-03 | 2016-02-24 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | チロシンキナーゼ調節剤としての化合物 |
| US20110124736A1 (en) | 2009-11-09 | 2011-05-26 | Allergan, Inc. | Compositions and methods for stimulating hair growth |
| CA2802644C (en) | 2010-06-25 | 2017-02-21 | Eisai R & D Management Co., Ltd. | Antitumor agent using compounds having kinase inhibitory effect in combination |
| RU2580609C2 (ru) | 2011-04-18 | 2016-04-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Противоопухолевое терапевтическое средство |
| EP3444363B1 (en) | 2011-06-03 | 2020-11-25 | Eisai R&D Management Co., Ltd. | Biomarkers for prediciting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
| CN103304468A (zh) * | 2012-03-13 | 2013-09-18 | 华东师范大学 | 一种氧化吲哚的一锅法串联合成方法 |
| AU2013364953A1 (en) | 2012-12-21 | 2015-04-30 | Eisai R&D Management Co., Ltd. | Amorphous form of quinoline derivative, and method for producing same |
| RU2641021C2 (ru) | 2013-02-15 | 2018-01-17 | Аллерган, Инк. | Имплантат для пролонгированной доставки лекарственного средства |
| WO2014185540A1 (en) | 2013-05-14 | 2014-11-20 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds |
| EP3012248B1 (en) * | 2013-06-20 | 2019-09-11 | Institute of Radiation Medicine, Academy of Military Medical Sciences, People's Liberation Army of China | Substance having tyrosine kinase inhibitory activity and preparation method and use thereof |
| KR102329681B1 (ko) | 2014-08-28 | 2021-11-23 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 고순도의 퀴놀린 유도체 및 이를 제조하는 방법 |
| KR20250024102A (ko) | 2015-02-25 | 2025-02-18 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 퀴놀린 유도체의 고미 억제 방법 |
| AU2015384801B2 (en) | 2015-03-04 | 2022-01-06 | Eisai R&D Management Co., Ltd. | Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer |
| ES2886107T3 (es) | 2015-06-16 | 2021-12-16 | Prism Biolab Co Ltd | Antineoplásico |
| SG11201801083UA (en) | 2015-08-20 | 2018-03-28 | Eisai R&D Man Co Ltd | Tumor therapeutic agent |
| US12303505B2 (en) | 2017-02-08 | 2025-05-20 | Eisai R&D Management Co., Ltd. | Tumor-treating pharmaceutical composition |
| CN108822017A (zh) * | 2017-04-11 | 2018-11-16 | 中国医学科学院药物研究所 | 新型吲哚酮化合物及其制法和药物用途 |
| US20200197384A1 (en) | 2017-05-16 | 2020-06-25 | Eisai R&D Management Co., Ltd. | Treatment of hepatocellular carcinoma |
| AU2019352075B2 (en) * | 2018-10-05 | 2022-07-21 | Ichnos Sciences S.A. | Indolinone compounds for use as MAP4K1 inhibitors |
| CN111285872B (zh) * | 2018-12-06 | 2022-05-17 | 北京志健金瑞生物医药科技有限公司 | 吲哚-2-酮衍生物及其制备方法与用途 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5976058A (ja) * | 1982-09-20 | 1984-04-28 | フアイザ−・インコ−ポレ−テツド | １−フエニル−２（１ｈ，３ｈ）−インドロン、精神治療剤 |
| WO1999015500A1 (en) * | 1997-09-05 | 1999-04-01 | Glaxo Group Limited | Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| WO2000056710A1 (en) * | 1999-03-04 | 2000-09-28 | Glaxo Group Limited | 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
| WO2001016130A1 (de) * | 1999-08-27 | 2001-03-08 | Boehringer Ingelheim Pharma Kg | Substituierte indolinone als tyrosinkinase inhibitoren |
| WO2001027081A1 (de) * | 1999-10-13 | 2001-04-19 | Boehringer Ingelheim Pharma Kg | In 6-stellung substituierte indolinone, ihre herstellung und ihre verwendung als arzneimittel |
| JP2004517049A (ja) * | 2000-09-01 | 2004-06-10 | グラクソ グループ リミテッド | チロシンキナーゼ阻害剤としての置換オキシインドール誘導体 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966849A (en) | 1985-09-20 | 1990-10-30 | President And Fellows Of Harvard College | CDNA and genes for human angiogenin (angiogenesis factor) and methods of expression |
| US5217999A (en) | 1987-12-24 | 1993-06-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Styryl compounds which inhibit EGF receptor protein tyrosine kinase |
| AT389506B (de) * | 1988-08-04 | 1989-12-27 | Voest Alpine Maschinenbau | Verfahren und vorrichtung zum graphitieren von kohlenstoffkoerpern |
| ES2064101T3 (es) | 1990-04-02 | 1995-01-16 | Pfizer | Compuestos de acido bencilfosfonico inhibidores de la quinasa de tirosina. |
| US5302606A (en) * | 1990-04-16 | 1994-04-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase |
| WO1992020642A1 (en) | 1991-05-10 | 1992-11-26 | Rhone-Poulenc Rorer International (Holdings) Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| JPH06503095A (ja) | 1991-05-29 | 1994-04-07 | ファイザー・インコーポレーテッド | 三環式ポリヒドロキシ系のチロシンキナーゼ阻害薬 |
| JPH08503450A (ja) | 1992-08-06 | 1996-04-16 | ワーナー−ランバート・コンパニー | 蛋白チロシンキナーゼを阻害し、かつ抗腫瘍特性を有する２−チオインドール（セレノインドール）および関連ジスルフィド（セレニド） |
| US5330992A (en) * | 1992-10-23 | 1994-07-19 | Sterling Winthrop Inc. | 1-cyclopropyl-4-pyridyl-quinolinones |
| AU687727B2 (en) | 1992-10-28 | 1998-03-05 | Genentech Inc. | Vascular endothelial cell growth factor antagonists |
| GB9226855D0 (en) | 1992-12-23 | 1993-02-17 | Erba Carlo Spa | Vinylene-azaindole derivatives and process for their preparation |
| US6316635B1 (en) * | 1995-06-07 | 2001-11-13 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
| US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
| DE19824922A1 (de) * | 1998-06-04 | 1999-12-09 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| WO2000012084A1 (en) | 1998-08-31 | 2000-03-09 | Sugen, Inc. | Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| JP2002525356A (ja) * | 1998-09-25 | 2002-08-13 | ベーリンガー インゲルハイム ファルマ コマンディトゲゼルシャフト | 新規置換インドリノン、それらの調製及び薬物としてのそれらの使用 |
| US6762180B1 (en) * | 1999-10-13 | 2004-07-13 | Boehringer Ingelheim Pharma Kg | Substituted indolines which inhibit receptor tyrosine kinases |
| EP1430048A1 (en) * | 2001-09-27 | 2004-06-23 | Allergan, Inc. | 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
-
2002
- 2002-09-27 EP EP02776036A patent/EP1430048A1/en not_active Withdrawn
- 2002-09-27 US US10/256,879 patent/US6765012B2/en not_active Expired - Fee Related
- 2002-09-27 US US10/259,703 patent/US20030225152A1/en not_active Abandoned
- 2002-09-27 JP JP2003530690A patent/JP2005508336A/ja active Pending
- 2002-09-27 AU AU2002341881A patent/AU2002341881B2/en not_active Ceased
- 2002-09-27 WO PCT/US2002/030882 patent/WO2003027102A1/en not_active Ceased
- 2002-09-27 CA CA2461812A patent/CA2461812C/en not_active Expired - Fee Related
-
2004
- 2004-02-20 US US10/783,325 patent/US7015220B2/en not_active Expired - Lifetime
- 2004-07-06 US US10/886,213 patent/US7098236B2/en not_active Expired - Lifetime
-
2005
- 2005-09-16 US US11/228,780 patent/US20060025413A1/en not_active Abandoned
- 2005-11-15 US US11/274,681 patent/US7414054B2/en not_active Expired - Lifetime
-
2006
- 2006-03-31 US US11/396,036 patent/US20060194863A1/en not_active Abandoned
-
2010
- 2010-01-25 JP JP2010013326A patent/JP2010116411A/ja active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5976058A (ja) * | 1982-09-20 | 1984-04-28 | フアイザ−・インコ−ポレ−テツド | １−フエニル−２（１ｈ，３ｈ）−インドロン、精神治療剤 |
| WO1999015500A1 (en) * | 1997-09-05 | 1999-04-01 | Glaxo Group Limited | Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| WO2000056710A1 (en) * | 1999-03-04 | 2000-09-28 | Glaxo Group Limited | 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
| WO2001016130A1 (de) * | 1999-08-27 | 2001-03-08 | Boehringer Ingelheim Pharma Kg | Substituierte indolinone als tyrosinkinase inhibitoren |
| WO2001027081A1 (de) * | 1999-10-13 | 2001-04-19 | Boehringer Ingelheim Pharma Kg | In 6-stellung substituierte indolinone, ihre herstellung und ihre verwendung als arzneimittel |
| JP2004517049A (ja) * | 2000-09-01 | 2004-06-10 | グラクソ グループ リミテッド | チロシンキナーゼ阻害剤としての置換オキシインドール誘導体 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010530401A (ja) * | 2007-06-21 | 2010-09-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | インドリン−２−オンおよびアザ−インドリン−２−オン |
| JP2009057299A (ja) * | 2007-08-30 | 2009-03-19 | Nippon Soda Co Ltd | 置換フェノキシアザビシクロオクタン誘導体およびその製造方法 |
| JP2016505549A (ja) * | 2012-12-06 | 2016-02-25 | 山東亨利醫藥科技有限責任公司 | チロシンキナーゼ阻害剤としてのインドリノン誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003027102A1 (en) | 2003-04-03 |
| US20030225152A1 (en) | 2003-12-04 |
| US20050228036A1 (en) | 2005-10-13 |
| JP2010116411A (ja) | 2010-05-27 |
| US20040198720A1 (en) | 2004-10-07 |
| US6765012B2 (en) | 2004-07-20 |
| US20060194863A1 (en) | 2006-08-31 |
| CA2461812C (en) | 2011-09-20 |
| US20030199478A1 (en) | 2003-10-23 |
| AU2002341881B2 (en) | 2008-05-08 |
| CA2461812A1 (en) | 2003-04-03 |
| US7015220B2 (en) | 2006-03-21 |
| US20060063940A1 (en) | 2006-03-23 |
| US20060025413A1 (en) | 2006-02-02 |
| US7414054B2 (en) | 2008-08-19 |
| US7098236B2 (en) | 2006-08-29 |
| EP1430048A1 (en) | 2004-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508336A (ja) | キナーゼ阻害物質としての３−（アリールアミノ）メチレン−１，３−ジヒドロ−２ｈ−インドール−２−オン類 | |
| AU2002341881A1 (en) | 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors | |
| US7060844B2 (en) | (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors | |
| US8809534B2 (en) | Compounds as tyrosine kinase modulators | |
| US6747025B1 (en) | Kinase inhibitors for the treatment of disease | |
| US6559173B1 (en) | 3-(heteroarylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors | |
| US6699863B1 (en) | Kinase inhibitors for the treatment of disease | |
| ES2292329B2 (es) | Inhibidores de quinasa para el tratamiento de enfermedades. | |
| US20100168199A1 (en) | Kinase Inhibitors | |
| US7439371B2 (en) | Indol kinase inhibitors | |
| JP2011225582A (ja) | 疾患の治療のためのキナーゼ阻害剤 | |
| CN106565682A (zh) | 取代吲哚满酮衍生物及其用途 | |
| WO2003027109A1 (en) | 3-(heteroarylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20050916 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050920 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050920 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20080911 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090218 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090224 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090522 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20090522 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090529 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090623 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090630 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090723 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090730 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090824 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090924 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100125 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20100407 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20100430 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111226 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120104 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120126 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120131 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120224 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120229 |